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Cell division is one of the most fundamental processes of life whereby one cell replicates 
itself to produce two. The molecular machinery that drives and regulates this fundamental 
process has been much studied but much remains unknown. This work describes the use of 
transcriptomics analyses to identify putative new proteins involved with this process and 
subsequent attempts to prove their association with this pathway. Using the latest array 
technology, in Chapter 2 I describe studies that examine the expression of genes regulated 
during different stages of the human cell cycle. Synchronous populations of neonatal human 
dermal fibroblasts (NHDFs) were generated by serum starvation and analysed in two 
separate microarray experiments. For the first set array experiments, samples were taken 
every 6 hours for 48 hours after serum refeeding, and every 2 hours for 24 hours for the 
second experiment. Using BioLayout Express3D, network structure analyses identified four 
major clusters of gene expression patterns associated with different stages of the cell cycle: 
G0-, early G1-, late G1-, and S/G2/M-phase. By comparison with datasets of other human 
cells and tissues, the list of genes in the S/G2/M cluster was refined; genes were only kept in 
the list if they were found to be co-expressed in cells and tissues with high levels of cell 
proliferation. 706 genes that were co-expressed during S/G2/M-phase were selected for 
further analyses. Manual curation showed that 484 are known cell cycle-associated genes, 78 
are genes with putative association to the cell cycle, and 75 have known roles in other 
biological processes, whilst 69 were entirely uncharacterised genes. In order to investigate 
the 69 genes with unknown function, in Chapter 3 I describe how RNAi was used to screen 
42 of these genes to see if their knockdown resulted in an effect on cell proliferation. After 
extensive assay optimisation, endoribonuclease-prepared siRNA (esiRNA) was delivered to 
NHDF cells and the effect of knockdown determined using a real time cell analysis (RTCA) 
system. This system monitors the change in electrical resistance induced by growing cell 
populations defined as the cell impedance index (CI). Using a Z-scoring cut-off to determine 
the hits of the RNAi screening, according to the average value of cell impedance growth rate 
(CIGR i.e. a value from transformed CI), 19 of 42 genes were found to significantly affect 
the dynamics of cell proliferation, supporting a potential role in cell division. In order to 
verify that the unknown proteins localise to structures compatible with a role in the cell 
cycle, in Chapter 4 I describe protein localisation studies on 11 of 19 genes of ‘hits’ from 
Chapter 3  (we were unable to obtain clones for the other 8 genes) and other genes of 
interest. Transfection studies of HEK293T cells with expression clones containing more than 






KIAA1549L appeared to be localised to the centrosome. In order to better understand the 
context in which the novel centrosomal proteins that FAM111B might operate, in Chapter 5 I 
describe the construction of a large-scale pathway model of centrosome life cycle based on 
an extensive literature review. The model is composed of 117 of the most important 
centrosome-associated proteins and has been constructed using the modified Edinburgh 
Notation (mEPN) scheme. This model was used to better annotate the genes in the original 
S/G2/M list and understand which of the genes in the model are regulated during cell 
division. This regulatory network model of the centrosome life cycle represents an important 
summary of current knowledge and provides a useful resource for further analyses of the 
novel centrosomal proteins. 
In summary, a list cell cycle gene was derived from microarray experiments by using 
network structure analyses. Subsequent analyses filtered the genes that co-expressed during 
S/G2/M-phase narrowing down into 706 genes. Of this list, 69 genes had not previously been 
associated with the cell cycle. 42 of these unknown genes were analysed by using real time 
RNAi screening, 19 of these genes were indeed associated with the cell proliferation, and 2 
of these genes with unknown function appear to localise to the centrosome. To predict their 
involvement in the centrosome life cycle, a pathway map composed of 117 centrosome-
associated proteins were formed. Although further research is needed to determine their 
position in the centrosome life cycle, the pathway can be used for computational modelling 













All living things (e.g. plants and animals) are composed of cells. For an organism to grow 
and repair itself, cells must divide to produce two daughter cells, a process called cell 
division or mitosis. Cell division can itself be divided up into a number of distinct stages. 
First the cell must grow in size. This is a stage called gap-phase 1 (G1-phase). It must then 
copy its DNA (S-phase). There is a second gap phase (G2-phase) during which the cells 
prepare for cell division and check that all is in order before their physical division (M-
phase). Depending on conditions, cells may stop from dividing further (when they are said to 
enter G0-phase) or if conditions are favourable re-enter the cell cycle and repeat the process. 
To properly regulate the complicated biological machinery behind the cell cycle, a large 
number of proteins are involved. In the past 20 years, many of their roles in the cell cycle 
have been studied. However, some of them remain unknown. In the past, largely due to 
limitations of technology, scientists could only study particular biological events controlled 
by proteins and genes individually. Recent advancements in technology, particularly the 
development of the microarray, have revolutionized the study of cell regulatory mechanisms. 
Microarrays allow scientists to monitor thousands of biological events by detecting the 
activity (expression) of all genes at the same time. By using the latest technology, I 
performed two microarray experiments following the gene expression of human cells 
undergoing cell division. Four major groups of genes were identified whose activity was 
associated with a specific stage of the cell cycle. Of particular interest were the genes whose 
expression was associated with S-, G2-, and M-phase. By studying the expression of these 
genes in many other types of cells and tissues, I have focused on 706 genes to be of 
particular interest. By searching the published literature and online resources, many of these 
genes were found to be the known cell cycle genes, however 69 of them were previously 
uncharacterised genes. Therefore I decided to investigate the biological function of genes in 
more detail. To further investigate their role in cell proliferation, I knocked down the activity 
of a number of the uncharacterised genes to see the effect on cell proliferation using a 
technique called RNAi. Out of 42 genes tested, 19 were found to alter the rate of 
proliferation adding support to the idea that they may play a yet to be defined role in cell 
division. In order to characterise their biological function further, I localised proteins 
encoded by 11 of 19 uncharacterised genes and other genes of interest by tagging them with 
green fluorescence proteins (GFP). The location of the florescence signal was used to find 
the position of the proteins in the cells using a microscope. FAM111B and KIAA1549L 






proteins of interest may potentially be involved in the centrosome life cycle. In order to 
better understand the role of the centrosome and therefore the novel proteins associated with 
it, I have built a pathway map of the centrosome life cycle. This pathway map of the 
centrosome life cycle includes the 117 most important centrosomal proteins. However 
further experimental approaches are required to position these two unknown proteins owing 
to poor information from the published literature. In summary, I have reanalysed the gene 
expression events associated with the cell cycle, tested a number of the novel genes 
associated with the cell proliferation by RNAi screening. Two proteins with unknown 
function appeared to be involved in centrosomal activity according to their subcellular 
localisation and important in cell proliferation when their activities were turn-off. A large-
scale pathway map was developed in order to help understand their position in the 
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AAAS achalasia, adrenocortical insufficiency, alacrimia 
AKAP9 a kinase anchor protein 9 
ANAPC anaphase promoting complex 
ASPM asp (abnormal spindle) homolog, microcephaly associated  
ATAD2 ATPase family, AAA Domain containing 2  
ATP adenosine triphosphate  
AURKA aurora kinase A 
BBS4 bardet-biedl syndrome 4  
BUB1 budding uninhibited by benzimidazoles 1 
C17orf53 chromosome 17 open reading frame 53 
CaMKII Ca2+/ calmodulin-dependent protein kinase II 
cAMP cyclic adenosine monophosphate 
CC2D1A coiled-coil and C2 domain containing 1A 
CCNA2 cyclin A2  
CCNB1 cyclin B1  
CCNB2 cyclin B2 
CCND1 cyclin D1 
CCNF cyclin F 
CCP110 centriolar coiled-coil protein of 110 kDa  
CDC20 cell division cycle 20  
CDC25A cell division cycle 25A  
CDC25B cell division cycle 25B  
CDC6 cell division cycle 6  
CDC7 cell division cycle 7 
CDH1 cadherin 1 
CDK cyclin-dependent kinase 
CDK1 cyclin-dependent kinase 1  
CDK2 cyclin-dependent kinase 2 
CDK4 cyclin-dependent kinase 4 
CDK5RAP2 CDK5 regulatory subunit associated protein 2 
CDK6 cyclin-dependent kinase 6  
CDK7 cyclin dependent kinase 7 
CDKN1A cyclin-dependent kinase inhibitor 1A  
CDKN2B cyclin-dependent kinase inhibitor 2B 
cDNA complementary DNA 
CDT1 chromatin licensing and DNA replication factor 1 
CENPF centromere protein F 
CENPJ centromere protein J  
CEP120 centrosomal protein 120kDa 
CEP135 centrosomal protein 135kDa 






CEP164 centrosomal protein 164kDa 
CEP170 centrosomal protein 170kDa 
CEP192 centrosomal protein 192kDa  
CEP290 centrosomal protein 290kDa  
CEP350 centrosomal protein 350kDa  
CEP55 centrosomal protein 55kDa  
CEP57 centrosomal protein 57kDa  
CEP63 centrosomal protein 63kDa  
CEP72 centrosomal protein 72kDa  
CETN1 centrin-1  
CI cell impedance index 




CROCC ciliary rootlet coiled-coil rootletin  
CTCF CCCTC-binding factor  
DAVID database for annotation, visualization and integrated discovery 
DBF4 DBF4 Zinc Finger 
DCTN1 dynactin 1 
DERL2 Derlin 2 
DISC1 disrupted in schizophrenia 1  
DNA deoxyribonucleic acid  
DNAH2 dynein axonemal heavy chain 2 
dsRNA double-stranded RNA  
E2F4 E2F transcription factor 4  
E2F5 E2F transcription factor 5 
ER endoplasmic reticulum 
esiRNAs endoribonuclease-prepared siRNAs  
EtOH ethanol 
FA fanconi anemia  
FANCA fanconi anemia, complementation group A 
FBS fetal bovine serum  
FBXW5 f-box and WD repeat domain containing 5 
FNTB farnesyltransferase, CAAX box, beta  
FOPNL FGFR1OP N-terminal like 
FZR1 fizzy/cell division cycle 20 related 1  
GFP green fluorescence protein  
GO gene ontology  
HAUS1 HAUS augmin-like complex, subunit 1  
HEK293T human embryonic kidney 293T  
HGNC human gene nomenclature 






HIST1H1A histone cluster 1, H1a  
HOOK3 hook microtubule-tethering protein 3  
HTS high throughput system  
HUGO human genome organisation  
IFM immune fluorescent microscopy  
IL-2 interleukin 2 
ING4 inhibitor of growth family, member 4  
INK4 inhibitors of CDK4  
KATNB1 katanin p80 subunit B1  
KEGG kyoto encyclopaedia of genes and genomes  
KIF11 kinesin family member 11  
KIF15 kinesin family member 15  
KIF24 kinesin family member 24  
KIZ kizuna centrosomal protein 
KPNB1 karyopherin β1 
LTBP latent transforming growth factor  
LTBP2 latent transforming growth factor beta binding protein 2 
MAD2L1 MAD2 mitotic arrest deficient-like 1  
MAPRE1 microtubule-associated protein, RP/EB family member 1 
MCL Markov CLustering 
MCM minichromosome maintenance  
MCM6 minichromosome maintenance complex component 6 
mEPN modified Edinburgh Pathway Notation 
MNAT1 MNAT CDK-activating kinase assembly factor 1  
MT microtubule 
MTOC micro tubule-organising centre  
MYT1 myelin transcription factor 1  
MZT1 mitotic spindle organizing protein 1 
MZT2 mitotic spindle organizing protein 2 
NEBD nuclear envelope break down 
NEDD1 neural precursor cell expressed, developmentally down-regulated 1 
NHDF neonatal human dermal fibroblast 
NIN ninein 
NPM1 nucleophosmin family member 1  
NUMA1 nuclear mitotic apparatus protein 1 
ODF1 outer dense fibre of sperm tails 1  
ODF2 outer dense fibre of sperm tails 2 
OFD1 oral-facial-digital syndrome 1 
ORC origin recognition complex 
ORC5 origin recognition complex, subunit 5 
ORFs open reading frames  
PAFAH1B1 platelet-activating factor acetylhydrolase 1B regulatory subunit 1 






PCM pericentriolar material  
PCM1 protein pericentriolar material 1 
PCNA proliferating cell nuclear antigen  
PCNT pericentrin 
PLK polo-like kinase  
PLK2 polo-like kinase 2 
PLK4 polo-like kinase 4  
POC1A proteome of centriolar protein A 
POC1B proteome of centriolar protein B 
POC5 proteome of centriolar protein 5  
POLA1 polymerase (DNA directed), α1 
PP2A protein phosphatase 2 α 
PPP1CA protein phosphatase 1 catalytic subunit α  
PPP1CC protein phosphatase 1 catalytic subunit 
PPP2R1B protein phosphatase 2, regulatory subunit A, beta  
PRC1 Protein regulator of cytokinesis 1  
pre-RCs  pre-replicative complexes 
PTGS post-transcriptional gene silencing  
RAD21 double-strand-break repair protein rad21 homolog  
RAD51C RAD51 paralog C  
RBM22 RNA binding motif protein 22  
RISC RNA induced silencing complex 
RMA robust multi-array average  
RNAi RNA interference  
RRM2 protein ribonucleotide reductase M2 
RTCA real time cell analysis  
SASS6 spindle assembly 6 
SAV1 salvador family WW domain containing protein 1 
SBGN systems biology graphical notation 
SGOL1 cohesin-associated protein shugoshin-like 1 
shRNAs short-hairpin RNAs  
siRNA small interfering RNA  
SKA1 spindle and kinetochore associated complex subunit 1 
SPAG5 sperm associated antigen 5 
ssRNAs single-stranded RNAs  
STAT5A Signal transducer and activator of transcription 5A  
STIL SCL/TAL1 interrupting locus  
STK3 serine/threonine kinase 3 
SV40 simian vacuolating virus 40  
TEKT1 tektin 1 
THP-1 human acute monocytic leukemia cell line  
TM7SF2 transmembrane 7 superfamily member 2 






TP53 tumour protein p53  
TPX2 TPX2, microtubule-associated  
TSG101 tumour susceptibility 101  
TUBE1 tubulin, epsilon 1 
TUBG1 tubulin gamma 1 
TUBG2 tubulin gamma 2 
TUBGCP2 tubulin gamma complex associated protein 2 
TUBGCP3 tubulin gamma complex associated protein 3 
USP33 ubiquitin specific peptidase 33 
UTR untranslated region 
XRCC1 X-ray repair complementing defective repair in Chinese hamster cells 1 
γ-TuRC γ-tubulin ring complex 
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Chapter 1.  
The cell cycle 
Introduction to the cell cycle 
Only by duplication of parent cells is life able to continue. Cells are considered as the basic 
units of life. The concept of the cell playing a role as the basic element of the living 
organism was first suggested and officially formulated during the 1830s. This eventually 
became known as cell theory and included three basic components. Firstly, all organisms are 
composed of one or more cells [1-3]. Secondly, in all living creatures, the cell is the basic 
unit [1-3]. Thirdly, all types of cells are produced by the proliferation and division of 
parental cells [3,4]. 
Cell theory was known to biologists for over 100 years before the pioneering work of Alma 
Howard and Stephen Pelc suggested that deoxyribonucleic acid (DNA) replication was only 
activated at a particular phase of the cell cycle and did not occur during mitosis [5]. Their 
work in the broad bean (Vicia faba) suggested that the cell cycle was composed of a number 
of stages before and after cell division [6]. Based on this discovery, cell biologists were able 
to define five different stages of the cell cycle based on their features at the molecular level, 
including G0-phase (gap with 0 growth), G1-phase (gap 1 phase), S-phase (DNA synthesis), 
G2-phase (gap 2 phase), and M-phase (mitosis) (Figure 1.1). The cycle of cell duplication 
and division is therefore termed the cell cycle and is the essential mechanism by which all 
living creatures reproduce.  
Eukaryotic cells have a complicated regulatory network of proteins controlling the cell cycle. 
The aim of this regulation is to accurately duplicate the DNA in chromosomes and then 
conduct the segregation of sister chromatids into two daughter cells (Figure 1.1). The cell 
cycle is composed of two major phases, interphase and M-phase (Figure 1.1). Interphase is 
composed of G1-, S-, and G2-phase (Figure 1.1). M-phase can be divided into prophase, 
prometaphase, metaphase, anaphase, telophase, and cytokinesis (Figure 1.1). During 
cytokinesis, the cytoplasm of a parental cell is physically divided into the two daughter cells. 
For typical mammalian cells, the interphase might require 23 h of a 24 h long cell cycle with 
M-phase taking one hour to complete.  
In preparation for S-phase, most cells require time to grow and increase their amounts of 





This is called the G1-phase. The duration of G1-phase is between 8 and 16 h for most rapidly 
dividing cell lines (doubling time < 30 h) [7] e.g. the doubling time of fibroblast is 
approximately 25 h [8]. In contrast, some transformed cells e.g. acute monocytic leukemia 
cell line (THP-1) have longer doubling times between 60 and 70 h [9]. For DNA duplication, 
S-phase needs less than 8 to 12 h, G2-phase requires less than 2 to 4 h, and less than one hour 
is needed for cytokinesis [7,10].   
 
Figure 1.1: The eukaryotic cell cycle is divided into a number of stages. Two gap phases (G1 and 
G2) allow cell growth in preparation for DNA duplication and chromosome segregation during 
interphase. DNA duplication is triggered after G1-phase and finished by the end of the S/G2 border, 
M-phase is composed of four stages, Prophase, Metaphase, Anaphase, and Telophase. This figure is 
courtesy of BD Biosciences Inc. [11]. 
Cell cycle control system  
The system controlling the cell cycle responds to the internal and external environment of 
the cell determining the progression or delay of the cell cycle (Figure 1.2). Progression 
through each phase of the cell cycle is monitored by checkpoints that can detect problems 
with cell growth, DNA replication, and mitotic sister chromatids segregation.  
These checkpoints are comprised of signalling cascades, which can block the progression of 
the cell cycle until recovery has been achieved. The first checkpoint, called the ‘start 
checkpoint’, is positioned at late G1-phase, where the conditions, i.e. cell size, nutrients 
supplied from the environment and DNA integrity, determine whether the cell commits to 







Figure 1.2: Cell cycle control and the checkpoint system. This diagram depicts the checkpoint 
system that can detect irregular biological events and block the progression of the cell cycle.   This 
figure was adapted from ‘The Cell Cycle, principle of control’ by Dr. D. O. Morgan [13]. 
The G2/M-checkpoint is the second checkpoint that controls initiation of events at an early 
stage of M-phase that eventually lead to alignment of duplicated chromosomes at metaphase 
(Figure 1.2). The size of cells and DNA duplication determine whether the cell commits to 
enter M-phase. The third checkpoint is located at the transition between metaphase and 
anaphase, and monitors the segregation of sister chromatids. The attachment between the 
mitotic chromosomes and spindles determines whether the cell commits enter the cytokinesis 
(Figure 1.2). Inappropriate environments that restrict cell growth result in blocking the cell 
cycle at the checkpoint near G1/S border [12]. Incomplete DNA duplication blocks the cell 
cycle at G2/M-checkpoint [14,15]. During the last checkpoint (i.e. metaphase to anaphase 
transition), the duplicated sister chromatids are segregated into two daughter cells, 
committing a cell to be divided into two daughter cells (Figure 1.2) [16,17]. 
Cyclins and CDKs  
Little was known about the complexity of the cell cycle regulatory network until the 
discovery of cyclins in the 1980s [18,19]. Mitotic cyclins were first identified in sea urchins, 
the synthesis and periodic degradation of these proteins were detected shifting between 
interphase and M-phase [20]. These proteins were given their name because of their 
periodical synthesis and degradation through different phases of the cell cycle [20].  
Cell cycle regulation is driven by a family of cyclins and their corresponding cyclin-
dependent kinases (CDKs). It is known that various combinations of cyclins and CDKs 
trigger the progression of the cell cycle through its different phases [21]. In contrast to the 
cyclins, which are periodically synthesized and degraded, the level of CDK proteins remains 










Figure 1.3: Periodical regulation of Cyclin/CDK complexes in the cell cycle. A) Activity of the 
cyclins in different phases of the cell cycle. B) Cyclins and their partner CDKs during different stages 
of the cell cycle. This figure was adapted from ‘The Cell Cycle, principle of control’ by Dr. D. O. 
Morgan [13]. 
The levels of cyclins periodically change between different phases of the cell cycle 
determine the assembly and activation of cyclin/CDK complexes, activating downstream 
biological processes via phosphorylation. In eukaryotic cells, four cyclins are heavily 
involved in the progression of the cell cycle, G1-cyclin (Cyclin D), G1/S-cyclin (Cyclin E), S-
cyclin (Cyclin A), and M-cyclin (Cyclin B).  
This regulatory network, composed of cyclin/CDK complexes, is therefore able to schedule 
the activities of cell cycle events. To control the activities of cyclin/CDKs complexes, CDK 
inhibitors (CKIs) negatively regulate the cell cycle by targeting CDKs. Further details of the 
biological events conducted by cyclins/CDKs will be introduced in following paragraphs. 
G0-phase 
G0-phase is a stage in the cell cycle where the cells are positioned in a quiescent state. The 
cells enter the G0-phase in response to the shortage of nutrients or due to a lack of growth 
factor signalling. The quiescent stage is also defined as a reversible cell proliferation arrest 
where the cell cycle machinery is silent. Current studies indicate that a specific set of genes 
is up-regulated in a ‘quiescent program’, which ensure the cells remain in a non-dividing 






G1-phase is the first stage in the cell cycle. During this early stage in interphase, the cell 
increases its size and generates enough proteins, preparing for DNA replication and 
centrosome duplication for mitosis. During G1-phase, cyclin D is synthesised, driving the 
transition between G1- and S-phase. The cascade of cyclin D regulation is initiated by its 
binding to cyclin-dependent kinase 4 (CDK4) or cyclin-dependent kinase 6 (CDK6). The 
cyclin D/CDK4/6 complex is involved in the activation of transcriptional activator E2F, 
cyclin E, A, and cell division cycle 25A (CDC25A). The self-activation of E2F sets a 
positive-feedback loop, which enhances the activation of the cell cycle-regulated proteins 
mentioned above.    
At the end of G1-phase, CDC25A is involved in the activation of the cyclin E/cyclin-
dependent kinase 2 (CDK2) complex, driving the cell cycle to pass through the restriction 
point (i.e. the first checkpoint in the cell cycle, see Figure 1.2), which results in an 
irreversible commitment to cell cycle entry. The level of cyclin E is reduced after the cell 
enters S-phase. Cyclin D also coordinates with cyclin E during the later stages of G1-phase to 
regulate progression to S-phase.  
Before entering the S-phase, DNA damage (if present) activates the CKIs and blocks the cell 
cycle at the G1-phase checkpoint until the damage is repaired e.g. inhibitors of CDK4 (INK4) 
family members (i.e. p15, 16, 18, and 19) specifically target CDK4 and 6, blocking the cell 
cycle [23]. Cip/Kip family members (i.e. p16, p21, and p27) inhibit activities of all CDKs 
combined with cyclins [24].  
The centrosome duplicates when a cell enters the cell cycle. The cyclin E/CDK2 complex 
not only triggers the transition between G1- and S-phase but also initiates the centrosome 
duplication indirectly. In order to prepare for centrosome duplication, the polo-like kinase 2 
(PLK2) catalyses the phosphorylation of protein nucleophosmin family member 1 (NPM1), 
shuttling it into the unduplicated centrioles, and licenses the development of cartwheel 
structure in G1-phase [25]. 
S-phase 
During S-phase, the cell cycle control system is heavily involved in chromosome [26,27], 
histone [28], and centrosome duplication [29,30], regulating by cyclin/CDK complexes. In 
eukaryotic cells, linear chromosomes are giant structures composed of DNA and proteins 







Figure 1.4: Cyclin conducted chromosome duplication in S-phase. Preparation for chromosome 
duplication is triggered in G1-phase when pre-RCs (pre-replicative complexes; see green ellipses) are 
recruited to the origins of replication (see blue line). During S-phase, activity of S-CDKs mediates the 
development of preinitiation complexes by unwinding the dsDNA at origins. DNA duplication occurs 
at the moving replication forks. Duplicated chromosomes are segregated during M-phase. Blue lines 
represent the replication origins. Orange lines represent the original template strand. Red lines 
represent newly synthesized DNA. This figure was adapted from ‘The Cell Cycle, principle of 
control’ by Dr. D. O. Morgan [13]. 
The biological processes combined with the CDKs regulation are shown as a flowchart in 
Figure 1.4. In G1-phase, the binding of pre-replicative complexes at multiple replication 
origins is preparation for the DNA duplication. During S-phase, activated S-phase CDKs 
conduct the formation of preinitiation complexes triggering the DNA duplication, following 
the replication forks. DNA duplication is completed by the end of S-phase as sister 
chromatids undergo condensation. In M-phase, activated M-phase CDKs conduct 
chromosome segregation until cell division is finished.  
DNA replication starts at numerous ‘origins of replication’ on chromosomes, at specific 
DNA sequences with high AT content where replication is physically triggered [31]. To start 
DNA duplication, initiator proteins bind to the origin positions and helicase works to unwind 
the double helix of DNA. Duplication enzymes are then loaded onto the single stranded 








Figure 1.5: Initiation of DNA replication. At the early stage of the G1-phase, CDC6 and CDT1 are 
both located near to the ORC and are then combined with the MCM resulting in the development of 
the pre-RC. During S-phase, the increase of S-CDK activity triggers the assembly of preinitiation 
complex binding at the origin of DNA replication. To avoid the reduplication of dsDNA, S-CDKs also 
targets and triggers the degradation of CDC6 by phosphorylation. In addition, CDT1 is inactivated by 
the protein geminin. This figure was adapted from ‘The Cell Cycle, principle of control’ by Dr. D. O. 
Morgan [13]. 
In order to avoid the re-duplication of chromosomes during the cell cycle, DNA duplication 
is divided into two major steps. Firstly, the proteins of pre-RC are recruited at origins of 
replication (Figure 1.5). The pre-RC recruitment not only licenses the initiation of DNA 
duplication but also guarantees the duplication only starts from the location, where the pre-
RC is located. Secondly, the accumulation of pre-RC located on the DNA results in the 
formation of the pre-initiation complex (Figure 1.5).  The DNA helix is then unwound by 
pre-initiation complex in preparation for the loading of DNA polymerases onto the single 
stranded DNA and to commence the DNA duplication. The pre-RC is then permanently 
dissociated from the binding sites on DNA without any reassembly (Figure 1.5) [32].  
Figure 1.5 shows the regulatory network involved at the beginning of DNA duplication [33]. 
During G1-phase, the ORC binds to the replication origins. CDC6 and CDT1 bind to a 
position nearby the ORC on DNA to form a large pre-RC complex and then recruits the 
minichromosome maintenance (MCM) complex. The binding of pre-RC licenses DNA 
replication to proceed. The MCM complex proteins are thought to unwind the DNA 
functioning as the major DNA helicase. This means that the aim of pre-RC is to recruit the 





In S-phase, once the assembly of pre-RC is finished, DNA duplication is ready to start from 
the ORC’s DNA. Activated S-CDKs that arise just after the G1/S border recruiting a number 
of additional protein complexes to become a giant pre-initiation complex unwinding the 
DNA helix and starting DNA duplication. A high level of S-CDKs also induces the 
dissociation of pre-RC located at the origin.  
Phosphorylation of the ORC and CDC6 by S-CDKs inhibit their function to initiate DNA 
duplication. In addition, anaphase progress complex (APC/C) is involved in the termination 
of pre-RC recruitment at the end of G1-phase. Between the end of mitosis and early stage of 
G1-phase, the protein geminin is destroyed by APC/C. The regulation between CDKs and 
duplication-regulated proteins (i.e. pre-RC) guarantee that DNA duplication can only be 
triggered once per cell cycle [32]. By the end of S-phase, duplicated DNA is undergoing the 
establishment of sister chromatid cohesion [35]. This is a process where the cohesin ring 
pairs sister chromatids together until metaphase, facilitating the attachment of mitotic 
spindles onto the chromosomes [35]. 
It is interesting that the centrosome and chromosome duplication share similar principles, 
in that they are semiconservative and controlled by S-phase cyclins/CDKs complexes 
[29,30]. In addition, the centrosome duplication is tightly controlled to allow only one 
duplication per cell cycle [36]. During S-phase, the activation of cyclin A and E in 
combination with CDK2 initiate centrosome duplication [29,37-41]. Duplication of the 
daughter centriole starts from the proximal end (cartwheel structure) to the distal end, which 
is surrounded by 9-fold symmetrical triplicate microtubules (Figures 1.6C and D). Matured 
daughter centrioles are surrounded by pericentriolar material (PCM). Owing to the 
complexity of the centrosome’s structure and duplication, this is discussed in more detail in 
chapter 5. 
G2-phase 
G2-phase is the final stage of interphase and takes place before the cell enters mitosis. This 
ends at the early stage of prophase whilst the duplicated DNA is undergoing condensation, 
preparing the cells for sister chromatid segregation in M-phase. In preparation for 
chromosome segregation, a matured daughter centriole separates from the mother centriole, 
giving two centrosomes.  
It is interesting that the transition between G2-phase and mitosis is determined by the activity 





DNA duplication and accumulates in the cytoplasm throughout the G2-phase whilst binding 
with CDK1. Chromosome duplication failure activates the p21 and blocks the cell cycle at 
the G2/M checkpoint until the damaged DNA is repaired. The activated p21 targets the cyclin 
B/CDK1 complex in the nucleus [42].  
M-phase 
The cyclin B/CDK1 complex regulates the final stage of the cell cycle i.e. the mitosis. Firstly, 
the cyclin B/CDK1 complex plays a remarkable role to initiate the nuclear envelope break 
down (NEBD). Secondly, the cyclin B/CDK1 complex mediates the condensation of sister 
chromatids into compact, rod-like shapes. In addition, the cyclin B/CDK1 complex conducts 
the assembly of the mitotic spindle ensuring that the sister chromatids are equally segregated 
into two daughter cells.  
In association with the cyclin B/CDK1 complex, the family of polo-like kinase (PLK) are 
involved in the regulation of the centrosome during M-phase. For example, CDK1 and PLK1 
are both involved in the regulation of centrosomal protein 55kDa (CEP55) [43-45] and 
kinesin family member 11 (KIF11) [46]. CEP55 governs the physical division of cells during 
cytokinesis. KIF11 is a protein that moves along the microtubule (MT) filaments i.e. mitotic 
spindle, by using the energy from adenosine triphosphate (ATP). KIF11 regulates the 
extension of microtubules attaching to sister chromatids [46]. Both the cyclin B/CDK1 
complex and centrosomes are important in determining a well-organized chromosome 
segregation during M-phase and cytokinesis. In M-phase, cyclin A is later degraded during 
metaphase of mitosis. Owing to the fact that the centrosome is heavily involved in the 
regulation of mitotic activities, the centrosome will be introduced first and then its role in 
mitosis. 
The centrosome 
The centrosome is known to be the centre of primary microtubule-organisation in animal cell 
and was first described at the end of 19th century. The centrosome governs the motility, 
adhesion and polarity of cells during interphase. The centrosome also regulates the spindle 
assembly during mitosis. Failure in the organisation of the spindle pole results in many 
cancers owing to the genomic instability [47]. This is because extra or abnormal centrosomes 
can lead to unequal chromosome segregation [48]. Therefore, a tight control of centrosome 





The role and importance of the centrosome was discovered in the end of the 19th century by 
Boveri who sensed the connection between the number of centrosomes and cancer. 
Centrosome duplication during S-phase was then discovered in the 1980s [49]. To better 
understand the centrosome life cycle, centrosome development, duplication, and maturation 
is described here.  
The major function of the centrosome is to conduct microtubule (MT) nucleation working as 
a microtubule organisation centre (MTOC). In connection with the centrosome by their 
negative end, MTs are able to provide the support for cytoskeleton influencing the cell 
polarity. In order to maintain the position of MT-connected organelles in the cells, as the 
supporter of MT, the centrosome is localised close to the nucleus.  
The structure and localisation of the centrosomes has been studied with the help of electron 
microscopy (Figures 1.6A and B). A regular centrosome is composed of a mother and a 
daughter centriole surrounded by PCM, which is an electron-dense matrix. The mother 
centriole has distal appendages anchoring the centrosome at a fixed position on the cell 
membrane [50]. Subdistal appendages govern the nucleating of the microtubule network [51]. 
The matured centrosomes conduct chromosome segregation during M-phase [52]. 
Mitosis 
Mitosis is composed of five stages according to the state of centrosome regulation including 
prophase, prometaphase, metaphase, anaphase, and telophase.  
Prophase  
Prophase is the stage where the sister chromatids are compacted, undergoing chromosome 
condensation. It is also the stage where the microtubules are assembled, conducted by the 
centrosome (Figure 1.7). In early prophase, the CDC25B and C are involved in the activation 
of cyclin B/CDK1 by removing the inhibitor WEE1 (i.e. G2/M checkpoint kinase) and 
myelin transcription factor 1 (MYT1) kinase. Activated cyclin B/CDK1 is then involved in 
the initiation of NEBD and spindle assembly conducted by centrosomes. 
During chromosome condensation, the condensins are activated by cyclin B/CDK1 complex 
to gradually compact a mass of partially catenated DNA into visible chromosomes [53,54]. 
Sister chromatids are attached to each other at the centromere, resulting in the X-shape 
(Figure 1.7A). Meanwhile, two centrosomes move to the opposite poles in the cytoplasm 
(Figure 1.7A). They initiate the microtubule assembly by recruiting the γ-tubulin, which 
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Figure 1.6: Structure of the centrosome and location in cells. A number of the best examples 
demonstrate the development of the centrosome and localisation in cells. A) The interphase 
centrosome including a mother and daughter centriole at longitudinal section. This figure is courtesy 
of Pihan et al., 2013 [52]. B) The development of a mother centrosome is shown in a cartoon flow 
chart. This figure is courtesy of Kitagawa et al., 2015 [55]. C) Cartoon graphic in 3D and images of 
protein localisation to demonstrate the structure of interphase and mitosis centrosomes. Chromosome 
is labelled with DAPI (blue). F-actin is stained by phalloidin (red) colour.  GFP signal is the 
centrosome where the arrow pointed. This figure is courtesy of Fukasawa et al., 2007 [56]. D) 
Longitudinal and cross section of the mother centrosome structure. This figure is courtesy of 
Azimzadeh et al., 2010 [57]. 
Prometaphase  
Prometaphase is the second phase of mitosis where the nuclear envelop dissociates into 
numerous ‘membrane vesicles’. It is also the stage where the mitotic spindles attach to the 
outer kinetochores on the sister chromatids (Figure 1.7B). The outer kinetochore is the area 
where the mitotic spindle connected with. The inner kinetochore is strongly connected with 






Metaphase is the third stage in mitosis, where chromosomes are at the most condensed stage. 
During this stage, the mitotic spindle emerges from two centrosomes and attaches the 
kinetochore at opposite sites. Chromosomes are aligned at the equator of the mitotic spindles, 
which are equally positioned between the two centrosomes (Figure 1.7C). This is due to the 
equal pulling force from opposite mitotic spindles.  
The metaphase to anaphase checkpoint senses whether the mitotic spindles have properly 
attached to chromosomes (Figure 1.7C). Only when all chromosomes are properly attached 
to mitotic spindles and are aligned in the middle between the two centrosomes, will the 
checkpoint allow the transition between metaphase and anaphase.  
The cyclin B/CDK1 complex activates the securin, which inhibits the separase activity by 
binding with it. Without the targeting from separase, the cohesin ring is able to pair sister 
chromatids together until the end of metaphase. The increase in Ca2+ activates the Ca2+/ 
calmodulin-dependent protein kinase II (CaMKII), mediating the activation of APC/C. 
Activated APC/C is then involved in the deactivation of cyclin B/CDK1 complex by 
degrading cyclin B, leading to the breakdown of the cohesin ring, preparing for chromosome 
segregation in anaphase [59]. The cyclin B/CDK1 complex is also involved in the metaphase 
arrest, ensuring the sister chromatids are properly attached to the mitotic spindle.  
Anaphase  
Anaphase is the stage where sister chromatids are segregated to the opposite poles of a cell. 
In addition to the regulation of cyclin B, the APC/C is also involved in the disassociation of 
sister chromatid cohesion by destroying the securin [60]. Paired sister chromatids, attached 
with the mitotic spindles, are pulled to opposite poles after the cohesin ring is dissociated 
abruptly (Figure 1.7D).  
Telophase 
Telophase is the final stage in mitosis where the interphase nuclear envelope is reformed and 
a mitotic cell is physically divided into two daughter cells. Materials for reshaping of the 
nuclear envelope are provided by parts of the endoplasmic reticulum [61]. The nucleoli also 
reappear following the reforming of the interphase nuclear envelope (Figure 1.7E). Once the 
reforming of the nuclear envelope is completed, the mitotic spindles start to be disorganized 








Figure 1.7: Summary of the morphological changes of centrosomes in mitosis. The centrosome is 
heavily involved in the M-phase regulation. A) The mother and daughter centrosomes are separated 
moving to opposite poles in early prophase. B) In prometaphase, the centrosomes initiate the spindle 
assembly and extension. C) In metaphase, the spindle checkpoint sense the proper attachment between 
the aligned sister chromatids and mitotic spindle, determining the transition between metaphase and 
anaphase. D) Anaphase chromosomes are pulled to opposite poles, whilst the mitotic spindles are 
contracting. E) The contracting of contractile ring physically F) divides the cell into two daughter 
cells, whilst the nucleus reform starts. G) The cytokinesis is completed, resulting in interphase cells. 
This figure is courtesy of Berridge et al., 2014 [62]. 
Cytokinesis 
Once mitosis is finished, cytokinesis ensures the equal separation of cells. Cytokinesis 
initiates with the development of the contractile ring, which leads to the accumulation of 
cleavage furrow. The cleavage furrow is the final connection of the cell membrane between 
two daughter cells undergoing cell division (Figure 1.7F).  
The contractile ring is attached to the cell membrane. Before two daughter cells are 
completely separated, a structure called the midbody maintains the final association between 
the two daughter cells (Figure 1.7F). In the last stage of cytokinesis is abscission 
disassociates the cell membrane connected by midbody. CEP55 is activated by CDK1 to 





In summary, during cell proliferation and division, a large number of genes are periodically 
expressed to regulate this complicated regulatory network. By the end of the 1990s, array 
technologies were developed to monitor cell cycle-associated genes in parallel. Hence 
microarrays have played an important role in the study of the cell cycle at the transcriptional 
level. The history of array technology application will be discussed in following paragraphs 
including approaches used to identify the cell cycle-associated genes. 
Transcriptomic analyses of the cell cycle 
The availability of large-scale genetic information from whole genome sequencing 
technologies revolutionised the study of gene expression from the single gene to whole 
transcriptome level. This information was used to develop microarray technology. 
Microarrays evolved from a technique called Southern blotting and the first microarray was 
made by attaching an array of microscopic DNA spots to a solid face [65]. Microarrays can 
be used to monitor the expression level of huge number of genes at once. The probe can 
include a short sequence of a gene, which hybridises with a target (cDNA) [65]. The cDNA 
is reverse transcribed from isolated mRNA from cell or tissue samples. The hybridisation of 
the probe and target generates a signal, which is detected by a digital optical sensor [65]. The 
strength of the signal is used to determine the quantity of cDNA sequences in the target and 
consequently the level of expression of the relevant gene. For further detail of the history of 
the array technology development will be shown in the following paragraphs. 
A brief history and principles of microarrays  
Microarray technology 
In 1975, the first array was created by plating E. coli containing different clones in an array 
format on agarose plates before transferring to a nitrocellulose filter; transferred clones were 
lysed releasing denatured DNA which was used to be hybridised with radioactively labelled 
RNA [66]  (Figure 1.8A).  
In 1979, the array production method was improved using robotic arms to spot a total 
number of 1,728 E. coli on to a 26 x 38 cm microtiter plate to increase the density of spots 
(Figure 1.8B). The concept of spotting techniques on filter papers was developed further in 
following years. For example, in 1980, the filter based array was used to identify the 
transcriptional activity of genes cloned in plasmids [67]. In 1986, the technique was used to 
study of single nucleotide polymorphisms (SNPs) by hybridising with chemically 
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Figure 1.8: Radioactive monitoring of the RNA hybridisation with DNA probe on filters. A) A 
handmade array by Bumgarner et al., 2013 [66].  B) A machine printed array by Gergen et al., 1979 
[69]. C) Assembly line manufactured array by Craig et al., 1990 [70]. 
In 1990, an assembly line was used to generate filter based arrays in large quantity, 
commercialised robot arms were used to spot E. coli from microtiter plates to filters (Figure 
1.8C) [70].  In 1992, oligonucleotide DNA probes were directly attached a glass support and 
facilitated more sensitive detection [65].  
Since the first array was created in the 1970s, the development of DNA array technologies 
has evolved rapidly. For example, the oligonucleotide sequence can be designed to target 
specific regions of the genes of interest, enhancing the accuracy of probe hybridisation [66]. 
Array technologies can be summarised into three basic categories from the 1990s to the early 
2000s and are discussed below.  
Spotted arrays 
The spotted array consists of synthesised oligonucleotides or PCR products used to target a 
set of genes of interest spotted on a chip at high density (Figure 1.9A). The spotted array 
allows flexibility and the array could be customised according to the experimental design. 
This technology allowed a very high density of probes to be spotted on poly-lysine coated 
glass supports by using slotted pins, these are similar to the structure of fountain pens 
(Figure 1.9B) [71]. Just by a single dip of a pin into a given DNA solution, this system can 
equally spot it on multiple arrays, allowing samples to be fluorescently labelled (Figure 
1.9A).  
In comparison with the radioactive labelling system, fluorescent labelling has a number of 
advantages. First, the fluorescent signal released is highly sensitive as the signal has a fairly 





and complexity of the fluorescent labelling system is less expensive than the radioactive 






            
 
Figure 1.9: Fabrication of the spotted array. A) Chemically synthesised probes were spotted on the 
solid surface of an array prior to the hybridisation of samples. This figure is courtesy of The Scripps 
Research institute [72]. B) Probes are spotted on the solid face of an array. This figure is courtesy of 
Bumgarner et al., 2013 [66]. 
In-situ synthesised arrays 
The in-situ synthesized array is produced using modern photolithographic technologies 
where the probes are generated in parallel using a number of approaches, these include solid-
phase synthesis [73], photolabile protecting groups [74], and photolithography [75] to 
conduct the chemical synthesis [74]. By combining these 3 technologies, light directed 
chemical synthesis probes can be directly generated on the array (Figure 1.10) [74].  
Encouraged by the successful approach in 1991, the company called Affymetrix was 
founded by Dr. Stephen Fodor.  In 1994, the in-situ synthesized array was commercialised 
by Affymetrix, demonstrating that a total number of 256 unique octa-nucleotides can be 
fabricated on a 1.28 cm2 array [76].  
The major advantage of modern photolithographic techniques is that the DNA probes are 
directly synthesised on the solid face of an array, allowing the fabrication of a complex array 
with a high density of probes (Figures 1.10A and B). In contrast, the disadvantage of spotted 
arrays is that a large number of cDNAs or PCR products need to be generated, purified, 
quantitated, and catalogued prior to probe spotting [77]. In addition, if some of the probes 
are generated from a cDNA library at low quantity, additional normalisation may be required 
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Figure 1.10: Modern photolithographic techniques. A) The processes of light directed 
oligonucleotide synthesis. The photolabile protection provided by the mask determines the sequence 
of probe synthesis. B) Schematic representation of the array-making device, including the lamp, 
mask, and array (chip). C) Gene expression level monitored by an in-situ synthesised array. D) The 
design of array and probes. The probes are chosen from the 3’ end of messenger RNA (mRNA) (i.e. 
near the poly A tail), which avoids the selection of partially degraded mRNA. Signals from perfect 
matches (PM) and mismatches (MM) are used to increase the quantitative accuracy. These figures are 
courtesy of Lipshutz et al., 1999 [75]. 
However, there are disadvantages when using spotted arrays, the probes are attached onto the 
charged lysine side chain of the spotted array by an interaction with the negatively charged 
phosphate back-bone of cDNA, and this interaction is thought to minimise the 
conformational freedom of attached cDNA probes, potentially reducing their affinity for 
complementary targets [77]. 
In the family of in-situ synthesized arrays, each array product requires a unique set of 
photolithographic masks to fabricate the DNA probes by directing the light to the array 
during different steps. As some of the probes are redesigned, the entire set of 
photolithographic masks must be reproduced, which increases the cost of production and 
limits the flexibility of each model of array.  
In 2002, the micro-mirrors technology was developed by Nimblegen Systems Inc., which 





digital light processor (DLP) to project a pattern of UV light (Figure 1.11) [78]. This digital 
mask provides another solution to generate the array without expensive and time-consuming 
photolithographic masks [78]. 
 
Figure 1.11: Schematic of the digital light processor (DLP). This is an illumination system with a 
UV light source. Filtered UV light is projected to the digital micro-mirror array, where the computer 
determines the sequence for oligonucleotide synthesis. The projection system accepts the UV light 
from the digital micro-mirror array and projects to the solid support of the DNA chip (microarray) 
and conducts the probe fabrication on the array. This figure is courtesy of Singh-Gasson et al., 1999 
[79]. 
The GeneChip developed by Affymetrix is the best example of signal channel arrays. The 
GeneChip is used to detect gene expression level by using a single labelling scheme for 
cDNA samples. For each probe set, there is a collection of probe pairs targeting a gene of 
interest. In general, a probe set includes 11 to 20 probe pairs, and each probe is a 25-mer 
oligonucleotide. Each pair of probes contains a complementary sequence to match the gene 
of interest perfectly, which is also called PM (Figure 1.10D). In contrast, another pair of the 
probes are designed as a control, which is used to discriminate non-specific match i.e. MM 
(Figure 1.10D). 
Inkjet printing arrays 
In 1996, the innovating inkjet printing technology allowed direct conduction of the synthesis 
chemistry on the solid face of arrays [80]. The inkjet printer is used to place nucleoside 
phosphoramidite (i.e. nucleotides used to synthesise probes) on the array, where the solid 





The hydrophilic region allows the coupling of phosphoramidites dropped by inkjet printers 
to synthesize oligonucleotide probes (Figure 1.12).  
  
  
Figure 1.12: In-situ synthesis of the printing process of inkjet arrays. A) First layer of nucleotides 
are printed on the hydrophilic section on the array solid surface. B) Multiple layers of nucleotides are 
printed to fabricate the DNA probes. C) and D) show the transition between one nucleotide being 
added to the chain to induce chemical synthesis. These figures are courtesy of Agilent microarray 
technology [81]. 
This technology was eventually improved, commercialised, and licensed to Agilent 
Technologies in 2001 [82]. The inkjet array shares the advantages of the Affymetrix arrays 
where they both directly synthesis the oligo nucleotides on the solid face directly. This 
technology was used to fabricate the probes for their array products until present. 
Self-assembled arrays 
In comparison with the array technologies discussed above, an alternative design of the array 
construction (i.e. the self-assemble array) was created by a group based in Tufts University 
lead by David Walt [83-86]. This technology was later licensed to Illumina. 
The self-assembled array is a technique that attaches the DNA probes onto small 
polystryrene beads. These beads are deposited on wells, created by etching the end of optic 
fibres and assembled together as a fibre optic array (Figures 1.13A, B, and C) [87]. The 





distal end where the fluorescence microscope magnifies the signal and projects onto a 
charged-couple device (CCS) camera [87].  
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Figure 1.13: Structure of typical self-assembly arrays, labelling of beads in early and later 
version arrays. A) The structure of assembled optic fibres, containing 50,000 to 60,000 fibres. B) 
Etched end of an array of optical fibres. C) Beads loaded into wells.  D) Localisation of randomly 
loaded beads by a sequential hybridisation process is demonstrated by taking a single bead as an 
example. The fluorophore signal is switched to different colours at different stages, resulting in E) a 
combination of binary digit code (i.e. 010101). Each unique combination of binary digit code 
represents a specific probe, providing the information for the target DNA samples. These figures are 
courtesy of Walt D.R. et al., 2006 and Gunderson et al., 2004 [87,88]. 
In early versions of this technology, the position of each probe was identified by labelling 
with different fluorophore combinations (i.e. fluorescent chemical compounds that can 
release signal by light excitation) [83-86]. However, this labelling system limited the 
maximal number of unique beads that can be localised. Therefore, the later version of the 
self-assembled arrays localise each unique bead by decoding the signal flash of fluorescently 
labelled oligonucleotide tags, which are sequentially released in a series of steps with 
different combinations (Figures 1.13D and E) [88]. 
Testing cell cycle synchronisation before studying transcriptional regulation in 
the cell cycle by microarray technologies 
The transcriptional and post-transcriptional regulation of genes is important in the regulation 





cell cycle, we can investigate particular biological events and their consequences to cell 
proliferation. This means that to identify the genes that are up-regulated in the cell cycle, 
cells must be synchronised before their periodical expression levels can be monitored by 
microarray [89]. Many studies have investigated cell cycle regulation in this way including 
in budding yeast [90,91], fission yeast [92], Gram-negative bacteria [93], HeLa cells [94], 
mouse embryonic fibroblasts [95], and human fibroblasts [22,96-98].  
Array analyses can be used to identify cell cycle-associated genes in human cells  
By investigating transcriptional control we can determine how cell cycle-associated proteins 
are regulated. The first microarray analysis used to identify human cell cycle-associated 
genes was performed in 1999 (Table 1.1) [96]. This pioneering work utilised the serum 
refeeding technique, validating the methodology and efficiency of this technique for 
investigating transcriptional regulation of the cell cycle.  
Cluster analysis of human fibroblast cells suggested that 517 of 8,613 human genes 
represented on the array were up-regulated in response to the refeeding of serum [96]. 224 of 
the 517 genes were previously uncharacterised genes suggesting they may have a putative 
function in response to serum refeeding (Table 1.1). Of the remaining genes with known 
functions, 25 cell cycle-regulated genes were identified.  
In addition, genes encoding G0-CDKs that inhibit cell proliferation, were shown to be up-
regulated in samples of cells harvested at a quiescent stage [22]. These findings validated 
that serum deprivation can block cells at G0-phase. After serum refeeding, up-regulation of 
cyclin and CDK genes encoding protein from the S- and M-phase indicated that serum 
deprived fibroblasts respond as expect to serum refeeding.  
The success of the first microarray analysis in identifying characterised and uncharacterised 
genes with a role in human cell proliferation gave rise to numerous subsequent studies 
(Table 1.1).  Cho RJ, et al., 2001 used double thymidine-blocks to halt human fibroblast at 
S-phase temporarily, before releasing them to generate a large population of synchronised 
cells [97]. They also used enrichment analysis to classify the biological function of cell-cycle 
associated genes. Of 6,800 genes monitored by microarray, 731 genes were clustered with 
cell cycle-regulated genes according to their expression pattern. For 344 of 731 genes, little 
functional information is available (Table 1.1) [97]. 
In another study from 2002, HeLa cells were used to identify genes that are expressed during 





different techniques; 1) double-thymidine block, 2) thymidine-nocodazole block, and 3) 
mitotic shake-off. The thymidine-nocodazole and mitotic shake-off arrested the cells at M-
phase while double thymidine arrested the cells at G1/S border. 874 cell cycle-associated 
genes were identified. 194 of identified genes were previously uncharacterised (Table 1.1). 
Their results also indicated that the genes involved in DNA duplication and sister chromatids 
segregation were highly up regulated in tumours [94].  
While some groups worked on the identification of genes up-regulated between the different 
phases of the cell cycle, other research groups focused on the regulation of genes that are up-
regulated during the quiescent stage e.g. Coller, et al., 2006 (Table 1.1) [22]. They 
investigated the expression patterns of genes that are up-regulated at G0-phase. Three 
different techniques were used to arrest the fibroblasts at a quiescent stage; 1) mitogen 
deprivation (removing of platelet-derived growth factor in cell culture arrested cells at a 
quiescent stage), 2) high cell density (contact inhibition), and 3) disruption of cell adhesion 
(culture plates coated with agarose to inhibit cell adherence). Interestingly they found that 
95% of DNA synthesis was decreased during the quiescent stage. They found that 
quiescence was not a prolonged pause in G1-phase. Up- and down-regulation of genes from 
array analysis suggested that quiescence is an activated stage in the cell cycle. In comparison 
with the control, they found a small set of genes that were up regulated across all three 
conditions that arrested the cells at a quiescent stage [22].  
To identify any overlap in the list of cell cycle-associated genes in fibroblasts synchronised 
either by serum deprivation or by thymidine-block, an array experiment was performed by 
Bar-Joseph, et al., 2008 (Table 1.1) [98]. In order to categorise the core set of cell cycle-
associated genes, they also compared their list of cell cycle-associated genes with the genes 
identified in previous research using HeLa cells in 2002 [94].  They identified 480 genes that 
were periodically expressed after arrested fibroblasts re-entered the cell cycle. Of these genes 
identified in fibroblasts, 362 genes were found both up-regulated in HeLa and fibroblast cells.  
However, the array that Bar-Joseph, et al., 2008 used only covered two thirds of genes (i.e. 
Affymetrix® Human Gene U133A 2.0, see Table 1.1) [98]. Therefore, a complete human gene 
dataset and the latest array technology can provide us more information of cell cycle-
associated gene expression, which was utilised in this thesis (i.e. Affymetrix® Human Gene 
























































































































































































































































































































































































































































































































































































































































































































































Microarray and bioinformatics 
In 1986, the human genome project was launched to fully sequence the human genome 
[100,101]. In 2003, the completion of the human genome project profoundly benefited the 
development of microarray. Scientists could now turn their attention to study the regulation 
of biological events at the transcriptional level e.g. the cell cycle. The application of these 
array approaches was one of the earliest examples where biologists entered into the big data 
era e.g. the gene expression activities in the human cell cycle [22,96-98,102,103].  
Many statistical approaches were developed to minimise the diversity of raw array datasets 
as the hybridisation between probes and samples can be considered as numerous interactions 
at the molecular level. The aim of a typical array data mining analysis is to identify genes 
that are statistically significant i.e. up/down-regulated at a fixed time point. Further 
approaches can be used to cluster sets of genes according to their expression levels across a 
number of time points. For each particular cluster, clustered genes with previously 
uncharacterised functions can be investigated according to additional analyses e.g. loss of 
function analysis (i.e. gene silencing) during cell division, subcellular protein localisation 
(i.e. predicts a putative role in the biological events based on the location in the cells). Before 
carrying out any of these analyses, the question of normalisation and data transformation of 
the array dataset has to be addressed. Various statistical techniques will be discussed in the 
following paragraphs.   
Equalise the diversity of array datasets 
Before we start to identify genes of interest, a number of questions need to be asked: 1) are 
probe intensities across multiple arrays comparable? 2) if not, does the experimental 
variability affect the distribution pattern? Statistical tools can be used to equalise the 
variability within array data or across an array dataset i.e. normalisation.  
The aim of normalisation is to remove the impact of non-biological effects in an array 
dataset, including experimental artefacts and random noise that are due to the technical and 
systematic variation [104]. Owing to the different array structure and labelling system, the 
normalisation for single channel array (e.g. oligo arrays from Affymetrix GeneChip) is 
different from dual channel array (e.g. spotted arrays).  
For single channel arrays, an array is only hybridised with one sample. In contrast, the same 
gene from different samples are hybridised with the same spotted array. Therefore, the aim 





robust multi-array average (RMA) normalisation [105]. The spotted or cDNA array 
associated normalisations are designed for within and also cross array normalisation.  
Using the Affymetrix GeneChip as an example for RMA normalisation, there are two steps 
in single channel array analysis, i.e. background correction and normalisation of array data. 
RMA uses PM probes to conduct the background correction. A second step, RMA conducts 
the quantile normalisation at probe level throughout an array dataset, the mean quantile is 
calculated to replace the raw value in the original data [106]. Normalised array data are 
ready for data mining. 
Data mining 
Array datasets are usually very large as the number of variables influences the analytical 
precision. Therefore it is very useful to narrow down the number of genes of interest as they 
are distinguished to the controls, which is based on the fold change of expression level (e.g. 
two-fold). There are several commonly used statistical methods used to filter the genes e.g. t-
test [107]. 
For the mining of gene expression data, cluster analysis appears to be one of the most 
popular methods, which can be used to find a set of genes, which are co-regulated and 
functionally related [108,109]. As an unsupervised approach, the clustering can divide entire 
data into groups where clusters of genes or samples have similar expression profiles e.g. S-
phase genes that are up-regulated at a specific time point in the cell cycle are clustered with 
genes whose roles are previously uncharacterised.  
There are two widely used clustering methods i.e. hierarchical and k-means. Hierarchical 
clustering is an unsupervised approach that places genes together where clustered genes 
share similar expression profile [110]. The relationship between each sample in data can be 
estimated quickly and shown using a large-scale tree diagram.  In contrast, K-means analysis 
is a non-hierarchical clustering method. K-means clustering undergoes an iterative process 
i.e. the re-evaluation is repeated to define the current centre in each existing cluster until the 
desired number of clusters is reached [111]. During the process of re-evaluation, a sample 
could be clustered in different clusters at different times [111]. Clusters are defined using 
Euclidean distances to minimise the difference between clustered samples but increase the 
difference between clusters [111]. 
For the last few decades, traditional statistical analyses are normally used to determine the 





the experiment to be done. However, for expensive analysis, such as array experiments, 
multiple repeats may become inherently expensive and traditional statistical analyses may be 
impractical for large-scale screens or analysis with various conditions.  
Gene co-expression network analysis 
In large-scale data mining, traditional analysis can only determine the level of an effect 
according to conditions in that experiment but are unable to explore the relationship between 
different samples i.e. the p-value of a t-test cannot be used to group genes, which have 
similar expression profiles. However, correlation based techniques can classify samples into 
multiple clusters e.g. the similarity between samples in hierarchal clustering can be 
determined by the Pearson correlation coefficient.  
Network analysis has been proved to be capable of analysing biological data [112,113]. 
However, it has been rarely used over the past few decades owing to a lack of supporting 
software and powerful computers. Only recently has software with a friendly interface been 
developed to allow biologists to analyse array datasets, e.g. BioLayout Express3D [113].  
An array data set is a collection of transcriptional measurements from thousands of genes 
[112]. To demonstrate the level of similarities of a particular gene’s expression profile 
between other genes, the network analysis uses edges to connect a node (i.e. each node 
represents a gene of interest) to others and creates a network. The concept of building a 
gene-expression network is described as follows. 
To investigate a gene’s expression profile within an array dataset in this thesis, I have 
performed network structure analyses. The networks are composed of nodes and edges. The 
strength of an edge represents the similarity between gene expression as represented as nodes 
and was determined by calculating pair-wise Pearson correlation matrix between each 
transcript on an array (Figure 1.14). The coefficient value is between +1 and -1 indicating 
that they are either positive or negative correlation, where 1 is total positive correlation, 0 
means no correlation, and -1 equals total negative correlation. Figure 1.14 demonstrates a 
simple network structure built based on the correlation coefficient that defines the 
similarities between different transcripts (using edges weight colours to demonstrate the 
similarity).  
Owing to the need for large-scale data mining at a systems level, BioLayout Express3D was 
developed to visualize data obtained through network structure based analysis, by clustering 





visualization of a network is approximately 45,000 nodes, which are connected by more than 
5x106 edges. MCL (Markov CLustering) algorithm is used for network clustering analysis.  
The Markov Cluster Algorithm (MCL) is an unsupervised cluster algorithm simulating the 
stochastic flow in a network structure i.e. a network composed of nodes and 
weighted/unweighted edges (Figure 1.14) [114]. This simulation is based on two operations 
(i.e. expansion and inflation) to identify clusters in which samples with similar features are 
placed together [114]. Expansion involves modelling the flow spreading out through the 
entire network. Inflation determines the contraction of flow in the network, making high/low 
current of flow in different network domains [114]. Taken together, undergoing the MCL 
simulation, the current of flow is high in a number of specific network domain but low 
between each other, determining the number of clusters (i.e. the number of specific network 
domains) [114]. This algorithm was developed by Dr. Stijn van Dongen [114]. 
 
Figure 1.14: Example of network structure composed of nodes (genes) and edges (correlation 
between the genes). Heat colours between red (High similarity) and blue (Low similarity) 
demonstrate the relationship between each of the nodes. Two clusters (Purple and green nodes) were 
identified based on the MCL calculation of network structure. The Pearson correlation coefficient 
determines the strength of relationship between nodes. 
The samples (e.g. nodes that represent the expression profile of genes in array data) are 
clustered mainly based on the properties of the network structure but not the similarity of 
gene expression profile. This means that the number and size of clusters are determined by 
1) the connectivity between nodes and 2) the weight of each particular edge connecting two 
nodes defined by Pearson correlation (degree of similarities between two nodes) in a network 






BioLayout Express3D also enables the freedom to determine the granularity of clusters by 
adjusting the MCL-inflation value that changes the stringency of the cluster membership. 
Higher inflation value of MCL enhances the strength of correlation between clustered 
members dividing a network structure into smaller clusters. In contrast, low inflation value 
of MCL dilutes the strength of correlation between clustered members and result in larger 
size clusters. 
RNAi and current approaches in cell-based genomic functional analyses 
RNA interference (RNAi) cascades inhibit gene expression by targeting homologous mRNA 
molecules, triggering the ‘knockdown’ of target genes [115]. Historically, RNAi was first 
discovered where sense and antisense RNA were equally involved in the inhibition of gene 
expression in plant cells by Napoli et al., 1990 [116]  and Caenorhabditis elegans (C. 
elegans) by Guo et al., 1995 [117]. In 1998, this phenomenon was first described as RNAi 
when the injection of double-stranded RNA (dsRNA) molecules into C. elegans induced the 
silencing of sequence specific genes [118]. RNAi that induced post-transcriptional gene 
silencing (PTGS) was also discovered in plants in 1999 [119]. In 2000, RNase III (Dicer) 
was identified to be involved in ATP-dependent dsRNA segregation, which resulted in 
dsDNA fragments of 21 to 23 nucleotide intervals in Drosophila embryos [120]. In 2001, 
RNAi was also found in mammalian cells [121]. In addition, Dicer was found to be 
evolutionarily conserved across different species e.g. mammals, plants, flies, and worms 
[122].  
The RNA pathway generally consists of two stages, initiated by Dicer, which cleaves long 
dsRNA into 21 to 23 nucleotides of dsRNA molecules. After being unwound, each dsRNA 
molecule is disassociated into a pair of single-stranded RNAs (ssRNAs) i.e. the passenger 
and guide strands where only the guide strand is involved in the RNA induced silencing 
complex (RISC) pathway.  
There are two types of small RNA molecules that play central roles in gene silencing i.e. 
short-hairpin RNAs (shRNAs) and small interfering RNA (siRNA). The siRNA is 
exogenous while shRNA is endogenous [123]. It is interesting that shRNAs are generated 
using mRNA pathways. However, shRNAs are not expressed as proteins. shRNAs are 
cleaved into shorter RNA molecules having a hairpin structure, also called shRNAs (Figure 






Figure 1.15: Schematic of human RISC pathways induced by siRNA and shRNA. A functional 
protein complex of RISC is composed of Ago2, Ago1, p54, proteins that have not been identified, and 
Dicer throughout the cytoplasm. A) The shRNA pathway represses the translational mRNA by 
storing the RISC/mRNA complexes in P-bodies or conducting the degradation. B) siRNA 
mediates the gene silencing by perfectly binding with homologous mRNA sequences in the 
cytoplasm. This figure is courtesy of Chu et al., 2006 [123]. 
The difference between siRNA and shRNA pathways is that the shRNA conducts gene 
silencing by imperfectly pairing with the homologous mRNA (Figure 1.9A) [123]. To 
repress the target gene expression, multiple RISC complexes are involved in the shRNA 
pathway by binding to target mRNA, accumulating in P-bodies, where the RISC complexes 
form a hairpin shape structure in the middle of target mRNAs (Figure 1.15A). Cellular 
conditions determine whether repressed mRNAs are stored in P-bodies or degraded (Figure 
1.15A). In contrast, siRNAs inhibit gene expression by perfectly pairing with homologous 
mRNA, leading to mRNA degradation in the cytoplasm (Figure 1.15B) [123].  
RNAi approaches 
To date, the genome-scale libraries of RNAi reagents (i.e. dsRNA molecules chemically 
synthesised) are built for high throughput system (HTS) approaches using genomic sequence 
data [125]. Benefitting from the miniaturisation and automation of technologies, RNAi 
screening can be used for functional genomic analyses in combination with HTS, identifying 
loss of function phenotypes [126]. Using the cell-based RNAi HTS, a large number of genes 
can be screened in small scale studies in parallel, which can be used to predict their putative 





roles in biological events and processes e.g. RNAi that knockdowns the expression of a gene 
of interest affects the phenotype of cells [127].  
The cell-based RNAi HTS can be applied in arrayed format as each gene is targeted by 
designed reagents in different wells where the cells are plated using microtiter plates e.g. 96 
or 384 well plates [124,128,129]. The readout can be evaluated using colorimetric analysis to 
determine the intensity of fluorescence/luminescence at the total well level [130,131], and 
using imagine screening to determine the cellular or subcellular fluorescence [132,133].  As 
it is easy to categorise a large number of RNAi reagents used in arrayed format, large-scale 
RNAi screening can be performed e.g. to identify unknown cell cycle-associated genes in 
Drosophila [130,131], human cells [132-134], and C. elegans [135].  
RNAi reagents 
As more was learnt about the RNAi pathways that repress gene expression, the design of 
RNAi reagents and their libraries were evolved for various applications. In the 1990s, the 
long dsRNA segments were found to induce gene silencing in C. elegans [135] and 
Drosophila [130,131]. However, gene silencing by long dsRNA segments was not identified 
in mammalian cells as a non-sequence response was triggered by molecules greater than 30-






Figure 1.16: Mammalian cell-based RNAi screening reagents. A) The siRNA molecule consists of 
a canonical structure (19 bps long) where 2-bps overhang at the 3’end of both strands. B) siRNA is 
designed as a low-complexity pools of less than 10 molecules targeting the same transcripts. C) 
esiRNA can be used as high-complexity pools to target the same transcripts. D) shRNA is a vector-
based library reagents which are introduced into cells virally. Diagrams are courtesy of Echeverri et 





Long dsRNA molecules in the cytoplasm in mammalian cells appear to activate various 
pathways of which repress protein synthesis, collectively known as the interferon response 
[137].  To provide a solution, short dsRNA were designed, inspired by the siRNA pathway 
in plant cells [119]. Therefore, short dsRNA segments are commonly used in mammalian 
cell-based research [132-134]. 
In most mammalian cell RNAi screening, short dsRNAs are designed following the principle 
that the dsRNA sequences closely mimic 21 nucleotides long endogenous sequences of 
homologous mRNA molecules with 2-bases extended at both 3’ ends (Figure 1.16A) [121]. 
There are the 4 popular types of short dsRNAs reagents i.e. standard siRNAs, low-
complexity siRNA pools, and endoribonuclease-prepared siRNAs (esiRNAs), shRNAs 
(Figure 1.16).  
Delivery system for RNAi reagents 
In addition to the design of the RNAi reagents, the delivery system for dsRNA molecules is 
also important in cell-based RNAi screening. Appropriate delivery systems determine their 
transfection/transduction efficiency. There are two common approaches including lipid-
conducted transfection and viral-conducted transduction [126]. For example, siRNAs and 
esiRNAs can be delivered by lipid-conducted transfection [127,132]. shRNAs can be 
introduced into the cells by viral-conducted transduction [133,134].  
Endoribonuclease-prepared siRNA  
RNAi induced gene silencing is a well-known mechanism that mediates mRNA degradation 
in plants [119,138] or animals [121,139] and is initiated by double-stranded RNA 
homologous with a targeted gene [121]. 
 
Figure 1.17: siRNA building to seed region on off-targeted of targeted mRNA.  Seed region on 
the antisense strand of siRNA (nucleotides between 2nd and 7th or 8th, shown in pink N) that is highly 





However, genes sharing similar sequence to a targeted gene may result in the off-target 
effects [140]. Microarray profiling of gene silencing experiments has demonstrated 
numerous off-target transcripts with a reduced expression level [115,141,142]. Other reports 
suggest that excluding the near-perfect matches between targeted sequences on mRNA and 
antisense of siRNA, off-targeting is mediated due to a perfect match between the antisense 
strand of siRNA, mediated by the 2nd ~8th bps (the seed region) and the 3’ UTR 
(Untranslated region) of the mRNA (Figure 1.17) [143].  
To minimize off-target effects, Ralf et al., 2007 [132] and Frank et al., 2006 [144] developed 
esiRNA. This involves enzymatically-preparing dsRNA to provide a heterogeneous 
population of siRNAs that target different regions of an mRNA, and results in a dilution of 
off-target effects. esiRNA has been shown to efficiently knock down the expression of 
targeted genes in human cells [145]. Since gene silencing was first demonstrated in 
mammalian cells by Elbashir et al., 2001 [121], this technology has been widely used to 
investigate the function of genes in biological systems combined with HTS [125]. 
Scoring cut-off used to determine the RNAi effect on cell proliferation 
The application of RNAi screening combined with HTS has been used to investigate gene 
function in cells in many different species e.g. Drosophila [130,139], C. elegans [131], 
mouse [133], and human [132,146]. In order to deal with a large number of measurements in 
HTS, most researchers use a Z-score to determine the hits at a particular threshold from the 
screen [130-135,147,148]. A Z-score (Z = ((x-µ))/σ; x represents sample, µ represents the 
mean of population of samples, σ represents the standard deviation of population of samples) 
is a statistical measurement of a score’s relationship to the mean in a group of scores. A Z-
score can be positive or negative, indicating whether it is above or below the mean and by 
how many standard deviations [149,150]. For example, if the Z-score is +3, then this means 
that the score is three times the standard deviation above the score of the population mean. 
Z-scores are often calculated for a specific time point. However, end-point analysis can only 
provide a “snapshot” at a particular time point and may miss differences that might be 
present at other time during the experiment. In order to analyse the real time data from the 
real time cell analysis (RTCA) experiments, it is therefore necessary to calculate a score 
based upon all or part of RTCA profiles.  
There have been a number of high throughput RNAi screening experiments monitored over a 





[151] used RNAi screening combined with automatic time-lapse microscopy and 
computational image processing to profile the phenotype of HeLa cells at a number of time 
points. In this experiment, around 21,000 human protein-coding genes were knocked down 
and images were recorded of chromosomes tagged with green fluorescence protein (GFP) on 
core histone 2B to determine the stages of the cell cycle. As histone duplication is coupled 
with DNA replication, changes to cell cycle profile were used to analyse the effects of 
knocking down individual genes on proliferation (chromosomes 2N: G0, G1; 4N: S, G2, M) 
[151,152]. In another RNAi screening experiment, Hutchins et al., 2010 used time-lapse 
microscopy to profile the localisation of proteins tagged with GFP in HeLa cells. The 
strength of GFP signals profiled by immune fluorescent microscopy (IFM) over a time 
series, were scored and used to determine the role of labelled proteins in association with 
chromosome segregation [153]. However, to find the best time-point for high-content bio-
image and the length transfection in RNAi screening is still a challenge of experiment design 
[115].  
RTCA system 
The best way to analyse the effect of RNAi on the cell cycle is therefore over a time series. 
The RTCA is a technology that indirectly monitors cell proliferation based on changes in 
electrical impedance as cells divide in a culture dish. Electrical impedance of cells is 
detected via a gold microelectrode array that covers the base of well and records the cell 
impedance index (CI) based on the electrical conductance of lipid bilayer of membrane of 
living cells.  [145,154-157]. In an RTCA experiment, CI increases as cells grow; this is 
roughly equivalent to cell proliferation although CI also increases if cells spread out and 
adhere more tightly to base of well (e.g. macrophages). We have used RTCA to analyse the 
effect of knocking down specific proteins. 
Since RTCA is a highly sensitive system, minimise data normalization is required to be 
essential to minimalize the difference between wells and plates [115]. The trace of CI at the 
point of normalization is readjusted from recorded value to 1.  
Determining the hits from RNAi screening 
However, it has been found that standard deviation increases in replicates as time progresses 
from the normalization point. To overcome this, Zhang, et al., 2011 suggest using the cell 
impedance index growth rate (CIGR) instead of CI [115]. The CIGR represents the rate of 
change of CI over time series, reflecting the kinetic of cell proliferation before and after gene 





not steadily accumulate following a fixed time point chosen for normalization but rather 
stayed constant [115]. This makes it possible to normalize at a fixed time point that does not 
result in an increase in standard deviation at later time points. 
Due to the limitation that Z-score can only determine which genes in the RNAi screening are 
hits by a single measurement value at a fixed time point, Zhang, et al., 2011 suggested 
calculating the average of CIGR over time series as a single value. Therefore averaged CIGR 
can be used to analyse effect of gene silencing on the cell proliferation [115].  
Subcellular protein localisation 
There are numerous biological processes happening in parallel to drive cell proliferation and 
other essential housekeeping events. The cell is a space that consists of different organelles 
with many proteins localised to specific locations. In general, proteins involved in the same 
biological processes, are also co-localised e.g. proteins localised in the centrosomes are 
generally involved in chromosome segregation (see Chapter 5).  
Subcellular localisation suggests a fundamental feature of a protein. To investigate an 
unknown protein and its function in a relevant biological processes, it is useful to localise 
their position in the cells for further experimental design.  
Protein subcellular localisation has become one of the most popular techniques, 
characterising the function of unknown proteins. There are various recombinant report 
proteins with a fluorescent signal, e.g. GFP that can be used. GFP was firstly isolated from 
the jellyfish Aequorea Victoria [158] and is widely used as a fluorescent tag to localise 
proteins of interest plants [159,160], yeast [161], and mammalian cells [162,163].  
GFP is commonly co-expressed with proteins in vivo by tagging, and localising by 
microscopy inspection. GFP has a self-emission fluorescent chromophore due to the specific 
sequence of three amino acids i.e. serine, tyrosine, and glycine [164]. As it is weakly 
phototoxic, GFP is commonly used to localise the protein of interest in living cells [165]. In 
addition, the self-emission signal does not require additional stimulators or cofactors to be 
activated [164].  
To avoid the interruption of the localisation signal (i.e. GFP) and over expression of protein 
that may saturate the cellular transportation machinery, a method was developed for tagging 





[166]. In addition, the coding sequence of GFP was inserted in-frame just in front of the stop 
codon in open reading frames (ORFs) [166]. 
With a robust expression system, protein subcellular localisation has been applied at a 
genome-wide level [167]. In doing so, a large-scale project ‘ORFeome’ was carried out that 
clone the entire set of ORFs, expressed in fission yeast [167]. ‘ORFeome’ cloning is a 
resource developed for the construction and sharing of sets of clones that can be used to 
study proteins of interest in a genome-wide manner [168]. The open-reading frame (ORF) is 
different to the protein-coding sequence (CDS). The CDS covers a region of sequence 
between the translation start and termination site. However, ORF includes the contiguous 
region but without the stop code. This is because the aim of ORFeome cloning is to express 
clones with the fusion protein of interest [169]. It is very important that the set of ORF 
clones can direct the synthesis of fused proteins. In order to express the clone with fused 
proteins i.e. GFP, the ORF clone must carry ORF without the original stop codon [169]. 
Therefore the expression of the GFP signal can be used for subcellular protein localisation. 
To perform the ORFeome cloning, it is important to choose an effective high-throughput 
cloning system as an appropriate expression vector e.g. Gateway cloning system. The human 
ORFeome project version 8.1 is a public resource, containing 12,230 clonal isolates (i.e. 
clonally-derived and sequence-verified ORFs cloned as a set of Gateway Entry clones) 
representing at least 11,149 human genes [170].  
The Gateway cloning System  
A traditional molecular cloning experiment includes four elements: 1) fragmentation of 
DNA, 2) ligation of fragmented DNA with a designed sequence, 3) transfection of 
recombinant DNA molecules into host cells, and 4) selection of host cells which are 
successfully transfected with the recombinant DNA molecules [171].  
One of many molecule-cloning methods is Gateway cloning technology. This technology 
allows the functional analysis of gene and protein expression. Gateway cloning evolved from 
typical molecular cloning technologies and was developed based on the concept of site-
specific recombination used by bacteriophage λ to infect the bacteria [172].  
Gateway cloning has a number of advantages enhancing the accuracy and robustness in 
generating recombinant DNA molecules. Firstly, this method provides a fast and efficient 
solution to deliver DNA sequences into multiple vector systems. Secondly, the cloning 





cDNA clones. Thirdly, transfection of DNA sequence, into destination vectors is relatively 
easy. Finally, it is suitable for HTS analysis. Given these advantages, Gateway cloning is 
widely used for subcellular protein localisation for functional analysis [173].  
Pathway modelling 
One of the many challenges encountered when studying an entire biological system is 
finding a solution to collating the huge amount of information obtained from textual 
descriptions and experimental observations. Pathway modelling enables the visualization of 
all the biological discoveries across different studies. The problem is that the complexity of 
biological events occurring during cell proliferation can be depicted in various network 
structures.  
It is known that using a pathway can help utilize the information available following 
previous experimental discoveries. Pathways still rely on the extensive textual description to 
explain aspects that cannot simply be demonstrated within the pathway itself. In addition, the 
design of the pathway is strongly influenced by the need of the developers and this increases 
the difficulty of information accessibility for other biologists. A pathway map should aim to 
provide a platform where biologists can utilize it to share their biological research and 
further research in the field. 
Figure 1.18 shows various pathway diagrams of the centrosome life cycle depicted according 
to different sources. Focusing on different biological events within the centrosome life cycle, 
it is difficult to understand a particular event and its relationship in association with other 
biological processes. In order to address this issue, a new approach to pathway notation 
inspired by the layout of an electronic circuit from the electronic industry was developed 
[174-176].   
In a consensus view, a pathway map is a regulatory network composed of proteins and genes 
connected by edges representing biological events [177,178]. The proteins are defined as 
components and interactions between them are depicted as arrows. To identify these 
components in biological events, the first task is to define interactions within these protein-
protein interaction networks [177,178]. Since the concept of pathway mapping was 
introduced, more and more biologists have started to develop approaches to depict the 
regulatory network of biological processes. To this end, many types of pathway map 





network map of events e.g. systems biology graphical notation (SBGN) [179], and modified 
Edinburgh Pathway Notation (mEPN) [177].  
A  B  
  
C  D  
  
Figure 1.18: Centrosome life cycle demonstrated in different formats. The ‘same’ pathway map 
shares poor consistence at layout consistency, standard graphical notation, and notation system (if any 
used) for pathway components. A) Centrosome duplication life cycle extracted from articles; Nigg EA 
et, al., 2002 [47]. B) Mardin BR et, al., 2012 [180], C) Jaspersen SL et, al., 2008 [181], and D) from 
Crasta K et, al., 2006 [182]. 
The SBGN is a graphical representation language developed by a community of computer 
scientists, modellers, and biochemists aimed to visualise the biological processes as a 
pathway map [179].  The mEPN is an alternative graphical language based on a pathway 
notation system first proposed by Moodie et al., [176] in 2006 and first published in this 
form by Raza et al., 2008 [174]. Both schemes evolved from similar concepts, such as 






To date, there are more than 60 pathway diagram databases accessible online [183], e.g. 
WikiPathways [184], REACTOME [185], and Kyoto Encyclopaedia of Genes and Genomes 
(KEGG) [186]. WikiPathways is a collective resources of biological pathways depicted by 
various participants in a community [184,187]. The publishing, updating, and maintaining of 
the pathway maps are reviewed by a group of experienced users [187]. REACTOME is an 
online database that provides pathway maps depending on different organisms [185]. The 
pathway maps are based on human biology [188]. Prior to the release of pathway maps 
which are reviewed by experienced pathway curators with PhD level training. KEGG is one 
of the most popular pathway databases and was developed since 1995. This database 
includes pathway maps of cellular processes e.g. metabolism, membrane transport, and the 
cell cycle [189]. The pathway maps were developed by a group of pathway biologists.  
Although pathway schemes are well developed in most cases, there is no standard 
international graphical notation system [183]. They are either depicted centrally, such as 
KEGG or by the community e.g. WikiPathways. This increases the threshold of information 
accessibility between different pathway databases due to their incompatibility between each 
other. In addition, regular pathway maps cannot be used for computational simulation as 
high performance computers are able for such approaches forecasting the regulation 
behaviour of a set of proteins in the pathways [190-192]. 
To this end, the mEPN pathway scheme was developed to provide pathway maps, which can 
be used to simulate the regulation behaviour of protein-protein interactions in BioLayout 
Express3D [113,177,179,193]. In addition, BioLayout Express3D can convert the mEPN 
pathway to other popular pathway schemes e.g. SBGN. An advantage of the mEPN pathway 
map is that it can be used for multi-task applications (e.g. simply mapping the biological 
processes of interest and storing the information in maps by attaching them in the nodes or 
edges), the mEPN scheme was used to incorporate and interpret the results i.e. array analyses 
(Chapter 2), RNAi screening (Chapter 3), and protein subcellular localisation (Chapter 4). In 









Aims and objectives of this works 
Transcriptomics analyses by the group commonly observed a cluster of genes in many 
datasets that were highly enriched in cell cycle genes. Amongst this cluster of known cell 
cycle genes we often observed genes of unknown function.  This thesis is based on the 
hypothesis that there are as yet unidentified human genes that play a role in cell cycle 
progression and that they will be co-expressed with known cell cycle genes. In order explore 
this hypothesis we have: 
● Surveyed the human cell cycle regulated transcriptional network using latest array 
technology and use more advanced data analysis techniques. 
● Characterised the putative novel cell cycle-associated genes particularly those associated 
with S- and G2/M- phase. 
● Identified the role of putative novel genes using RNA interference monitored by RTCA 
systems, flow cytometry, and RT-qPCR to check the expression level of targeted genes. 
● Characterised the cellular localisation of novel cell cycle-associated proteins. 










































Chapter 2.  
Transcriptional network analysis of cell cycle-associated 




A scheduled progression of the cell cycle across its different phases is essential to the growth 
and development of all organisms [194]. Many of these processes have been well studied at 
the molecular level, such as quiescent program regulation [22], DNA replication [195], 
chromosome segregation [196], and the checkpoint systems [197]. The cell cycle is one of 
the best-studied pathways by transcriptomic analyses with hundreds of genes up regulated as 
cells pass from S-phase to M-phase.  
Studying cell cycle-regulation at a genome-wide transcriptional level has been performed in 
human cells by microarray e.g. HeLa cells [94] and human fibroblasts [22,96,98]. To study 
cell cycle-regulated transcription, cells must be synchronized before cell cycle-associated 
genes can be identified [7]. Therefore the synchrony of cell cycle is important in array 
analysis.  
There are two factors that determine the synchrony of mammalian cell populations. Firstly, 
normal diploid mammalian cells lose their synchronization relatively soon after re-entering 
the cell cycle following cell cycle arrest [96]. Furthermore, it is thought that the degree of 
synchrony after re-entering the cell cycle varies by cell type [89]. In addition, when a cell 
divides it has been shown that the two daughter cells may have different cell kinetics [89]. 
Secondly, it is known that only 50 to 70% of mammalian cells re-enter the cell cycle after 
cell cycle arrest [98]. For mammalian cells, chemical inhibitors can be used to mediate 
partial cell cycle synchronization. For example, metabolic inhibitors thymidine [198] and 
aphidicolin [199] both arrest the cells at G1/S-border. In addition, nocodazole can be used to 
arrest the cells at M-phase [200]. However, other methods utilize a non-chemical inhibitor to 
mediate partial synchronization. Mechanical synchronization methods such as mitotic shake-
off can select cells at G2/M-border but yield a low number of cells [201]. Fibroblast cells are 
arrested in G0/G1-phase by serum deprivation but re-enter the cell cycle when fed serum. The 
response of fibroblasts to serum stimulation allows the study of cell cycle-regulated gene 





In previous studies, around 700 cell cycle-regulated genes relevant to G1-, S-, G2-, and M-
phase were identified by Cho RJ, et al., 2001 in human fibroblasts synchronized by a double 
thymidine block [202]. In addition, due to the limitation of having an incomplete human 
gene expression data set (U133A arrays), the array that Bar-Joseph, et al., 2008 used only 
covered two thirds of total gene expression. Hence, in this study, a complete human gene 
data set can render us a more complete view of cell cycle-associated gene expression.  
The aim of this chapter is to survey the human cell cycle regulated transcriptional network 
using latest array technology and use more advanced data analysis techniques. To create a 
list of all the known cell cycle-associated proteins particularly those associated with S-, G2-, 
and M-phase. 
In order to identify the best cell lines for array analyses, serum starvation is tested to find the 
best cells for synchronization. We have tested human embryonic kidney 293T (HEK293T), 
human acute monocytic leukemia cell line (THP-1) and neonatal human dermal fibroblast 
(NHDF). Conditions were optimised to try to create a synchronous major population of cells 
progressing through the different phases of the cell cycle. In addition, 40 new microarrays 
for two time course experiments were performed, at 6 h intervals (24 arrays) and at 2 h 
















Materials and Methods 
Overview of approach to identify cell cycle associated genes 
The flow chart below shows an overview of the strategy to identify cell cycle-associated 
genes and is composed of a number of stages (Figure 2.1). Firstly, to identify the most 
appropriate cell whose mitotic division could be arrested by serum-deprivation and then 
reactivated by serum refeeding to enter the cell cycle. Secondly these cells would be used to 
assess cell cycle-associated transcription by microarray analysis and then mined to derive a 




Figure 2.1: Overview of experiments toward, the identification of cell cycle-associated genes. 
HEK293T, THP-1, and NHDF cells were selected to monitor synchrony after re-entering the cell 
cycle. Conditions of synchronization included the %, length of serum starvation, and seeding density 
were optimised. NHDF cells were found to be able to generate a major population with synchronised 
cells. To identify cell cycle associated gene expression, two time course microarray experiments were 
performed and data mining was used to monitor the pattern of gene expression. Normalized dataset 









HEK293T cell culture and cell cycle synchronization 
HEK293T cells are the HEK293 cell line containing the simian vacuolating virus 40 (SV40) 
large t-antigen [203]. HEK293T cells between passage number 7 to 12 were cultured in 
DMEM (Dulbecco’s Modified Eagles Medium, Sigma-Aldrich, Gillingham, UK), including 
10% (v/v) Fetal Bovine Serum (FBS) (GE Healthcare, Little Chalfont, UK), antibiotics (25 
U/ml penicillin and 25 µg/ml streptomycin) (Life technologies, Paisley, UK), 0.1 mM Non-
Essential Amino Acids (NEAA, Glycine 0.1 mM, L-Alanine 0.1 mM, L-Asparagine 0.1 mM, 
L-Aspartic acid 0.1 mM, L-Glutamic Acid 0.1 mM, L-Proline 0.1 mM, L-Serine 0.1 mM) 
(Life technologies), 1 mM glutamax (Life technologies), and fungizone antimycotic (1.25 
µg/ml) (Life technologies). In the study of HEK293T cells, different percentages of serum 
were used to starve the cells. Cells were cultured until the proportion of coverage was 
30~40%. Serum starvation was performed by washing with serum free medium twice and 
culturing in medium with 0.5% serum for 48 h. The starved cells were subsequently placed 
in medium with 10% serum (refeeding) and cultured for 20 h before harvesting. 
THP-1 cell culture and cell cycle synchronization 
The THP-1 cell line was originally isolated by Tsuchiya et al., 1980, from a patient with 
acute monocytic leukemia [9]. For culture and passage, THP-1 cells at passage number 
between 7 and 12 were cultured in 175cm2 Thermo tissue culture flasks at a density of 1x105 
cells/ml. The cells were cultured in RPMI 1640 medium (Sigma-Aldrich), with 10% (v/v) 
FBS (GE Healthcare), 1 mM glutaxmax (Life technologies), and antibiotics (25 U/ml 
penicillin and 25 µg/ml streptomycin) (Life technologies).  Cells were cultured between a 
density of   1x105 and 1x106 cells/ml. Medium (30 ml) with 0.2% (v/v) FBS was used to 
starve the cell for 48 h followed by refeeding with serum. THP-1 cells were harvested at 0, 6, 
and 24 h intervals. 
NHDF cell culture and cell cycle synchronization 
NHDF cells isolated from neonate foreskins were kindly provided by Dr. Finn Grey’s lab 
(The Roslin Institute, Edinburgh, Scotland, UK) [204]. For culture and passage, adherent 
cells were plated on 175cm2 Thermo tissue culture flasks at density of 6 x 103 cells/cm2. 
NHDF cells at passage number between 7 and 12 were cultured in DMEM (Sigma-Aldrich) 
with 10% (v/v) FBS (GE Healthcare), and antibiotics (25 U/ml penicillin and 25 µg/ml 
streptomycin) (Life technologies). Cells within the flasks were grown under the condition of 





0.5% (v/v) serum for 48 h starvation and then re-fed by placing them in complete medium 
and harvesting at different time points. 
Flow cytometry 
Flow cytometry was used to monitor and determine the number of cells in each phase of the 
cell cycle at each time point showing the effect of serum starvation and refeeding on NHDF, 
HEK293T and THP-1 cells. Cells were re-suspended in 50 µl PBS and then mixed with 1 ml 
70% (v/v) cold ethanol (EtOH). Samples were fixed at 4oC for at least 24 h. Cells were 
centrifuged at 400xg for 5 min and the supernatant discarded. The cell pellet was then re-
suspended in 100 µl 1X PBS. After pipetting the mixture vigorously to break up the cells, 
they were washed twice in 1 ml of PBS, and re-suspended in 100 µl of staining solution (38 
mM sodium citrate buffer containing 138 µM propidium iodide, 10 µg/ ml RNaseA solution, 
and pH 8.0). After adding a further 200 µl staining solution, samples were placed in the dark 
at room temperature for at least 2 h. Synchrony of the cell cycle progression was analysed 
using BD FACS Aria lllµ Cell Sorter (BD bioscience, Oxford), and data was analysed by BD 
FACSDiVaTM software (BD bioscience). 
Microarray Analysis 
NHDF samples were harvested at different time points following serum refeeding, snap 
frozen in dry ice, and stored at -80oC until use (Figure 2.2). Total RNA was isolated using 
the RNeasy Mini Kit (QIAGEN, Manchester, UK) according to manufacturer’s instructions. 







Figure 2.2: Design of microarray studies. A) Samples of NHDF were harvested at 6 h intervals 
following serum-refeeding (10% FCS) of cells cultured in 0.5% serum for 48 h. NHDF cells were 
analysed by microarray (Affymetrix® Human Gene ST 1.1 Arrays) on Affymetrix GeneTitan®system 
in the facility of ARK-Genomics at the Roslin Institute. B) A second microarray was performed where 
cells were treated as above, but samples were collected every 2 h after serum refeeding and analysed 
on Affymetrix® Human Gene ST 1.1 Arrays on the Affymetrix GeneAtlas® microarray system. 
Arrays were run as part of the Wellcome Trust Advanced Course on Functional Genomics and System 
Biology, Hinxton, Cambridge.  Figures of Affymetrix GeneTitan/Atlas system are courtesy of 





(Nano-Drop Technologies, Wilmington, North Carolina, USA) based on the ratio of sample 
absorbance at 260 nm. The ratio of absorbance at 260 and 280 nm was used to assess the 
purity of RNA.  
RNA quality was assessed using the Agilent RNA 6000 Nano Kit (Agilent Technologies, 
Santa Clara, California, USA) and ran on the Agilent 2100 Bioanalyser using electrophoretic 
separation on micro-fabricated chips. The quality of RNA samples was determined by the 
ratio of 18S and 28S ribosomal subunits.  Labelled cDNA fragments for microarray were 
generated by the reverse transcription of total RNA (500 ng) using the Ambion® WT 
Expression Kit (Life technologies), fragmentation, and then labelled by TdT DNA labelling 
reagent using GeneChip® WT Terminal Labelling Kit (Affymetrix, Bucking hamshire, UK) 
according to manufacturer’s instruction (Affymetrix, GeneChip® WT Terminal Labelling 
and Hybridization User Manual). 
mRNA expression analysis by quantitative RT-qPCR 
RNeasy Mini Kit (QIAGEN) was used to isolate total RNA from a major population of 
synchronized NHDF cells following time points after serum refeeding. Two-step RT-PCR 
was performed to generate cDNA. For RNA samples and given primers, each reaction was 
performed in 30 µl volumes using MicroAmp Optical Caps (Applied Biosystems).  
0.5 µg of total RNA mixed with ddH2O in total volume 18.9 µl and was initially heated to 
72oC for 5 min. It was then incubated for 2 minutes on ice. For subsequent reverse 
transcription, each reaction used primer Ploy (dT) (5.0 µM) 1.5 µl, RNAse inhibitor 0.6 µl 
(Promega) and dNTP 1 µl. 2 µl of the Reverse Transcriptase MMLV (13.3 u/µl, Invitrogen) 
was added in 1x Reaction/PCR buffer (Invitrogen) for each reaction. Samples were 
incubated at 42oC for 65 min and 95 oC for 5 min, and stored storing at -20 oC until further 
use. 
Using the primers shown in Table 2.1, real time reverse transcription qPCR was performed 
using SYBR® Green I (Roche) and the LightCycler® 480 II real-time PCR system (Roche, 
Hertfordshire, UK). In each PCR, 2 μl of cDNA was combined with gene-specific primers 
(0.5 μM) and 12.5 μl of QuantiTect SYBR Green PCR Master Mix to a total volume of 25 
μl.  
To enable calculation of efficiency of the PCR reaction and to check that the PCR reaction 
was quantitative, a representative cDNA was serially diluted. Serial dilution was performed 





product being amplified. Other controls performed in each run included water blank and 
samples which did not have Reverse Transcriptase.  
The conditions used to perform qPCR were as follows: First, denaturation step 95°C for 5 
min; second, annealing step 59°C for 10 sec; third, extension step 72°C for 20 sec; and 
fourth back to first step for 45 cycles with 10 sec for the 95°C denaturation step.  At the end 
of each run, melting curve analysis was performed between 65°C and 97°C. LightCycler® 
480 (Roche, Hertfordshire, UK) analysis software version 1.5, was used to compare 
amplification in experimental samples during the log-linear phase to the standard curve from 
the dilution series of control cDNA. Comparisons were displayed as bar charts with standard 
deviation. Comparison between the expression level of amplified genes and GAPDH 
(Glyceraldehyde-3-phosphate dehydrogenase) as a ratio were displayed as histograms with 
standards deviation.  
Quality assessment and data processing 
The Bioconductor package ‘oligo’ was used to perform the quality assessment of array 
dataset [207]. To determine the quality of data, pseudo image, density plots, and boxplots of 
the probe reading intensities of arrays were performed using R software, an environment for 
statistical computing and graphics plotting graphics (version 2.14.2) [208]. Following QC, 
the datasets including the array samples derived from NHDF cells at 2 or 6 h intervals were 
combined and normalized together utilizing robust multi-array average (RMA) [209]. Array 
data were saved as '.expression' file, and then investigated by network analysis using 
BioLayout Express3D [112,113]. Based on the similarity of gene expression, the expression 
profile of genes correlated with a Pearson number above or equal to 0.7 (r ≥ 0.7) were 
included and saved in the format as '.pearson' file. Cell cycle-associated genes were 
identified in a number of clusters. 
Marker Sequence (5' to 3')  
CDK1 U-TATGCCTTGGTCAGAGTAATAACT  
 D-ATACGGAACCAGTCTCATTATTGA  
BUB1 U-TCCTCCTTTGGCAAATGCTATT  
 D-AGGAGGAAACCGTTTACGATAA  
GAPDH  Hs_GAPDH_2_SG QuantiTect Primer Assay (200) (QIAGEN, 
Manchester, UK) 
  
Table 2.1: Sequence of primers for qPCR. U and D refer to upstream and downstream primers. 





Using network analysis to identify S-, G2-, and M-phase associated 
genes 
Probes of the RMA normalized dataset (total 33,298 transcripts) with signal intensity read 
levels below 35 were firstly removed from all array samples (11,456 transcripts removed) 
and then dataset clustered using BioLayout Express3D with settings of Pearson correlation (r) 
= 0.85 and MCL-inflation value = 3.0 (Markov Clustering Algorithm). The size of clusters 
determines the ranking of clusters i.e. the cluster with largest number of nodes is labelled as 
cluster 001. Graphs of each dataset were explored extensively in order to identify the 
members of the gene clusters and their relevance to the cell cycle progression.  
Clusters of genes with inconsistent expression profiles between the two data sets were 
removed (4,400 transcripts). After removal of negative and positive controls of transcripts 
providing reference signal for array scanning machine from the dataset (2,620 transcripts), 
remaining transcripts (14,822 transcripts) were clustered at lower constraint with MCL-
inflation value = 1.7 in order to include most of the genes correlated with the periodicity of 
known cell cycle regulatory genes. Cluster associated with particular phase of the cell cycle 
was identified by presence of known cell cycle genes within the cluster (see List of 
additional information [22,94]), and then coloured blue (G0), red (G1-Early), purple (G1-late), 
and green (S, G2, and M) (Figure 2.16). We specifically emphasised on the investigation of 
genes that up-regulated during S-, G2-, and M-phase.  
To summarise the major biological events which clustered genes were involved in, clustered 
genes were manually annotated as unrelated, unknown, putative association, or known S-, 
G2-, and M-phase associated genes, according to GeneCards (http://www.genecards.org/) 
[210], universal protein resource (UniProt, http://www.uniprot.org/) [211], REACTOME 
(http://www.reactome.org/) [185], database for annotation, visualization and integrated 
discovery (DAVID, http://david.abcc.ncifcrf.gov/) [212], and gene ontology (GO, 










Using network structure analysis to re-investigate published array 
data 
 
To further investigate the effects of chemically induced cell cycle synchronisation at the 
transcriptional level in fibroblast cells against serum deprivation, the array dataset from Bar-
Joseph, et al., 2008 was downloaded, normalised, and annotated [98].  Raw data were 
normalized by RMA normalization resulting in 22,277 transcripts. Extracted transcripts were 
then associated with gene names (19,940 transcripts, 12493 unique genes). This was saved as 
an ‘.expression’ file. Array samples with their maximum expression levels below 35 were 
filtered out. Dataset saved as ‘.expression’ format were clustered at the condition of r = 0.85, 
MCL-inflation value = 1.6. 
Functional annotation of clustered cell cycle-associated genes by GO 
slim mapping and regular GO enrichment analysis 
Following the approaches that identified four major cell cycle-associated clusters based on 
the temporal expression profile and clustered key cell cycle-regulated genes, a simplified 
version of GO was firstly used to provide a broad review of the ontology content without the 
detail of specific terms [214]. GO slims are composed of a subset of the terms compared to 
the entire GO [214].  
GO slims are useful to summarize the results of GO annotation of a microarray analysis 
when various classifications of gene product functions are needed. In order to further profile 
the genes up-regulated in the progression of the cell cycle, the list of genes was mapped to 
functional categories of biological process defined in GO slims. 
Classification of clustered genes according to manual annotation 
To further annotate the function of genes clustered with cell cycle-association, genes of 
interest that were co-expressed during the S-, G2-, and M-phase were manually curated based 
on reference mining and other online resources.  
It is important to define the rule by which genes were categorised according to data curation 
e.g. reference mining. Genes that have known function relevant to non-cell cycle associated 
events, but expression periodicity in our data implying that they are associated with mitotic 
activity were classified as ‘unrelated function’.  
Genes that with putative association (i.e. indirect evidence from experimental observation in 





according to publications were labelled as ‘putative association’.  Genes that were not 
previously characterised but expression periodicity suggested they were in association with 
the cell cycle were classified as ‘unknown function’. Genes, which had been completely 
characterised as cell cycle-regulated elements, were classified as ‘known S-, G2-, and M-
phase association’.  
To further investigate and refine the list clustered genes, Prof. Tom Freeman’s group filtered 
the list by comparing with datasets of other human cells and tissues, the list of genes in the 
S/G2/M cluster was refined; genes were only kept in the list if they were found to be co-
expressed in cells and tissues with high levels of cell proliferation [215]. This work included 
the participation of all the team members in Prof. Tom Freeman’s group for over two years 
to polish and refine the list of genes identified in two array data sets.  
Evidence from the literature (e.g. PubMed) and other online resources (e.g. REACTOME 
[188]) were carefully reviewed by members of the Freeman group, where each member 
shared an equal number of genes listed in this thesis.  
Information on gene, were categorised into columns according to their features e.g. pathways 
proteins were involved in cellular locations where expressed proteins were trafficked, protein 
complexes where expressed proteins were recruited, cell cycle phase where they were up-
regulated, chromosome location of genes, and the accession number of each gene (e.g. 
ENSEMBL gene ID [216]).   
From the completed table, three of each gene’s major functions associated with biological 














In this experiment, a number of cells lines were selected for analyses. HEK293T, THP-1, 
and NHDF cells were examined for the effect of variables on the synchrony of cells after 
starvation such as period of serum starvation and the percentage of serum used in 
deprivation. To identify cell cycle-associated gene expression, two time course microarray 
experiments were performed and data mining was used to monitor the pattern of gene 
expression. Normalized data sets from microarray were surveyed in order to identify to find 
novel cell cycle-associated genes. 
The cell cycle of HEK293T cells cannot be synchronized by serum 
starvation 
In order to identify a suitable cell line for these studies, an experiment was performed to 
synchronize HEK293T by serum starvation. HEK293T cells were starved in 0.2% serum for 
48 hours (h) and re-fed with 10% serum. 20 h following the refeeding with serum, cells were 
analysed by flow cytometry and compared to cells, which had been cultured in 10 % serum 
throughout the experiment. There was little evidence for the synchronization of the 
HEK293T population (Figure 2.3). 
 
Figure 2.3: Experiment to show synchronization of HEK293T cells using serum starvation. Cells 
were serum starved for 48 h, re-fed with 10% serum and fixed after 20 h. Three replicates were 
performed for starved and non-starved control. Cells were stained with PI and analysed by flow 
cytometry. Percentage of cells in each phases of cell cycle is shown in graph. Mean % cell cycle phase 
± standard deviation. Error bars represent standard deviation. Results based on biological repeats n = 
3. 
20 h after serum deprivation, the proportion of the cell population at different phases of the 





starved cells (Figure 2.3). This suggests that serum deprivation cannot provide a major 
population of HEK293T cells with a synchronized cell cycle after serum refeeding. 
Synchronization of THP-1 by serum starvation 
We next examined the response to serum-deprivation from THP-1 cells to serum refeeding. 
THP-1 cells were starved by placing them in medium with 0.2% serum for 48 h and were 
then re-fed in medium containing 10% serum. Flow cytometry was used to monitor the 
shifting of cell cycle from G0/G1- to S-phase at time points 0, 6, and 24 h after the serum 
refeeding in this experiment. Cells were cultured in the medium with 10% serum served as 
the control group (non-starved) (Figure 2.4).  
 
A                 Non-starved B           Starved 
 
Figure 2.4: Synchronization of THP-1 cells. Percentage of control non-starved A) and starved B) 
cells in each phase of the cell cycle at t = 0, 6, and 24 h after the medium was renewed (mean % cell 
cycle phase ± standard deviation). Results based on biological repeats n = 3. 
In Figure 2.4A, the percentage of non-starved cells in G0/G1-phase at t = 0 h showed no 
difference when compared to the percentage of cells at 24 h. Figure 2.4B shows that the 
percentage of cells in G0/G1-phase had decreased at t = 24 h compared to t = 0 h (T test P < 
0.01). In addition, the percentage of cells in S-phase showed an increase in population at t = 
24 h when compared to t = 0 h (P < .05). This suggests that starved cells responded to the re-
feeding of serum, and that approximately 16% of the cells had re-entered the cell cycle by 24 
h post-feeding.  This indicates that the population of non-starved cells has similar cell cycle 








Serum deprivation can provide a major population of NHDF cells 
with a synchronized cell cycle 
As it was not possible to effectively synchronise HEK293T or THP-1 cells, an experiment 
was performed to synchronize NHDF cells. Figure 2.5 shows a profile of a major group of 
48 h serum starved NHDF cells released from a quiescent stage following the time points at 
6 h intervals after refeeding with 10 % serum. Compared with the proportion of control, 
starved cells responded to serum refeeding and then migrated from G0-phase to mitotic 
activity. Between 18 and 24 h, a large population of cells shifted to enter the mitotic activity 
(Figure 2.5B).  
 
A             Non-starved               B               Starved 
 
Figure 2.5: Synchronization of NHDF cells. A) Percentage of control non-starved cells in each 
phase of the cell cycle at t = 0, 6, and 24 h following the serum refeeding (mean % cell cycle phase ± 
standard deviation). The percentage of cells in G0/G1-, S- or, G2/M-phase showed no significant 
difference at different time points. B) Percentage of cells at a particular phase of the cell cycle at t = 
0, 6, and 24 h after the medium was replaced with 10% FCS containing medium (mean % cell cycle 
phase ± standard deviation). There was a 34.3 % decrease in the number of cells at G0/G1-phase at 24 
h when compared to t = 0 h (P < 0.01) whilst the percentage of cells in G2/M-phase increased by 
(22.3%) at t = 24 h when compared to t = 0 h (P < 0.01). Results based on n = 3. 
Figure 2.6 demonstrates evidence of the migration of synchronous cell population responded 
to serum re-feeding and re-entered the cell cycle. Synchrony of cell populations responded to 
the serum refeeding was determined by flow cytometry at 6 h intervals over 48 h. In 
comparison with the percentage of non-starved cell populations, starved cells responded to 
re-supplementing the medium with 10% serum and then released from G0/G1-border across 









Figure 2.6: Arrest and release of NHDF cells. A. Flow cytometry profile of asynchronous NHDF 
cells cultured in medium with 10% serum. B. NHDF cells arrested at the G0/G1-phase by serum 
deprivation for 48 h and released by 10% serum refeeding were monitored at 6 h intervals in first cell 
cycle experiment and 2 h intervals in the second. Pie charts are used to visualize the % of cells in each 
phase of the cell cycle at different time points (Blue: G0/G1-phase, Red: S-phase, G2- and M-phase is 









RT-qPCR of mRNA expression of genes up-regulated in M phase  
A                                                      CDK1  
 
B                                                      BUB1 
 
Figure 2.7: mRNA expression profiles of A) CDK1 and B) BUB1 following serum refeeding. Specific 
Primers for CDK1 and BUB1 were used to analyse the level of their expression in partially 
synchronous NHDF cells at 6 h intervals.  Samples were harvested from cells following the 10% 
serum refeeding at 6 h intervals after 48 h 0.5% serum starvation and analysed by RT-qPCR. Controls 







Primers specific to M-phase regulated genes CDK1 and BUB1 were used to detect the 
expression of these mRNAs by qPCR (Figure 2.7). CDK1 is involved in the regulation of 
eukaryotic cell cycle, including modulating the centrosome cycle between G2- and M-phase 
[44]. CDK1 expression increases dramatically at 18 h and at 24 h following 10% serum 
refeeding.  
BUB1 is involved in the regulation of the spindle checkpoint at M-phase [217]. BUB1 
expression peaked at 24 h after refeeding with 10% serum. Gene expression profile of BUB1 
gradually increased from 18 h, then gradually reduced from the peak expression at 24 h to 
the end of time course monitoring at 6 h intervals. Gene BUB1 expression appears to 
increase slightly again in the latter part of the time course (T= 36 to 48 h) (Figure 2.7B). 
Both CDK1 and BUB1 gene expression profile confirm that partial synchronization has been 
achieved. 
Normalization of microarray dataset 
Before the data analysis, the quality of raw microarray data must be assessed to ensure the 
integrity of the data and then normalized to minimize technical variance between samples. 
To discover potential problems in quality with in the array samples, the chip pseudo-images 
visualization with probe level model of array samples at 2 h and 6 h intervals were used in 
this quality assessment. 
Pseudo-images of microarray chips are useful for detecting special artefacts on arrays that 
could potentially result in quality issues. Samples with the label ‘A EXP 1 h’, and ‘A EXP 4 
h’ were found to have artefacts (Figure 2.8A). In addition, arrays processes by Affymetrix 
GeneAtlas® System were found to be brighter than Affymetrix GeneTitan® System 
suggesting that there was technical variation between two systems. The difference between 
the two data sets can also be observed in the box plots and histogram pre-normalisation 
(Figures 2.8B-E). 
Figure 2.9 shows a heat map generated by Pearson correlation clustering where two major 
clusters of array samples at 2 and 6 h intervals were placed. For the array samples collected 
at 6 h intervals, the cluster analysis placed them into 6 different groups i.e. group A to F. 
Group A includes samples harvested at 30 and 36 h. Group B includes samples harvested at 
24 h after serum refeeding and control. Group C includes two array samples harvested at 18 
h and one at 42 h. Group D includes two samples harvested at 48 h and one at 0 h. Group E 
have two samples harvested at 6 h and another two samples harvested at 12 h. Group F 







Figure 2.8: Visualization of microarray dataset and probe reading intensities. Two array 
experiments (samples harvested at 2 and 6 h intervals) were performed and analysed by Affymetrix® 
Human Gene ST 1.1 Array and then performed by Affymetrix GeneAtlas® System and Affymetrix 
GeneTitan® System respectively. A) Pseudo-image of raw data visualized as a probe level model with 
heat colours. B) Raw data of Log2 density boxplot. C) Smoothed histogram of probe reading levels at 
log2-intensities versus the density of probes from raw data. D) Log2 density boxplot of array samples 









Figure 2.9: Heat map representation of the distance between RMA normalized array samples of 
log2 probe intensities clustered by Pearson correlation. Samples labelled starting with AE are array 
samples harvested at 2 h intervals; AC means array samples harvested at 2 h intervals as the control 
group. Samples labelled starting with TE indicates array samples harvested at 6 h intervals as the 
experimental group; AC means array samples harvested at 6 h intervals as the control group.  
For the second array experiments, samples were harvested at 2 h intervals (Figure 2.9). Array 
samples were clustered into four major groups. Group G includes array samples collected 
from 14 to 22 h post serum refeeding (Figure 2.9). Group H includes the array samples 
collected from 8 to 12 h. Group I includes samples between 1 and 6 h. Group J includes 
samples harvested at 0 and 24 h after serum refeeding and two controls (Figure 2.9). 
PCA analyses show the grouping of samples according to array intensities before and after 
RMA normalisation (Figure 2.10). For array samples collected at 6 h intervals, the array 
intensity of samples with repeats at 0, 12, 18, 36, and 42 h were variously distributed, 
suggesting the diversities between samples harvested at the same time point (Figure 2.10A). 
RMA normalisation minimalized the diversity of array intensity of repeat sample at 0, 12, 





A                  Before Normalisation B                   After Normalisation 
  
Figure 2.10: Principle component analysis (PCA) using array probe reading intensities at 2 or 6 
h intervals A) before and B) after RMA normalisation. ‘C 0 h’ and ‘C 24 h’ represent the samples 
of control harvested at 0 and 24 h.  
 
Figure 2.11 Using network analyses to determine the continuity between 40 arrays following a 





For the samples harvested at 2 h intervals, PCA analysis suggests that samples were 
randomly distributed suggesting the probe reading intensities of each array is diverse (Figure 
2.10A). In contrast, RMA normalised array intensities shows an ordered position following a 
sequence of time points from 0 to 24 h, which means that sample harvested at one time point 
was similar between its neighbour time points. This suggests that the RMA normalisation 
minimised the diversity between samples harvested following an ordered time points e.g. 
samples harvested at 8, 10, and 12 h were closed to each other (Figure 2.10B). 
In Figure 2.11, network analysis was used to perform quality assessment of array samples 
composed of transcripts associated with the cell cycle. As can be seen, array samples from 
two time course experiments, across similar periods of each time point, were placed near to 
one another i.e. G0: time points at early stage of the cell cycle from 0 to 4 h, G1 early stage: t 
= 6 ~ 8 h, G1 late stage: t = 10 ~ 14 h, S, G2 and, M stage: t = 16 ~ 24 h, time points after t = 
24 h, and control. The array samples from two individual time course experiments, 
composed of cell cycle-associated transcripts, consistently follow a sequence of time points, 
suggests that the pipeline of data mining is reliable and robust.  
Identification of cell cycle-associated genes by network structure 
analysis 
After quality assessment, probes with normalised expression value of < 35 (normal scale) 
were filtered out, resulting in a total of 21,842 transcripts out of 33,298 evaluations (Figures 
2.11A and B). Using network analysis in BioLayout Express3D, a number of batch effects 
were found using a MCL-inflation value of 3.0 and r = 0.85. 4,400 (20%) transcripts, 
correlated with the pattern of batch effect, were filtered out, resulting in 17,442 transcripts 
(Figures 2.12B and C). Negative and positive controls of probe reading of array were 
removed, resulting in 14,882 transcripts remaining in the dataset (Figures 2.12C and D). A 
graph containing 10,184 nodes and 270,338 edges was generated based on the correlation cut 
off r = 0.85. The minimum size of sub-graph components included in the network was 6.  






Figure 2.12: Identification of genes with putative or unknown function clustered with the cell 
cycle-associated genes.  A) Transcripts with probe reading levels at natural scale of transcripts below 
35 (natural scale) were filtered, resulting in 21,842 transcripts in the dataset. B) A network structure 
composed of clusters of gene expression profile with batch effect was determined and filtered under 
the condition of r = 0.85, MCL-inflation value = 3.0, and smallest cluster number = 6, resulting in 
17,442 transcripts. C) Transcripts as negative and positive control of array were filtered, resulting in 
14,822 transcripts. D) Cell cycle-associated clusters i.e. non cell cycle-associated transcripts (63.3 %), 
G0-phase associated genes (16.7 %), G1-phase associated genes (12.8 %), and S-, G2/M-phase 
associated genes (7.2 %), were identified under the conditions of r = 0.85, MCL-inflation value = 1.7, 
and smallest cluster number = 6. E) 982 unique genes up-regulated during S-, G2-, and M-phase were 
identified. F) Array dataset composed of the cell cycle-associated transcripts clustered from the 
dataset at step C was assessed by network analysis at r = 0.96 ensuring the integrity between array 





















Figure 2.13: Clusters due to batch effect. Mean expression profiles of two types A) and B) of 
identified batch effect-associated clusters are calculated from the expression levels of all transcripts 
within the given clusters. Expression levels are plotted across different time-points of two 
experiments sampled at 2 h (plots with grey back ground) or 6 h (plots with white back ground) 
intervals of partially synchronized NHDF cells. 
Overview of temporal expressed genes in one cell cycle 
Following the removal of genes whose expression was not associated with the cell cycle, 
around 5,000 genes were placed in clusters and grouped based on four major waves of gene 
expression levels (Figure 2.12). To get an overview of the patterns of gene expression level 
at time points after serum refeeding, snapshots of the real-time gene expression level 
following a sequence of time points were animated by BioLayout Express3D at 2 h intervals 
(Figure 2.14). The higher the expression level of genes, the stronger the red colour is 
displayed; the lower the expression level, the weaker the red colour (stronger the blue) and 






Figure 2.14: Animation of cell cycle-associated gene expression levels at 2 h intervals following 
the serum refeeding. Nodes represent up-regulated transcripts and are coloured according to their 







        2 h interval                   6 h interval 
A                                          G0-phase (0 h) 
  
B                                           G1-Early-phase (0~6 h) 
  
C                                            G1-Late-phase (6~12 h) 
  
D                                             S-, G2-, and M-Phase (12~24 h) 
  
Figure 2.15: Four major waves of average clustered cell cycle-associated gene expression. Gene 
expression profile in two array data sets (array samples harvested at 2 and 6 h intervals) co-expressed 
with the cell cycle-associated genes were identified by network structure analysis classifying into A) 
G0-phase, B) G1-Early-phase, C) G1-Late-phase, and D) S-, G2-, and M-phase. Dashed lines represent 







Figure 2.16: Cluster analysis of time-course data for synchronized NHDF cells following serum 
refeeding. Transcripts of array samples were harvested from synchronized NHDF cells following 
serum refeeding in two repeated time-course experiments at 2 and 6 h intervals. Gene expression was 
measured across a sequence of time points on Affymetrix Human Gene 1.1 ST Arrays and a network 
graph of the data was built by BioLayout Express3D. The network was filtered to display only 
relationships with the cell cycle, resulting in a graph with 5,443 nodes (transcripts) connected by 
303,403 edges. The network composed of cell cycle-associated transcripts was then clustered using 
the graph-based clustering algorithm MCL, set at an inflation number of 1.7. Clusters of nodes sharing 
similar expression feature associated with different phases of the cell cycle were given the same 
colours. 
Based on the validation of known regulatory genes placed in clusters and their expression 
periodicity consistent with the cell cycle, it is suggested that construction of co-expression 
networks in BioLayout Express3D has identified 4,528 unique genes with an expression 
periodicity that correlates with cell cycle of the cells including 1780 G0-phase clustered 
genes, 885 genes up-regulated in the early stage of G1-phase, 881 genes expression peaked at 
the late stage of G1-phase, and 982 genes are associated with the genes in S-, G2-, and M-












Figure 2.17: 8 sub-clusters of the major cluster associated with S-, G2-, and M-phase. Number of 
clusters were categorised according to the size of sub-clusters belonging to the entire network 
structure. The size of each sub-cluster determines the order of their numbers. For example, the 
number of nodes in cluster 01 is bigger than cluster 170. For more details of sub-clusters please see 
table 2.2.  
To further investigate genes that clustered with known cell cycle-regulated genes, figure 2.17 
was used to demonstrate the network structure of a major cluster composed of 8 sub-clusters 
in different colours. Cluster 1 (901 unique genes) included the major population of genes’ 
expression profile associated with the S-, G2-, and M-phase. Cluster 57, 60, 62, 76, 86, 87, 








Functional annotation of the cell cycle-associated genes by GO slim 
mapping  
In Figure 2.18, the number of S/G2/M-phase genes categorised to the terms of the cell cycle 
and cell proliferation is higher than the number of genes associated with other cell cycle 
phases. In contrast, the number of G0-phase genes is higher than the number of genes 
associated with other phases in the cell cycle i.e. signal transduction, multicellular 
organismal development, metabolic process, ion transport, lipid metabolic process, cell 
differentiation, carbohydrate metabolic process, transport, and protein modification process. 
 
Figure 2.18: Profiling of the list of cell cycle-associated genes by GO slim mapping. A cut down-
version of GO ontologies was used to give a broad overview of functional categorized list of cell 
cycle-associated genes. Clusters of genes were categorized into different terms of biological 
processes.  
For example, the number of categorized genes in S- and, G2/M-phase is only one fifth of the 





cellular process where a signal is transferred to initiate the change of the state of cells, such 
as the regulation of transcription or metabolic process. This suggests that at the level of 
biological process, starved NHDF cells respond to the serum refeeding and re-enter a 
synchronized cell cycle. 
 
Figure 2.19: GO slims mapping of the cellular components of cell cycle-associated gene. The list 
of cell cycle-associated genes was categorized by a cut-version of GO ontologies based on cellular 
components. Terms of localised gene products in different phases of the cell cycle were simply 
classified into cytoplasm and nucleus.  
Using GO slims, the list of genes up-regulated in the cell cycle were mapped providing a 
profile of cellular location of gene products. The distribution of nucleus localised gene 
products in G0-phase is only around one third of gene products in cytoplasm (Figure 2.19). 
The distribution of gene products in G1-Early and late phase comprises nearly two thirds of 
the gene products located in cytoplasm. In contrast, during S-, G2-, and M-phase, protein 
expressed by genes in nucleus is around one and half times greater than in the cytoplasm.  
GO term enrichment analysis of clustered genes  
To further investigate clustered genes as their expression periodicities are in association with 
the cell cycle, they were investigated by GO term enrichment analysis i.e. genes that are up-
regulated in G0, G1-early, G1-late, and S/G2/M-phase. GO term ID enriched for associated 
genes, and their p-values were visualised in Figure 2.20. Details of enriched terms and genes 
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Figure 2.20: Bar chart showing the score of the top 20 GO term enriched by the analysis of 
genes clustered in A) G0, B) G1 Early stage, C) G1 Late stage, and D) S/G2/M-phase groups. 
Colour key of frequency shows the ratio of genes, which are annotated to specific GO term against 
input number of genes. Horizontal bar represents transformed p-value at –log10 scale. 
G0 1780 genes 
G1 Early  
885 genes 









    G0 (2080 transcripts, 1780 unique genes) 
Example regulatory genes: TFDP2, CDKN1A 
Cluster: 3, 5, 8, 13, 14, 23, 24, 26, 32, 36, 41, 42, 46, 55, 61, 73, 80, 81, 100, 104, 118,125, 131, 
138, 156, 157, 161, 162 
GO terms: sterol metabolic process, cholesterol metabolic process, lipid biosynthetic process 
 B 
   G1-E (1364 transcripts, 885 unique genes) 
Example regulatory genes: CCND1, CDK6, E2F4, E2F5 
Cluster: 2, 11, 18, 19, 20, 25, 29, 30, 31, 47, 48, 51, 56, 58, 68, 84, 98, 108, 120, 122,129, 133, 
143, 149, 153, 164, 175 




   G1-L (926 transcripts, 881 unique genes) 
Example regulatory genes: CCNE1, CCNE2, CDC25A, MNAT1, ORC5, MCM, CDC6, PPP2R1B 
Cluster 7, 9, 10, 37, 45, 49, 59, 70, 74, 99, 106, 119,160, 166,167, 178,179 
GO terms: protein transport, intracellular protein transport, protein localisation in organelle, 
ncRNA metabolic process, ribosome biogenesis, ribonucleoprotein complex biogenesis, tRNA 
metabolic process, rRNA metabolic process 
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   S/G2/M (1067 transcripts, 982 unique genes) 
Example regulatory genes: TOP2A, PCNA, MCM2, CCNA2, CCNB1, CCNB2, CDC25B, CDK1, 
BRIC5, BUB1, MAD2L1, CDC20, CENPF 
Cluster: 1, 57, 60, 62, 76, 86, 87, 109, 170 
GO terms: cell cycle, cell cycle process, mitotic cell cycle, cell division DNA replication initiation, 
G2 DNA damage checkpoint, DNA repair, chromatin assembly, DNA recombination, spindle 
organization, mitotic spindle elongation, attachment of spindle microtubules to kinetochore, mitotic 
cell cycle checkpoint, mitotic sister chromatid segregation 
 
 
Table 2.2: Number of transcripts, number of unique genes placed in four major clusters, sub-
clusters, and results of the enrichment analyses.  
In Table 2.2A, GO associations of clustered genes associated to G0-phase were enriched for 
the ‘sterol metabolic process’, ‘cholesterol metabolic process’, ‘lipid biosynthetic process’, 
and ‘isoprenoid metabolic process’, such as transmembrane 7 superfamily member 2 
(TM7SF2) were involved in the regulation of conversion of lanosterol to cholesterol [218]. 
In Table 2.2B, for clustered genes up-regulated between 0 and 6 h were enriched for the 





metabolic process’. Major biological events are relevant to transcription activities. For 
example, histone cell cycle regulator (HIRA) is involved in the regulation of histone gene 
transcription [219].  Signal transducer and activator of transcription 5A (STAT5A) responds 
to cytokines stimulation (i.e. interleukin 2 (IL-2)), shifting into the nucleus as a transcription 
activators [220]. 
In Table 2.2C, genes with peak expression between 6 and 12 h were enriched for the major 
biological activity as post-transcriptional regulation, including the GO terms ‘protein 
transport’, ‘intracellular protein transport’, ‘intracellular transport’ and ‘protein localisation 
in organelle’. For example, RNA binding motif protein 22 (RBM22) is involved in the 
positive regulation of RNA splicing [221]. Latent transforming growth factor beta binding 
protein 2 (LTBP2) belongs to the latent transforming growth factor (LTBP) family, which is 
involved in protein secretion [222]. Derlin 2 (DERL2) is involved in the endoplasmic 
reticulum (ER)-associated ubiquitin-dependent protein catabolic process [223]. This suggests 
that from 6 to 12 h after serum stimulation, the cell cycle regulation system progresses from 
the stage of the transcriptional level to the transcriptome level.  
In Table 2.2D, the list of genes up-regulated between 12 and 24 h was enriched by GO 
analysis for terms associated with the cell cycle from the beginning of S–phase to the end of 
mitotic activity, such as ‘DNA replication initiation’, ‘G2 DNA damage checkpoint’, ‘DNA 
repair’, ‘chromatin assembly’, ‘DNA recombination’, ‘spindle organization’, ‘mitotic spindle 
elongation’, ‘attachment of spindle microtubules to kinetochore’, mitotic cell cycle 
checkpoint, mitotic sister chromatid segregation’. Example genes of S-phase include DBF4 
Zinc Finger (DBF4), essentially to the initiation of DNA replication with Cell Division 
Cycle 7 (CDC7) [224]. Claspin (CLSPN) is involved in the G2/M checkpoint of DNA 
damage [225]. RAD51 paralog C (RAD51C) is important in activating the checkpoint kinase 
arresting the cell cycle for DNA damage [226]. Following S-phase, CCCTC-binding Factor 
(CTCF), a zinc finger protein, physically connects cohesion and chromatin [227]. In M-
phase, Centrosomal Protein 72kDa (CEP72) is involved in the recruiting of key centrosomal 
proteins to the centrosome, providing a focused bipolar spindle which gives proper tension 
between sister chromatids [228]. Protein regulator of cytokinesis 1 (PRC1) is involved in 
mitotic spindle elongation and is required for cytokinesis [229]. GO term enrichment 
analysis suggested that genes which were placed in these clusters and expressed between 12 
and 24 h following serum refeeding, were associated with the mitotic activity of the cell 





phase for the further study of putative novel genes e.g. the consistence of gene expression 
periodicity during S-, G2-, and M-phase, identification of mitotic-associated regulatory 
genes, and GO term enrichment. 
Identification of genes up-regulated in the cell cycle 
The four major waves of gene expression were observed and well correlated with the 
different phases of cell cycle (Figures 2.15 and 2.16). Using known cell cycle-regulation 
genes provided by the pathway browser ‘REACTOME’ and previously published literature, 
important cell cycle-associated genes were identified in four main clusters of their 
expression periodicity correlated with the cell cycle. 
Genes up-regulated in G0-phase 
Using the information provided by Hilary A. Coller et al, 2006, 29 known G0-phase 
associated genes in this main cluster were identified, suggesting that these genes were 
associated with a quiescent stage [22] i.e. important known G0-phase regulatory genes 
cyclin-dependent kinase inhibitor 1A (CDKN1A) [230] and cyclin-dependent kinase inhibitor 
2B (CDKN2B) [231] were both the inhibitors of G1-phase CDKs.  
Genes up-regulated during the early stage of G1-phase 
Following G0-phase, two waves of gene expression correlating with early and late stage in 
G1-phase were identified. Genes placed in G1-Early stage-associated clusters showed an 
increased expression level, peaking between 0 and 6 h (Figure 2.15B). In these clusters of 
the early stage of G1-phase (G1-ealry-phase), important cell cycle-regulated genes were 
identified as known G1-associated genes expressed following the serum refeeding i.e. 
regulatory genes cyclin D1 (CCND1) [232] and CDK6 [233] both play key positions during 
the G1-phase cell cycle control system. E2F transcription factor 4 (E2F4) and E2F 
transcription factor 5 (E2F5) are both involved in the positive regulation of transcription in 
the early stage of the cell cycle [234].  
Genes up-regulated in the late stage of G1-phase 
Clusters of genes with peak expression levels between 6 and 12 h were classified as G1-late 
stage associated genes (Figure 2.15C). In these clusters, important cell cycle-regulated genes 
were identified, determining that these clusters were associated with G1-phase, such as cyclin 
E1 (CCNE1) [232] and cyclin E2 (CCNE2) [235]. Example regulatory genes in the late stage 
of G1-phase, such as CDC25A which activates CDK2 in the progression from G1- to the 





involved in the stabilization of cyclin H/cyclin dependent kinase 7 (CDK7) complex, 
providing a functional CDK-activating kinase enzymatic complex [237]; Origin recognition 
complex, subunit 5 (ORC5) involved in the early stage of DNA replication, recruiting 
essential factors, such as CDC6 [238] and  MCM [239]; Protein phosphatase 2, regulatory 
subunit A, beta (PPP2R1B), involved in the regulation of extrinsic apoptotic signalling 
pathway [240]. 
Genes up-regulated in S-, G2-, and M-phase 
Clusters of genes up-regulated between 12 and 24 h following serum refeeding were 
identified as being associated with S-, G2-, and M-phase (Figure 2.15D). Comparison to the 
cell cycle-associated gene list from the REACTOME pathway database, there were 56 S-
phase regulated genes clustered with other genes. Regulatory genes, such as topoisomerase 
(DNA) II α (TOP2A), and proliferating cell nuclear antigen (PCNA) were used to determine 
the clusters. TOP2A is involved in the alternation of the topological state of DNA during 
transcription and replication [241].  
41 cell cycle-associated genes involved in the transition between G2- and M-phase were 
identified in S-, G2-, and M-phase associated clusters; essential regulatory genes such as 
cyclin A2 (CCNA2), cyclin B1 (CCNB1), cyclin B2 (CCNB2), and cell division cycle 25B 
(CDC25B) provided the best evidence for the identification. CCNA2 is essential in driving 
the cell cycle during G2- and M-phase and involved in the regulation of the mitotic G2-phase 
DNA damage checkpoint [242]. Proteins expressed by CCNB1 and CCNB2 both function as 
activators of CDK1 in mitosis [243]. CDC25B activates CDK1 in cytoplasm during S- and 
G2-phase and then conducts the cells into mitosis [244]. 
95 genes involved in M-phase were identified, such as CDK1, budding uninhibited by 
benzimidazoles 1 (BUB1) and cell division cycle 20 (CDC20) were used to identify clusters 
associated with mitotic activity in the cell cycle. BUB1 is a mitotic checkpoint kinase [217]. 
CDC20 revises the activation of mitotic anaphase-promoting complex activity [245]. For the 
rest of the example genes, BUB1 is involved in the regulation of mitotic spindle assembly 
[217]; MAD2 mitotic arrest deficient-like 1 (MAD2L1) is involved in positive regulation of 
the spindle assembly checkpoint [246]; centromere protein F (CENPF) is involved in 







Categorization of cell cycle genes in S-, G2-, and M-phase 
Following identification of the cell cycle genes up-regulated in different phases, a functional 
list was developed to profile cell cycle-associated genes. In order to further survey the 
function of identified genes in S-, G2-, and M-phase, defined annotations were used to 
classify the list of genes based on their characterization in the cell cycle. Associated terms of 
classification include ‘unknown function’ (Unknown function of genes expressed in the cell 
cycle), ‘unrelated function’ (Unrelated function of genes up-regulated in the cell cycle), 
‘putative association’ (Putative associated function of genes involved in the cell cycle 
regulation), and ‘known function’ (Known function of genes in the cell cycle). 
The key cell cycle-regulated genes were annotated as ‘known cell cycle associated function’; 
a good example is CCNB1. Genes potentially involved in the biological processes in S-, G2-, 
and M-phase were annotated as ‘putative associated function in the cell cycle’, for example 
ATPase family, AAA domain containing 2 (ATAD2) which may have a role in the 
modification and co-regulation of occupancy of chromatin [248]. Known genes up-regulated 
in S-, G2-, and M-phase, without direct evidence of involvement, were annotated as 
‘unrelated function in the cell cycle’, for example achalasia, adrenocortical insufficiency, 
alacrimia (AAAS) which may play a role in the development of the nervous system [249]. 
Genes without supportive information to indicate their roles either in cell proliferation or 
biological activities were annotated as ‘unknown function’, for example chromosome 17 
open reading frame 53 (C17orf53).  
Manual curation and functional annotation of genes  
To further refine the list of S-, G2-, and M-phase genes, genes that are highly expressed in 
human cells and tissues with high levels of cell proliferation were selected. Of 982 clustered 
genes that were up-regulated during S-, G2-, and M-phase genes, 623 of them were found to 
also be highly expressed across different human cells and tissues. In addition, 83 genes that 
appear to be up-regulated during S-, G2-, and M-phase were selected from our array dataset 
whilst they were also highly activated between various human cells and tissues. This resulted 
in a total number of 706 genes of interest. 
Manual curation showed that 484 of these are known cell cycle-associated genes, 75 have 
known roles in other biological processes, 78 are genes with putative association to the cell 





process and potentially represent new components of the cell cycle machinery. This table 
was developed leading by Prof. Freeman’s group (Table 2.3).  
In table 2.3, the functional gene annotation categorised genes of interest into four major 
groups, including 1) the genes with known cell cycle function (i.e. 484 genes), 2) genes with 
a putative role in the cell cycle (i.e. 78 genes), 3) genes co-expressed with known cell cycle-
associated genes but with poor information determining their involvement (i.e. 69 genes), 
and other known genes involved in non-cell cycle events (i.e. 75 genes).  
Known cell cycle-associated genes 
Of the genes classified as known S-, G2-, and M-phase associated (484 genes), 113 genes are 
involved in the cytokinesis pathway, 99 genes are involved in chromatin organisation, 91 
genes are involved in DNA repair, 58 genes are involved in DNA synthesis. In addition, 52 
genes are involved in the cell cycle regulation, 36 genes are involved in centrosome 
maturation and duplication, 15 genes are involved in nucleotide biosynthesis, 15 genes are 
involved in the transcription regulation network, and 5 genes are involved in G1/S phase 
transition. The following paragraphs are a summary of the population of genes involved in 
different biological process driving the cell cycle. 
Of the 113 genes that are involved the cytokinesis pathway, one of the biggest sub-groups is 
the kinetochore complex pathway e.g. spindle and kinetochore associated complex subunit 1 
(SKA1) [250]. Another sub-group is the family of kinesin-associated genes e.g. Kinesin 
Family Member 15 (KIF15) which is involved in the mitotic spindle assembly [251]. It is 
interesting that for the 99 genes which are involved in chromatin organisation, histone family 
genes occupy the biggest proportion of sub-groups including 56 genes e.g. histone cluster 1, 
H1a (HIST1H1A) [252].  
For the known genes that are involved in DNA repair pathways, it is interesting that the 
biggest population of gene family is fanconi anemia (FA) associated genes. FA is a genetic 
disease induced by a genetic defect in a cluster of proteins involved in DNA repair. For 
example, fanconi anemia, complementation group A (FANCA) encodes a DNA repair protein 
[253]. Another interesting group of genes are involved in X-ray repair e.g. X-ray repair 
complementing defective repair in chinese hamster cells 1 (XRCC1) involved in the 
correction of defective DNA strand-break repair [254].  
In addition, of those genes that are involved in DNA synthesis, there are 9 genes belonging 





complex component 6 (MCM6) that initiates the DNA duplication [255]. Others such as 
genes encoded for polymerase, replication factors, and origin recognition complexes, provide 
consolidated evidence to determine the rotation of cell cycle e.g. polymerase (DNA 
directed), α1 (POLA1) is involved in the initiation of DNA replication [256].  
For genes involved in the regulatory network of cell cycle, the most import evidence is the 
up-regulation of cyclins (i.e. cyclin A2, B1, B2, and F), CDKs (i.e. CDK1, 2, and 4), 
determining the rotation of the cell cycle. For genes that are involved in the centrosome life 
cycle (i.e. 36 genes), this group includes the HAUS augmin-like complex and centrosome 
protein family e.g. HAUS augmin-like complex, subunit 1 (HAUS1) and centrosomal protein 
135kDa (CEP135). Proteins encoded by HAUS family involves in the regulation of mitotic 
spindle assembly [257]. CEP135 is the core elements of the cartwheel structure of 
centrosomes [258].  
Putative cell cycle-associated genes 
For putative cell cycle-associated genes, 24 genes were thought to be involved in nuclear 
transport, 11 genes were potentially involved in apoptosis, 8 genes were potentially involved 
in RNA processing, 4 genes may play roles in transcription regulation, and 3 genes had 
putative function in ubiquitination.  
Of those proteins encoded by genes, which were thought to involve in the apoptosis (i.e. 11 
genes), 6 of them were located at the nucleus, the others were with poor information. For 
genes, which are labelled as nuclear transport, 12 of these are localised at the nuclear 
membrane, 5 of them are localised at the nucleus and the others are remained unknown. 
Other genes localised at the nucleus are associated with the biological processes of RNA 
processing, transcription regulation, and ubiquitination.  
Co-expressed genes with unknown function in the cell cycle  
Of unknown function genes that co-expressed with the known genes in the cell cycle, 56 of 
69 genes were found with poor information to locate their role in the cell cycle-associated 
events. For the rest, 12 of them were zinc finger proteins, which are in association with the 
transcription but with poor information to determine their role in the cell cycle pathways. 
One of them is associated with the metabolism at mitochondria but has no information 
relevant to the cell cycle (i.e. farnesyltransferase, CAAX box, beta (FNTB)) [259].  
For the genes with known function but which are not involved in the cell cycle, they were 





having “other functions”. 20 genes were found to be involved in RNA processing. The others 
were found to be involved in metabolism, transcription, and ubiquitination. 
Known S/G2/M-phase protein 484 
Chromatin organisation 99 
Cytokinesis 113 
DNA repair 91 
DNA synthesis 58 
Centrosome maturation and duplication  36 
Regulation of cell cycle 52 
Transcription regulation  15 
Nucleotide biosynthesis 15 
G1-S phase transition 5 
  
Putative association 78 




RNA processing 8 
Transcription regulation 4 
Ubiquitination 3 
  Unknown function 69 
Metabolism 1 
Transcription regulation 10 
Transcriptional regulation 2 
Unknown 56 
  
Unrelated function 75 
Metabolism 8 
Other 40 
RNA processing 20 











Serum deprivation dependent technique can provide samples with 
up-regulated gene expression correlated with the progression of the 
cell cycle 
As can be seen from Figure 2.21, there are inconsistent expression features of genes in 
fibroblasts synchronized by different techniques, such as serum deprivation and serum 
deprivation with additional thymidine block. This suggests that different synchronization 
techniques may potentially result in distinct gene temporal expression profiles. In contrast, 
patterns of temporal transcription of cell cycle-associated genes are similar to results of gene 
expression provided by the serum deprivation dependent techniques of Bar-Joseph, et al., 
2008 (Figure 2.21) [98].  


















Figure 2.21: Unrepeatable expression features of genes.  Gene expression profile of the cell cycle 
between fibroblasts synchronized by serum deprivation (plots with grey back ground) and fibroblasts 
synchronized by serum deprivation with additional thymidine block (plots in white background) 
across different time points. A. Peak expression at 0 h of genes after medium replacement. B. Peak 
expression between 0 and 6 h of genes after medium replacement. C. Peak expression between 6 and 
12 h of genes after medium replacement. D. Peak expression of genes 12 h after medium replacement. 






In order to identify cell cycle-associated genes up-regulated in S, and G2/M-phases, human 
NHDF cells were synchronized by serum deprivation and RNA was extracted for microarray 
analysis followed by network analysis. Results demonstrate that serum deprivation was 
successfully used to generate a major population of cells with a synchronized cell cycle. The 
effectiveness of cell cycle synchronization was determined by flow cytometry. Under the 
condition of starvation, the cell cycle regulation system holds cells at a quiescent stage (G0) 
which is a natural physiological response to serum deprivation [260].  
To understand the cell cycle regulation mechanism at the transcriptional level, two array 
experiments were used to globally survey the pattern of gene expression. Genes with a 
similar profile of temporal expression were clustered by network structure analysis. The 
presence of known cell cycle genes in four major clusters was used to identify which phase 
of the cell cycle that each cluster was associated with. To further understand the biological 
role of clustered genes, the enrichment of GO term analysis was used to functionally profile 
the set of genes in a cluster. Four major clusters of genes associated with the cell cycle were 
found to be enriched for the terms associated with ‘sterol metabolic process (G0)’, 
‘transcriptional regulation (G1-Early)’, ‘protein transport (G1-Late)’, ‘DNA replication (S)’, 
and ‘mitotic sister chromatid segregation (G2/M)’. This suggests that the lists of genes in 
these four major clusters are associated with the terms of particular biological processes in 
the cell cycle.  
In order to profile the genes up-regulated in S-, G2-, and M-phase, they were manually 
annotated using published data. Of the genes identified in the S, G2/M-associated clusters, 
484 genes were genes were already known to be involved in the cell cycle, 69 were novel 
genes with unknown function, 78 were genes with putative cell cycle function, and 75 were 
genes with a known function that is unrelated to the cell cycle. This suggests that clustering 
based on similarity of expression is a good way to study complex biological systems. 
Furthermore, using the latest array technologies, graphic based network structure analysis is 
capable of providing a new insight into cell cycle-associated gene profiling.  
Synchronization of cells by serum deprivation  
In order to survey the cell cycle-associated genes that peak in expression during S-, G2-, and 





synchronized cell cycle [7]. Synchronization by serum deprivation was attempted for three 
different cell lines; HEK293T, THP-1, and NHDF. 
Synchronization of cell cycle was not achieved with HEK293T cells 
The HEK293T cells were starved for 48 h and then stimulated by serum refeeding. The 
synchrony was then determined by flow cytometry 20 h after serum refeeding. The serum 
deprivation didn’t arrest the cell cycle of HEK293T cells. This suggests that a serum-
dependent technique is not appropriate to generate a major population of synchronized 
HEK293T. This is because the HEK293T is a cell line transformed with SV40 large T 
antigen. This is a proto-oncogene derived from polyoma virus SV40, which can potentially 
transform host cells into tumours. SV40 large T-antigen binds and inactivates tumour 
suppressor proteins (p53, p105). This causes the cells to leave G1-phase and enter into S-
phase, promoting DNA replication. HEK293T cells are therefore not good candidates for 
synchronizing by serum starvation since the presence of SV40 T antigen is promoting DNA 
replication [202].  
Synchronization and loss of synchrony of THP-1 cells after first 
division 
THP-1 is a suspension cell line cultured from the blood of an acute monocytic leukemia 
patient [9]. THP-1 cells were starved in 0.2% serum for 48 h and then stimulated by serum 
refeeding. Around 75% of the cell population was found in G0/G1-phase just 48 h after 
starvation suggesting that serum deprivation can arrest the cell cycle of THP-1 cells. 
However, only 18% of cells left quiescent stage and re-entered the cell cycle 24 h after 
serum refeeding. It has been suggested that the synchrony of cells diminishes each time they 
pass the G1-phase in an exponential culturing system i.e. each cell divides independently 
with unsynchronized cell cycle in the exponential growth culturing system [7]. The longer 
the doubling time the higher the possibility that cells may lose their synchrony between each 
other. It might be that a long doubling time for THP-1 cell proliferation (the average 
doubling time is 50 to 70 h [9]) results in a smaller synchronous cell population than cell 
types with a shorter doubling time, such as NHDF, which has a doubling time of about 25 
hours [8]. Nevertheless, it has been suggested that an ideal cell line for synchronization 
should not have doubling time above 30 h [9]. Serum deprivation is therefore not believed to 






Serum deprivation can generate a major population of synchronized 
NHDF cells  
The serum dependent technique can efficiently generate a major group of NHDF cell 
population at a quiescent stage; 85.2% at G0/G1-phase, 8% at S phase, and 6.9% at G2/M-
phase (Figures 2.5 and 2.6). The NHDF cells were released from the quiescent stage 
reaching mitosis 18 h after serum refeeding (Figure 2.6). This renders a major population of 
cells with synchronized transcriptional activity and is consistent with the result of array 
analyses [22,96,98]. Encouraged by the effectiveness of serum deprivation, NHDF cells were 
therefore chosen to be synchronized and to be used for array analyses.   
This technique has been widely used in a number of important microarray experiments to 
classify the cell cycle genes [22,96,98]. It is also has been suggested that the feature of 
transcriptional regulation is relevant to the cell physiology in cells synchronized by serum 
starvation [261]. In contrast, the serum independent technique, such as chemical 
synchronization, has disadvantages in synchronizing the cells. It is believed that chemical 
treatment is potentially linked to the possible disruption of normal cell cycle regulation 
unbalancing the cell growth. For example, Gong et al., 1995 [262] showed that cyclin E and 
B1 were over expressed in thymidine, mimosine, or aphidicolin synchronized human cells.  
In addition, Kung et al., 1990 [263] suggested that short term exposure of aphidicolin or 
colcemid between 12 to 18 h may result in an unscheduled G2/M-phase in the cell cycle. To 
study the cell cycle, it is therefore important that serum deprivation can provide cells with 
synchronized transcriptional activity at normal expression level.  
In order to check the synchrony of the cell cycle after serum refeeding, total RNA was 
isolated from NHDF cells at a sequence of time points with regular intervals and then 
analysed by RT-qPCR. For marker up-regulated in S-, G2-, and M-phase, the profile of 
mRNA expression suggests that the G2/M-phase genes CDK1 and BUB1 were both up-
regulated at 24 h following the serum refeeding. This confirmed the achievement of 









Reproducibility of biological replicates of array samples 
A Pearson correlation matrix of the normalized signal intensity of array samples were 
calculated to test whether the two experiments were reproducible. First, biological repeats of 
array samples in both experiments were placed together (Figure 2.9). Second, the position of 
array samples in the clustering hierarchy tended to follow the time course (Figures 2.9B, C, 
E, F, G, H, I, J). It can be concluded that the two array experiments were reproducible.  
Batch effect between experiments 
After the reproducibility had been validated by a Pearson correlation matrix, network 
structure analysis was used to cluster genes based on their temporal expression profiles. It 
was found that of two major clusters, the level of batch effect expression profile was higher 
in one experiment than another and vice versa (Figures 2.13A and B). To further test whether 
the associated terms of biological process of identified genes were not associated with the 
cell cycle, GO term enrichment analysis was used to profile the list of genes.  The result 
suggests that the associated terms of biological process are not associated with the cell cycle, 
such as ‘Parkinson’s disease’. It is possible that these genes were randomly expressed. 
GO slim mapping of cell cycle-associated genes 
In order to give a quick and broad profiling of the distribution of genes in the cell cycle, the 
list of cell cycle-associated genes were mapped with GO slim, a cut-down version of the GO 
ontologies. GO slim consists of a subset of terms compared to the full version of GO. The 
number of G0-phase genes, which are associated with the terms of specific biological events 
is higher than the number of genes belong to S-, G2-, and M-phase e.g. signal transduction, 
multicellular organismal development, and metabolic process. In contrast, the list of gene 
relevant with the term for cell cycle for S-, G2-, and M-phase is higher than for G0-phase. 
Relevant biological processes with the associated term of cell cycle of the listed genes in S-, 









GO term enrichment analysis of cell cycle-associated genes clustered 
by network structure analysis 
Following a quick GO slim profiling of genes identified by network structure analysis, the 
full-scale GO analysis was used to further subset the genes by associated terms of biological 
process. In the major cluster associated with G0-phase, around 1780 genes up-regulated 
during this phase were clustered into 28 clusters by network structure analysis (Figure 2.18). 
The lists of genes in the biggest cluster (688 genes) and third biggest cluster (120 genes) 
were enriched by GO analysis for the term associated with ‘chromosome organization’.  
A good example is that known gene i.e. inhibitor of growth family, member 4 (ING4) and 
tumour protein P53 (TP53) were both clustered together. The protein expressed by gene 
ING4 involved in chromatin remodelling and TP53 regulation [264]. TP53 is a well-known 
tumour suppressor protein expressed at a low level in normal cells, involved in 
transcriptional activation, and DNA binding. In response to cellular stress, such as serum 
deprivation, the half-life of TP53 is dramatically increased resulting in fast accumulation of 
gene products in the cell arresting the cell cycle [265]. 
On the other hand, the list of G0-phase associated genes in the second largest cluster (cluster 
05, 487 genes) was enriched for the term ‘lipid biosynthetic processes. It has been reported 
that serum deprivation dramatically increases the level of lipid biosynthetic process in order 
to increase lipid stability in stressed human cells for survival [266]. The up-regulation of 
genes associated with the biological process of lipid biosynthesis suggested that cells were 
under stress caused by serum deprivation.   
G0-phase genes up-regulated in fibroblasts were previously reported by Coller et al., 2000. 
The author suggested that: i) quiescent stage is not an extended period belonging to G1-
phase, but an individual phase with correlated regulatory genes based on identified 
expression features from array analysis, ii) genes with up regulation during this stage 
suggests that quiescence is an active stage of the cell cycle, and iii) many changes of gene 
expression levels were found after arresting the cell cycle for more than a 24 h arrest [22]. In 
addition, the quiescent-associated genes were found to be involved in the suppression of 
apoptosis and differentiation, which prevented the reversible cell cycle arrest. This explains 





There are 27 clusters (885 genes) and 17 clusters (881 genes) found to be associated with the 
early and late stage of G1-phase in the cell cycle, respectively (Figures 2.18 and 2.19). In the 
early stage of G1-phase, the list of genes in the biggest cluster (724 genes) of the G1-early 
phase major cluster was enriched for the term ‘RNA processing’. In addition, the list of 
genes placed in the second biggest cluster (132 genes) of G1-early phase major cluster was 
enriched for the term ‘regulation of transcription’.  
It has been suggested that due to the degradation of RNA molecules in G0-phase, the proteins 
are therefore not able to resynthesize rapidly maintaining the balance in need. The efficiency 
of macromolecular syntheses is therefore only around one-third compared to regular cells 
[268]. Following serum refeeding, cells responded to the serum stimulation. In order to re-
enter the cell cycle, the efficiency of RNA processing and protein re-synthesis must be 
recovered to regular efficiency in normal cells depending on high regulation of associated 
genes. The associated biological terms of ‘RNA processing’ and ‘regulation of transcription’ 
of genes up-regulated in the early stage of G1-phase suggests that the cells were entering the 
cell cycle.  
In the late stage of G1-phase, the list of genes was found to be enriched for the terms 
associated term ‘RNA processing’ and ‘intracellular transport’, suggesting that the response 
of cells shifted from the transcriptional level to proteomic level. This is consistent with the 
discovery by Campisi et al., 1984, that the cells initiated DNA synthesis 12 h after serum 
refeeding [260,269]. The change of biological activity starting from the early to late stage of 
G1-phase suggests that i) cells re-enter the cell cycle, ii) cells started to prepare for the 
mitotic activity.  
There are in total 9 clusters (982 genes) which contain identified genes up-regulated during 
S-, G2-, and M-phase (Figure 2.21). In the GO enrichment, the list of genes placed in the 
biggest cluster of S-, G2-, and M-phase (901 genes) was enriched for the terms ‘cell cycle’, 
‘M phase’, ‘DNA metabolic process’, ‘chromosome segregation’, ‘microtubule-based 
process’, ‘chromosome organization’, ‘mitotic cell cycle’, and ‘cell cycle checkpoint’. It is 
notable that the associated biological process of GO term ‘cell cycle’ was only enriched for 
the clusters of gene up-regulated in S-, G2-, and M-phase. This suggests that genes with 
unknown function clustered with key cell cycle-regulated genes potentially involved in the 
progression of cell cycle. This result of GO term enrichment analysis suggests that using 
network structure analysis is a robust strategy to forecast the role of genes with unknown 





How to develop a functional list of cell cycle-associated genes  
Due to the complexity of various annotations from identified genes, the functional gene list 
should be manually annotated. A functional list should include the stage which genes were 
associated with, function of expressed genes, and annotated by universal annotation system, 
such as cell cycle genes list of Coller, et al., 2006 [22] and Bar-Joseph, et al., 2008 [98]. In 
addition, different annotations of each gene should also be summarized in the table. For 
example, this list should include the symbol of genes, description of genes, genomic location 
of genes, associated phase in the cell cycle of genes, associated function of genes in the cell 
cycle e.g. Entrez ID [270], ENSEMBL ID [216], GO term annotation [271], UNIGENE ID 
[272], UniPort (universal protein resource) ID which catalogue functional proteins 
supporting biological research [273], and reference numbers of genes with associated 
functions. 
Functional annotation of genes manually curated according to 
published literatures 
Given a functional gene list curated mainly based on the literature mining, we found that 484 
of 706 genes of interest were involved in important mitotic cell cycle biological processes, 
including DNA repair, synthesis, chromatin organisation, and centrosome duplication in S-
phase. The M-phase biological processes include cytokinesis. This key evidence of gene 
expression profile of cell cycle and other clustered genes sharing similar periodicity strongly 
suggesting these groups of genes are relevant to the cell cycle.  
Our analyses based on the manual curation found 78 co-expressed genes of interest were 
putatively involved in cell cycle-associated events but without clear evidence according to 
literature mining. 69 co-expressed genes of interested were with unknown function. To 
forecast their putative role in the cell cycle regulation, subcellular localisation of proteins 
encoded by the genes of interest were curated according to literature mining. It is interesting 
that they are mostly located in association with the nucleus, suggesting that there may be 
numerous unknown pathways involving this cell cycle regulatory network.  
In contrast, for the co-expressed genes labelled as unknown cell cycle gene (i.e. 69 genes), 
there was a lack of information to provide their location in the cells according to literature 
mining, suggesting less than half are associated with the nucleus (i.e. 22 genes). The others 





Further experimental analyses are needed to identify and characterise their role in the cell 
cycle.  
In comparison with the GO analyses that enrich the major biological events of associated 
genes, functional annotation evidenced by published literature providing detailed 
information from major biological processes to subcellular location in our analysis.   
The transcription feature in cells synchronized by the serum 
dependent technique is different from chemical treatment 
It has been suggested by Coller et al., 2006 that the population of genes up-regulated in G0-
phase may potentially be different due to the techniques used to arrest the cell cycle [22]. 
This suggests that different conditions of synchronization may result in various transcription 
profiles in the cells. However, they only provided evidence at the quiescent stage rather than 
an entire cell cycle. Therefore, to further profile the difference of gene expression between 
NHDF cells synchronized either by chemical or serum dependent techniques, the data set of 
Bar-Joseph, et al., 2008 was reanalysed by network structure analysis [98]. In that 
experiment, chemical and serum dependent techniques were both used to synchronize cells 
and then profiled transcription by array analyses. Time series dataset of gene expression 
were then clustered into four groups of cell cycle-associated genes.  
In Figure 2.15, the transcription profile of cell cycle-associated clusters suggests that the 
temporal expression level of genes in cells synchronized by serum deprivation were up-
regulated following a complete cell cycle. It was also found that the profile of temporal gene 
expression in NHDF cells synchronized by serum deprivation shared higher similarity 
between my results and those of Bar-Joseph, et al., 2008 suggesting the reproducibility 
between two individual experiments [98]. In contrast, cells synchronized by thymidine block 
didn’t provide a cell cycle expression profile associated with each phase of the cell cycle. 
This evidence may explain why chemical dependent synchronization may potentially induce 
the transcription activities irrelevant to the cell physiology [261-263]. 
In summary, a total number of 706 genes were thought to be associated with cell 
proliferation. Of this cell cycle list, 69 genes were co-expressed during S-, G2-, and M-phase. 
To further investigate their role in cell division, loss of function analysis (i.e. RNAi), and 
subcellular protein localisation were used to characterise their role in the cell proliferation in 





Chapter 3.  




In Chapter 2, we identified 706 genes up-regulated during the S-, G2- and M-phase, 69 have 
not previously been associated with the cell cycle and potentially represent new components 
of the cell cycle machinery. In order to provide evidence that these unknown cell cycle-
associated genes are involved in cell proliferation, we developed an esiRNA screening assay 
to identify the effect of gene knock down on the cell proliferation by using a RTCA system 
[115].   
RNAi induced gene silencing is a mechanism that mediates mRNA degradation. Degradation 
is initiated by the presence of double-stranded RNA (dsRNA) that shares homologous 
sequence with a targeted gene [121]. However, genes sharing similar sequence to a targeted 
gene may result in an off-target effect of RNAi induced gene silencing [140].  
To minimize the off-target effects, Ralf et al., 2007 [132] and Frank et al., 2006 [144] 
developed esiRNA. This process of enzymatically preparing dsRNA provides a 
heterogeneous population of siRNAs that target many different regions of an mRNA, and 
results in a dilution of off-target effects. esiRNA has been shown to efficiently knock down 
the expression of targeted genes in human cells [145]. Since gene silencing was first 
demonstrated in mammalian cells by Elbashir et al., 2001 [121], this technology has been 
widely used to investigate the function of genes in biological systems combined with HTS 
[125].  
The application of RNAi screening combined with HTS has been used to investigate gene 
function in cells from many different species, for example Drosophila [130,139], C. elegans 
[131], mouse [133], and human [132,146]. In order to deal with the large number of 
measurements from silenced genes in HTS, most researchers use a Z-score to determine the 
hits from a screen [130-135,147,148]. A Z-score is a statistical measure of a score’s 






This type of analysis calculates a Z-score for a specific time point. However, end-point 
analysis can only provide a ‘snapshot’ at a particular time point and may miss differences 
that might be present at other times during the experiment. In order to analyse the real time 
data from the RTCA experiments, it is therefore necessary to calculate a score based upon all 
or part of RTCA profiles.  
The best way to analyse the effect of RNAi on the cell proliferation is therefore over time to 
monitor the effect of gene knock down. RTCA is a technology that indirectly monitors cell 
proliferation based on changes in electrical impedance as cells divide in a culture dish. 
Electrical impedance of cells is detected via a gold microelectrode array that covers the base 
of a well and recorded as CI, based on the electrical conductance of the membrane lipid 
bilayer of living cells.  [145,154-157]. In an RTCA experiment, CI increases as cells grow; 
this is roughly equivalent to cell proliferation although CI also increase if cells spread out 
and adhere more tightly to the base of the well. We have used RTCA analysis to analyse the 
effect of knocking down specific proteins and used a modified Z-score cut-off suggested by 
Zhang et al., 2011 to quantify the effect of RNAi on the cell proliferation [115,274]. 
In this analysis, 42 and 28 genes with unknown and known function in the cell cycle were 
screened by RNAi. In doing so, I have provided supporting evidence that these genes are 
novel components of the cell proliferation. I have carried out RNAi induced gene silencing 
experiments to demonstrate the effect of their knock down on the proliferation profile of 












Materials and methods 
The RTCA system is a highly sensitive real time cell monitoring system that utilizes an array 
of electronic sensors on the base of cell culture wells to measure impedance. In order to 
optimise conditions for the RNAi screen, a number of parameters were investigated. Firstly, 
laminin coating the wells was tested to evaluate its effect on cell proliferation compared with 
uncoated wells. Secondly, in order to analyse the effect of RNAi on CIGR over time, an 
experiment was performed to find the optimal seeding density. Thirdly, knowing that 
cytotoxicity of the transfection reagent can lead to a synchronized cell cycle of plated cells 
[115], a number of transfection reagents were tested to evaluate their effects on cell 
proliferation. Fourthly, the knock down efficiency using two types of RNAi was compared 
and contrasted (Smart Pools of siRNA vs. esiRNA). Unknown cell cycle genes identified in 
Chapter 2 were then screened for the effect of RNAi knockdown. The knocking down that 
decreased or increased cell proliferation, was determined by a process of evaluation and 
scoring.  
RTCA measurement of cell proliferation 
The real time cell analyser (RTCA, xCELLigence Roche, Penzberg, Germany) system was 
used to monitor the change of cell impedance over time. A RTCA profile of cell dynamics is 
positively correlated with the coverage of adherent cells and detected by microelectrodes in 
the base of wells [275]. Prior to measuring CI before and after transfection across a number 
of time points, a background impedance measurement was recorded by adding 100 µl of 
DMEM with 10% (v/v) FBS and with antibiotics (25 U/ml penicillin and 25 μg/ml 
streptomycin) to all wells of the plate. Cells at seeding density of 6,000 cells/cm2 were then 
plated equally in each well with 100 µl of complete medium.  
The 96 well E-plate (with NHDF cells) was then docked on the xCELLigence cell analyser 
SP (96-well signal E-plate) station and recording of CI commenced (Figure 3.1 A). Readings 
were taken every 15 min for the first 200 sweeps (turns), every 30 min for the next 200 
sweeps, and finally at 60 min intervals for the last 100 sweeps. Data was obtained as an 









Figure 3.1: Experimental design of 96 well E-plate for real time RNAi screening. A) Time line of 
experiment from cell plating at t = 0 h to transfection conducted by silenceMagTM at 24 h for 30 min 
followed by replacement of medium. The development of RNAi on cell proliferation was then 
monitored by RTCA system. B) Example of the layout of cells in a 96 well E-plate given esiRNA 
targeting the genes of interest. 
Optimization of seeding density and plate coating 
NHDF cells were plated in 96 well E-plates for the RTCA system at a seeding density of 
250, 500, 750, 1,500, 3,000, and 6,000 cells/cm2 in DMEM (Sigma-Aldrich, Gillingham, 
UK) with 10% (v/v) FBS (Heat inactivated serum, GE Healthcare, Little Chalfont, UK), and 
antibiotics (25 U/ml penicillin and 25 µg/ml streptomycin, Life technologies, Paisley, UK). 
Serially diluted cell densities were plated to test the correlation between seeding density and 
the exponential growth phase in cell proliferation. Cells were grown in 5% CO2, at 37oC.  
To optimize conditions for culturing NHDF cells in 96 well E-plates, laminin (Life 
technologies) at concentration of 50 µg/ml was used to coat wells and was compared to 
uncoated wells. Laminin was added to each well and left for 3 h, before washing with 1xPBS 








Optimisation of Transfection  
Lipofectamine® 2000 transfection  
Lipofectamine® 2000 (Life technologies) is a cationic lipid compound mediating the 
formation of RNA-cationic lipid complexes which fuse with the negative charged cell 
membrane [276,277]. NHDF cells were plated in 6 well plates in complete medium at a 
seeding density of 6,000 cells/cm2 and cultured for 24 h before addition of transfection 
reagents. For the transfection of each well, esiRNA was prepared by combining 3 µl of 
esiRNA at a stock concentration of 0.5 or 5 µM (for the final concentration at 5 or 50 nM of 
esiRNA, respectively) and 27 µl Opti-MEM (Life technologies). To prepare the transfection 
reagent, 1.5 µl of lipofectamine® 2000 was mixed with 28.5 µl Opti-MEM. The solutions 
were then left at room temperature for 5 min, before being combined and left at room 
temperature for a further 25 min (total volume 60 µl). The combined solution was then 
mixed with 240 µl serum-free medium and added to NHDF cells. Cells were cultured for 24 
h in an incubator at 37oC with 5% CO2 before being replaced with complete medium.  
SilenceMagTM  
The transfection reagent silenceMagTM (OZ bioscience, Marseille, France) comprises of 
positive nanomagnetic particles mediating the formation of RNA-particle complexes, 
delivering RNA by the magnetic force provided by a strong magnetic plate (OZ bioscience) 
[278].  For each sample of silenceMagTM reagent transfections, 6 µl of esiRNA at 5 µM or 
0.5 µM (for the final concentration of esiRNA at 5 or 50 nM respectively) was mixed with 6 
µl ddH2O and 6.6 µl reagent silenceMagTM. The transfection reagent mix was added to a 
total volume of 600 µl antibiotic free medium which was then added to each well at the 
seeding density of 3,000 cells/cm2. Cells in a 6 well plate were placed on a strong magnetic 
plate in an incubator at 37oC with 5% CO2 for 30 min before replacing the medium with 
complete medium. Samples of total RNA were harvested from each well individually.   
RT-qPCR 
To test the knock down efficiency of targeted genes selected by array dataset analysis, cells 
were analysed at 48 h after esiRNA induced gene silencing and knock down tested by RT-
qPCR. RNA samples were isolated by adding 350 µl buffer RLT (Lysis buffer for lysing 
cells prior to RNA isolation, QIAGEN, Manchester, UK) per well of a 6 well plate at 48 h 
after transfection. Extraction was performed using the RNeasy Mini Kit (QIAGEN) and total 
RNA was isolated according to manufactures’ instruction. 0.5 µg of total RNA was used for 





analyse known and unknown cell cycle genes are shown in Table 3.1. GAPDH was used as a 
control.  
Analysis of cell viability 
Before transfection, NHDF cells seeded at a density of 6,000 cells/cm2 in 25 cm2 TC flasks 
were cultured for 24 h in DMEM (Sigma-Aldrich) with 10% (v/v) FBS (GE Healthcare), and 
antibiotics (25 U/ml penicillin and 25 μg/ml streptomycin) (Life technologies). 
SilenceMagTM transfection with 50 nM esiRNA was performed in antibiotic-free DMEM 
with 10% (v/v) FBS for 30 min before replacing with complete medium. Samples were 
harvested 72 h after transfection and 1 × 106 cells were stained with SYTOX® Blue (Life 
technologies) at 1 µM for 5 min before analysis using BD FACS Aria lllµ Cell Sorter (BD 
bioscience, Oxford, UK). Data was analysed by BD FACSDiVaTM software (BD bioscience). 
 



























GAPDH Hs_GAPDH_2_SG QuantiTect Primer Assay (200) (QIAGEN, Manchester, UK) 
  
 
Table 3.1: Primer sequences used in qPCR analysis. F and R refer to forward strand and reverse 







RNAi screening in RTCA measurement over time 
The library of esiRNAs (endoribonuclease-prepared short interfering RNAs) employed here 
has been described elsewhere [146,279,280]. Cell cycle-regulated gene CCNB1 was chosen 
as a positive control. CCNB1 is essential to regulation of mitosis [243,281].  Two types of 
negative controls were used. Firstly, esiRNA was used to target the SI gene, which is 
specifically expressed in small intestinal enterocytes and not expressed in fibroblasts. 
Secondly, esiRNA was used to target COL1A2, a gene expressed in fibroblast but not 
thought to effect cell proliferation when expression is perturbed. In comparison to the gene 
COL1A1, which plays an essential role in fibril-forming collagen in most connective tissue, 
mutation of COL1A2 seems to be less important in the formation of collagen fibrils [282]. To 
perform the screening, three wells of a 96-well plate were used for each esiRNA and each 
plate was repeated three times.  
In this analysis, there were 21 96 well E-plates used to screen 42 unknown and 28 known 
cell cycle-associated genes classified from two typical array experiments (Figure 3.1 and 
Table 3.2). Unknown and known cell cycle-associated genes were selected according to the 
scoring of their expression profile developed by senior statistician Dr. Helen Brown at The 
Roslin Institute. A score was developed to provide an objective measure of the ‘importance’ 
of a gene. A range of features from gene expression profiles were constructed and assessed 
statistically in terms of their ability to predict whether the genes were classed ‘Very good’, 
‘Good’ or ‘Medium’ following a visual assessment of the gene expression profiles by Tom 
Freeman. Ordinal logistic regression was used to determine the most predictive weighted 
sum of the selected features. The score was developed using data from existing datasets and 
was calculated as: 
 Score = 10 - 7.553*Max_diff + 5.394*Max_ratio + 4.613*Max3 - 18.430*Slope_pos + 
14.426*Slope_neg 
 Max_diff = maximum difference from baseline (0-6 hour average) over profile 
 Max_ratio = maximum ratio to baseline (0-6 hour average) over profile 
 Max3 = maximum average of 3 adjacent measurements (taken at 2 h intervals) over 
profile 
 Slope_pos = slope during 0-6 hour period, but set to zero if negative 
 Slope_neg = slope during 0-6 hour period, but set to zero if positive 
 






Data transformation of cell impedance index 
Calculation of CIGR was performed using the R package RTCA (version 1.12.0) using R 
software (version 2.14.2) [208,283]. Figure 3.2 and 3.3 demonstrates the growth profiles of 
positive and negative controls as CIGR over time. The RTCA package was used to transform 
CI over time into CIGR at regular 30 min time intervals during the course of experiment 
(Figure 3.2 B) [115,284]. Average of the CIGR over time per well was calculated as a Z-
score representing the effect of RNAi (Figures 3.2 B and C).  
An example of Z-score normalisation is shown in Figure 3.3. For the raw value (i.e. averaged 
CIGR) of each sample (Figure 3.3A), its biological and technical triplicates (Figure 3.3D) 
were normalised using the robust version of Z score normalisation (Figure 3.3B), minimising 
the variety between each sample (Figure 3.3C). 
Quality assessment and scoring of collected dataset 
Quality assessment of CI data set was performed in R [285]. To evaluate the quality of the 
dataset, quantile-quantile plots (q-q plots) were used to compare the distribution between the 
collection of data and theoretical distributions [286]. The degree of non-parametric approach 
between normal theoretical quantiles and collected data quantiles determined ‘the goodness 
of fit’. The higher the better goodness of fit between the collected data and theoretical 














A             S-, G2-, and M-phase genes with unknown function (42) Ensemble No. 
  ANKRD32 Ankyrin repeat domain 32 ENSG00000133302 
  ANP32E Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E ENSG00000143401 
  ARHGAP11A Rho GTPase activating protein 11A ENSG00000198826 
  ARHGAP11B Rho GTPase activating protein 11B ENSG00000187951 
  ATL2 Atlastin GTPase 2 ENSG00000119787 
  C17orf53 Chromosome 17 open reading frame 53 ENSG00000125319 
  C18orf54 Chromosome 18 open reading frame 54 ENSG00000166845 
  C19orf48 Chromosome 19 open reading frame 48 ENSG00000167747 
  C4orf46 Chromosome 4 Open Reading Frame 46 ENSG00000205208 
  C5orf34 Chromosome 5 open reading frame 34 ENSG00000172244 
  CCDC15 Coiled-coil domain containing 15 ENSG00000149548 
  CCDC18 Coiled-coil domain containing 18 ENSG00000122483 
  CCDC77 Coiled-coil domain containing 77 ENSG00000120647 
  CLN6 Ceroid-lipofuscinosis, neuronal 6, late infantile, variant ENSG00000128973 
  DEPDC1B DEP domain containing 1B ENSG00000035499 
  FAM111A Family with sequence similarity 111, member A ENSG00000166801 
  FAM111B Family with sequence similarity 111, member B ENSG00000189057 
  FAM161A Family with sequence similarity 161, member A ENSG00000170264 
  FAM72B Family With Sequence Similarity 72, Member B ENSG00000188610 
  FIGNL1 Fidgetin-like 1 ENSG00000132436 
  FOXRED1 FAD-dependent oxidoreductase domain containing 1 ENSG00000110074 
  GPN3 GPN-loop GTPase 3 ENSG00000111231 
  GSTCD Glutathione S-transferase, C-terminal domain containing ENSG00000138780 
  HIST2H4B Histone cluster 2, H4b ENSG00000270276 
  IQGAP3 IQ motif containing GTPase activating protein 3 ENSG00000183856 
  KIAA0586 KIAA0586 ENSG00000100578 
  KIAA1524 KIAA1524 ENSG00000163507 
  KIAA1549L  KIAA1549-like ENSG00000110427 
  MGME1  Mitochondrial Genome Maintenance Exonuclease 1 ENSG00000125871 
  MTFR2 Mitochondrial Fission Regulator 2 ENSG00000146410 
  PRR11 Proline rich 11 ENSG00000068489 
  REEP4 Receptor accessory protein 4 ENSG00000168476 
  RIBC2 RIB43A domain with coiled-coils 2 ENSG00000128408 
  RPL39L Ribosomal protein L39-like ENSG00000163923 
  SPATA5 Spermatogenesis associated 5 ENSG00000145375 
  SPIN4 Spindlin family, member 4 ENSG00000186767 
  THAP10 THAP domain containing 10 ENSG00000129028 
  TMEM194A Transmembrane protein 194A ENSG00000166881 
  UBR7 Ubiquitin protein ligase E3 component n-recognin 7 ENSG00000012963 
  WDR76 WD repeat domain 76 ENSG00000092470 
  ZGRF1  Zinc Finger, GRF-Type Containing 1 ENSG00000138658 






B            Known genes (28) Ensemble No. 
  AURKB Aurora Kinase B ENSG00000178999 
  BUB1 BUB1 mitotic checkpoint serine/threonine kinase ENSG00000169679 
  CCNA1 Cyclin A1 ENSG00000133101 
  CCNA2 Cyclin A2 ENSG00000145386 
  CCND1 Cyclin D1 ENSG00000110092 
  CCNE1 Cyclin E1 ENSG00000105173 
  CCNE2 Cyclin E2 ENSG00000175305 
  CDC20 Cell division cycle 20 ENSG00000117399 
  CDC25A Cell division cycle 25A ENSG00000164045 
  CDC25B Cell division cycle 25B ENSG00000101224 
  CDC45 Cell Division Cycle 45 ENSG00000093009 
  CDC6 Cell division cycle 6 ENSG00000094804 
  CDK1 Cyclin-Dependent Kinase 1 ENSG00000170312 
  CENPA Centromere protein A ENSG00000115163 
  CEP85 Centrosomal protein 85kDa ENSG00000130695 
  E2F1 E2F transcription factor 1 ENSG00000101412 
  E2F7 E2F transcription factor 7 ENSG00000165891 
  E2F8 E2F transcription factor 8 ENSG00000129173 
  ESPL1 Extra spindle pole bodies homolog 1 ENSG00000135476 
  GINS1 GINS complex subunit 1 ENSG00000101003 
  KIAA0101 KIAA0101 ENSG00000166803 
  KIF11 Kinesin family member 11 ENSG00000138160 
  MAD2L1 MAD2 mitotic arrest deficient-like 1  ENSG00000164109 
  MCM10 Minichromosome maintenance complex component 10 ENSG00000065328 
  ORC1 Origin recognition complex, subunit 1 ENSG00000085840 
  PARPBP PARP1 Binding Protein ENSG00000185480 
  PCNA Proliferating cell nuclear antigen ENSG00000132646 
  SPACA1 Sperm acrosome associated 1 ENSG00000118434 
 
C           Controls (3) Ensemble No. 
CCNB1 Pos Cyclin B1 ENSG00000134057 
COL1A2 Neg Collagen, type I, alpha 2 ENSG00000164692 
SI Neg Sucrase-isomaltase ENSG00000090402 
Table 3.2: Genes studied in the RNAi screening. List of genes includes A) genes with unknown 


















Figure 3.2: Example of the CIGR transformation and scoring of RNAi. A. Plots of CI over time 
after transfection. Red line represents cell proliferation affected by RNAi. Green line represents 
control. B. Transformation of CI to CIGR. Dash line in green as negative control and red as positive 
control calculated from the averaged of CI including each measurement time points. C. Boxplot of CI 
consists of a sequence of measurement time points after transfection. Green and red line is the 
average of CI as single number value represents the effect of RNAi after transfection in each well of a 

























Figure 3.3: Examples of transformed CIGR values rescaled before and after the robust version 
of Z score normalisation. A) Raw value per sample of transformed CIGR from technical and 
biological triplicates i.e. n = 9 green/red spots. B) Equation used to normalise the raw value of 
transformed CIGR resulting in rescaled values. C) Normalised values after the robust version of Z 













Score cut-off for RNAi screen  
Z-score thresholding was performed in R using the RTCA package [283]. In order to 
compare the effect of esiRNA induced gene silencing and determine the hits, the robust 
version of Z-score based normalization of averaged CIGR was performed at regular time 
intervals prioritizing unknown novel genes for further analysis [274,287]. Robust version of 
Z-score normalization (robust Z-score = x – median (sample)/MAD (sample)*1.4826; MAD 
= median (|x – median (population of samples)|) is relatively tolerant to ‘outliners’ reducing 
their effect on the results (Figures 3.2 B and C). The score cut-off was determined by p-value 




Figure 3.4: Flow chart of RTCA profile analysis determining hits of genes important in cell 
proliferation. Raw data of CI were extracted from RTCA system. Rational transformation of CI was 
then calculated as CIGR. Quality of dataset was then assessed by the degree of non-parametric 
approach between the distribution of collected data and theoretical normal distribution. Average of 
the CIGR was then calculated across each measurement time. Normalization was performed to reduce 
diversities between samples. Score cut-off of samples was determined depending on their p-value 
from t-test smaller than 0.05. Genes’ role in dividing cells was then classified as activators or 




































The RTCA system monitors the effect of RNAi on cell growth in real time. Firstly, to 
optimize transfection conditions, the seeding density and cell-plating environment were 
tested. Secondly, in order to find the best transfection techniques that minimized any side 
effects that might affect cell proliferation, silenceMagTM, a non-cytotoxic magnet-assisted 
transfection reagent was tested in comparison with lipofectamine® 2000, a liposome-based 
reagent. In addition, to evaluate the knockdown efficiency provided by transfection reagents, 
RT-qPCR was performed to determine the effect of gene silencing. With diluted off-target 
effect, esiRNA was used to knock down genes that were identified in two array experiments. 
Using multiple statistical analyses, such as Z-score cut-off, an effect of RNAi on cell 
proliferation was identified with weak effect at 48 h and maximal effect at 72 h after 
transfection. Of the 42 unknown cell cycle-associated genes, 19 influenced the state of cell 
proliferation. 
The exponential phase of growth was positively correlated with serially diluted 
seeding densities  
In order to determine the optimal seeding density and the duration of the exponential growth 
phase in RTCA, serially diluted cells were plated on an E-plate 96. The length of the 
exponential phase of CI over time was positively correlated with seeding density (Figure 
3.5).  
The seeding of cells in preparation for transfection requires 24 h for adhering. The timing of 
maximal RNAi effect on cell proliferation varies between 24 and 72 h after transfection 
depending on which genes are targeted. Taken together, the minimal duration of cells at log 
phase is 96 h. The seeding density of NHDF cells at 6,000 cells/cm2 results in stationary 
growth phase by 96 h, making it the optimal seeding density for in this experiment (Figure 
3.5). It is interesting to note there was a rapid increase in the CIGR measurement between 0 






Figure 3.5: Duration of exponential phase was positively correlated with serially diluted seeding 
densities. The length of exponential phase in cell proliferation was positively correlated with serially 
diluted seeding densities of NHDF cells at 250, 500, 750, 1,500, 3,000, and 6,000 cells/cm2 in E-plate 
96. The CI over time of serially diluted seeding densities was profiled by RTCA.  
NHDF cells can adhere to the wells of a culture dish without laminin coating  
In order to find the best conditions for cell culture in RTCA system, a trace of CI over time 
in RTCA profile was used to determine the effect of laminin coating 96 well in E-plates. As 
can be seen in Figure 3.6, plated cells can adhere to plates with or without laminin coating. 
The trace of CI over time indicated cell proliferation was higher on wells without a laminin 
coating than wells with a laminin coating. The result suggests that laminin coating reduces 
the sensitivity of the sensor recording the CI. 
Transfection reagent silenceMagTM has minimal side effects on cell proliferation 
In order to evaluate the potential side effects of transfection reagents on cell growth, two 
transfection reagents lipofectamine® 2000 and silenceMagTM were compared to test for any 
inhibition in cell growth. Cell growth was arrested when the cells were treated with 
lipofectamine® 2000 until the replacement of complete medium (Figure 3.7A). The 
transfection reagent silenceMagTM did not arrest the proliferation of cells (blue line) when 
compared to the CI over time of cell medium only. This suggests that treatment with 








Figure 3.6: Laminin coating E-96 plate reduced the sensitivity of electrode sensor in RTCA 
profile. Trace of cell proliferation as CI over time in 96 well E-plate with and without laminin 




Figure 3.7: Transfection reagent silenceMagTM had minimal side effect in cell proliferation. A. 
The transfection reagent Lipofectamine® 2000 arrests the cell proliferation relative to untreated 
control (see Figure 3.7A red line) compared to cell medium only (green line). B. The transfection 
reagent silenceMagTM has minimal side effect on cell proliferation relative to untreated control. Dot 






Knock down efficiency of gene silencing 
In order to find the best cell culture conditions for RNAi screening using the RTCA system, 
four combinations including two transfection reagents (Lipofectamine® 2000 and 
SilenceMagTM) and two kinds of dsRNA (siRNA and esiRNA) were evaluated by testing 
knock-down efficiencies through RT-qPCR. The percentage knock-down was calculated 









Figure 3.8: Knock down efficiency using two methods of RNAi was compared and contrasted 
(Smart Pools of siRNA vs esiRNA). A) Knock down efficiency of dsRNA or esiRNA CCNB1 
induced gene silencing delivered by lipofectamine® 2000 conducted transfection. B) Knock down 
efficiency of dsRNA or esiRNA CCNB1 induced gene silencing delivered by silenceMagTM 
conducted transfection. C) Knock down efficiency of dsRNA or esiRNA FOXM1 induced gene 
silencing delivered by lipofectamine® 2000 conducted transfection. D) Knock down efficiency of 
dsRNA or esiRNA FOXM1 induced gene silencing delivered by silenceMagTM conducted 
transfection. Data shown as mean ± SD of replicates (n = 3). Expression ration was normalized in the 






Viability of NHDF cells after silenceMagTM conducted transfection  
In order to ensure that the apparent reduction in cell proliferation was not due to cell death 
induced by the transfection reagents, the cell viability was measured. This was performed by 
flow cytometric analysis following staining the cells with SYTOX® Blue. The results in 
Figure 3.9 illustrate that transfection with esiRNA for the genes involved in cell proliferation 
(CCNB1 and FOXM1) did not affect cell viability when compared with the untreated 





Figure 3.9: High viability of cells treated by esiRNA induced gene silencing 48 h after 
silenceMagTM-conducted transfection. Results of cell viability analysis determined by flow 
cytometry using PI staining. Essential cell cycle-regulated genes CCNB1, FOXM1, and non-essential 
fibril-collagen gene COL1A2 expressed in fibroblast were knocked down by esiRNA induced gene 
silencing. The population of live fibroblasts given esiRNA was determined by flow cytometry using 
SYTOX® Blue staining. The analyses were performed in three biological replicates for every esiRNA 
induced gene silencing. Error bars represent the standard deviation of replicates (n = 3). The cell 








Analysis of negative and positive controls of RNAi 
An analysis was performed to investigative the effect of RNAi on cell proliferation using 
three genes selected as positive and negative controls (Figure 3.10). CCNB1 is an important 
M-phase cyclin that conducts the biological processes in dividing cells. The CI trace (red) of 
cells given CCNB1 esiRNA showed that cell proliferation began to decrease at 48 h after 
transfection (72 h after seeding). In contrast, silencing of the non-essential gene COL1A2 or 
SI in the fibroblast, as negative controls, showed no effect on the CI over time (Figure 3.10 
green lines). Differences between the negative and positive control genes were statistically 
significant 90 h after cell plating (transfection was performed at 24 h after cell plating). This 
suggests that esiRNA induced gene silencing potentially required more than 48 h to affect 
cell proliferation.  
 
Figure 3.10: CI over time for the positive control and negative controls profiled by RTCA 
system. Monitoring of the CI over time of cells given gene silencing of the positive (gene CCNB1) 









Hits of genes in RNAi screening determined by Z-score cut-off 
This experiment was designed to test the optimal conditions for monitoring gene silencing 
and cell division in real time using the RTAC system. There were 70 genes screened by 
RNAi, each with biological and technical replicates. Considering the variation between 
samples across experiments, data transformation of CI was performed and used for the 
CIGR. Normalization of the averaged CIGR over the time was performed based on a robust 
version of Z-score normalization. A t-test was used to determine the hits of genes playing an 
essential role in cell division with p-values ≤ 0.05 for the Z-score (Table 3.3).  
To determine the gene function as activators or regulators in cell division, samples were 
compared with the experimental controls. The cell proliferation was enhanced by gene 
silencing suggesting that these genes potentially inhibit cell division i.e. regulator. In 
contrast, cells with arrested proliferation induced by gene silencing suggested that these 
genes were involved in dividing cells i.e. activator. For example, the effect of esiRNA ATL2 
on the trace of CIGR over time was scored by -3; this means that the score is three times 
standard deviation below the score of population mean, suggesting a strong effect induced by 
gene silencing (Table 3.3).  Analysis on the knock down of genes hypothesised to affect cell 
proliferation, 16 classified genes as activators that may play important roles in cell 
proliferation (Table 3.3). In addition, the knocking down of 3 unknown genes was found to 
regulate the cell proliferation (Table 3.3). For the known genes knocked down by RNAi 
screening, 7 and 4 genes were found to be involved in cell proliferation or regulated by cell 
proliferation respectively. Taken together, 19 of 42 (45.2%) tested unknown cell cycle-
associated genes were found to be potentially involved in cell proliferation; 11 of 28 (39.2%) 
















  Gene Z-score p-value 
 









ATL2 -3 p < 0.001 THAP10 0.7 p < 0.01 
C17orf53 -3 p < 0.001 
 
ARHGAP11B 0.8 p < 0.001 
ARHGAP11A -2.5 p < 0.01 
 
GPN3 0.8 p < 0.01 
FIGNL1 -2.5 p < 0.001 
 
  (3 genes) 
FAM111A -2.4 p < 0.001  
RIBC2 -2.3 p < 0.001 
    CCDC77 -1.7 p < 0.001 
   ZNF367 -1.5 p < 0.001 
    KIAA1549L -1.4 p < 0.001 
   RPL39L -1.3 p < 0.01 
    REEP4 -1.2 p < 0.001 
   GSTCD -1.1 p < 0.001 
    FAM72B -0.9 p < 0.001 
   TMEM194A -0.9 p < 0.001 
    UBR7 -0.9 p < 0.001 
   DEPDC1B -0.5 p < 0.001 
    
 











CCNE1 -1.9 p < 0.001 
 
AURKB 0.8 p < 0.01 
ESPL1 -1.3 p < 0.001 E2F7 0.9 p < 0.01 
CEP85 -0.8 p < 0.01 
 
SPACA1 1.1 p < 0.001 
CENPA -0.6 p < 0.01 
 
ORC1 1.3 p < 0.001 
KIF11 -0.5 p < 0.01 
 
(4 genes) 
MAD2L1 -0.3 p < 0.05 
    GINS1 -0.2 p < 0.05 
     (7 genes)     
 
 
Table 3.3: Gene with unknown function and known cell cycle-associated genes found to be 
important in function and regulation of dividing cells. Averaged CIGR from transformed CI for 
each sample was then normalized, minimizing the diversity between whole dataset of RNAi screen. 
Score cut-off was determined by t test with p-value below 0.05. Genes with normalized Z-score 
below 0 were classed as being essentially associated with cell proliferation (i.e. activators). Genes 






















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Cell proliferation affected by RNAi 
In order to systematically demonstrate the effect of RNAi on cell proliferation, RTCA 
profiles were summarized into a number of groups. The grouping was based on the effect of 
RNAi on the CIGR classified by Z-score cut-off, which was categorized according to hits. In 
addition, according to the negative control releasing time point, the CIGR trace demonstrated 
where the maximal effect of RNAi affect was (Figure 3.11 and Table 3.3). To systematically 
summarize the RTCA profile and efficiently determine the effect of RNAi on cell 
proliferation, the trace of CI, CIGR, and CIGR with respect to the negative control over time 
were demonstrated side by side in Figure 3.11 across each RTCA profile.  
A                (Activator) Growth profile of genes of unknown function with hits 
        CI        CIGR        CIGR 































   
Figure 3.11: RTCA profile of the trace of CI, CIGR, and CIGR with respect to time. The trace 
of CI for each gene in RNAi screening is composed of technical triplicates in each 96 well E-plate 
and each E-plate was repeated three times. Plots of RTCA profiles were demonstrated in CI, CIGR, 
and CIGR with respect to negative control over time. For the column of CI over time, the transfection 
is at 24 h after cell plating. Red line indirectly represents that cell proliferation before and after 
transfection. Green line represents the negative control. Error bars represent mean ± SD. For the trace 
of CIGR and CIGR with respect to control over time, red line represents the CIGR of cells after 
transfection. Green line represents the negative control. Error bars represent mean ± SE. RTCA 
profile of tested genes were categorized based on the Z-score cut-off in A) growth profile of genes of 
unknown function as activators in cell proliferation, B) known cell cycle-associated genes as 
activators in cell proliferation, C) Genes with unknown function potentially functioning as regulators 
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A                (Activator) Growth profile of genes of unknown function with hits 
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A                (Activator) Growth profile of genes of unknown function with hits 
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A                (Activator) Growth profile of genes of unknown function with hits 
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B                                 Known cell cycle-associated genes with hits 
        CI        CIGR        CIGR  










































































B                                 Known cell cycle-associated genes with hits 
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C                            (Regulator) Genes of unknown function with hits 
        CI        CIGR        CIGR  




















































   
 
















D                        (Regulator) Known cell cycle-associated genes with hits 
        CI        CIGR        CIGR  































   
 
 
A               Distribution of raw data B      Quantile-quantile plot of raw data 
  
Figure 3.12: Distribution of CIGR in real time RNAi screening determined by histograms and 
quantile-quantile plots. A) Histograms with density plots represent the distribution of samples of 
biological triplicates of raw data of CIGR. B) The linearity of points between the quality of collected 
samples and theoretical distribution determines that there is no need to normalize collected data. The 
quantile-quantile is generally used to compare the normal distribution of collected samples against 
theoretical model, providing an assessment of “goodness of fit”. If the plot is roughly linear, then the 
data are approximately normally distributed. The linearity of raw data distribution suggests that there 





Robust knock down efficiency of gene silencing induced by esiRNA 
RT-qPCR was used to evaluate whether cell proliferation arrest was induced by the targeted 
gene in the RNAi screen at each time point by analysing the genes with the greatest knock 
down efficiency, which were identified using Z-score cut-off. In comparison to the relative 
expression level of the housekeeping gene GAPDH, the relative expression levels of five 
genes were reduced by greater than 80%, including REEP4 (83.4%), CCDC77 (84.1), FIGL1 
(83.1%), and ZNF367 (82.2%) (Figure 3.11).   
 
Figure 3.13: Knock down efficiency of genes identified as activators in in dividing cells. % of 
knock down efficiency was calculated between the expression level of targeted genes and 
housekeeping gene GAPDH. Data shown as mean ± SD of replicates (n = 3). Expression ratio was 
normalized relative to the housekeeping control (negative control), GAPDH.  
There were 8 genes which had greater than 70% reduction in relative expression levels after 
transfection e.g. CCDC77 (84.1%), REEP4 (83.5%), and FIGNL1 (83.2%) (Figure 3.13). 
There were only two genes with a knock down efficiency below 70%; FAM111A (68.7%) 
and KIAA1549L (51.1%) (Figure 3.13). This suggested that gene silencing provided robust 

































To further investigate the role of a number of unknown cell cycle-associated genes, 42 
unknown cell genes were screened by RNAi to see if knocking down their expression had 
any effect on cell proliferation.  
Given that the knock down efficiency of RNAi was on average around 70% at 48 h 
following the transfection (Figure 3.8), a minimal period of real time RNAi monitoring has 
to be at least 72 h or longer to determine the effect on cell proliferation (Figure 3.10). After 
cell seeding, 24 h is the recommended time required before it is ready for transfection 
according to manufacturers’ recommendation. Therefore, 96 h is the minimal time period 
required to provide sufficient CI measurements over time to determine the effect of RNAi on 
cell proliferation.  
In addition, a sufficient seeding density for cell proliferation to arrive at the stationary phase 
between 96 and 120 h is also required. The length of exponential phase of CI over time is 
positively correlated with serially diluted seeding densities from 250 to 6,000 cells/cm2 
(Figure 3.5). In comparison with other seeding densities, only 6,000 cells/cm2 density can 
provide a sufficient number of cells to arrive at the stationary phase in 72 h (96 h after cell 
plating) i.e. 100% cell confluency. 
It is also important to note that a dramatically increased measurement of CI at the time point 
immediately following cell plating is induced by cells adhering to plate (Figure 3.5 red box). 
This was also observed by Zhang et al., 2011 [115].  
To perform the RNAi screening in the RTCA system, it is important to provide a culturing 
environment in which the cells can adhere to a 96 well E-plate, for example, by using a 
laminin coating. Laminin contributes to the structure of an extracellular matrix that enhances 
the cell adhesion. However, since the electrode on 96 well E-plate is a highly sensitive 
sensor, coating may also influence the accuracy of real time monitoring. The CI of cells 
plated on laminin coated and coating free plates were compared. In contrast to cells without 
coating, the trace of CI with laminin coating was reduced after 40 h following the initial cell 
plating (Figure 3.6). This suggests that the cells can adhere and proliferate without a coating 
of laminin on the E-plates. 
In Figure 3.7A, the trace of CI over time showed that transfection reagent Lipofetamine® 





medium. Zhang, et al., 2011 also found that using liposome to conduct transfection may 
potentially result in cell proliferation arrest, resulting in synchronization of the cell cycle 
[115]. Both cationic liposome and magnetic nanoparticles can effectively conduct the 
transfection (Figure 3.8). However, it has been suggested that cationic liposome has a dose-
dependent cytotoxicity on cultured human cells, such as macrophages [289-291]. Cationic 
liposome inhibits 3H-thymididine during DNA duplication, inhibiting cell proliferation[289].  
In contrast, the trace of CI using silenceMagTM for transfection (Figure 3.7B) shows only a 
slight effect on cell proliferation after reagent replacement. The silenceMagTM was therefore 
considered the optimal transfection reagent for RNAi screening.   
A comparison of knock-down efficiency using two methods of RNAi (siRNA vs. 
esiRNA) 
In order to find the best conditions for RNAi screening that can robustly affect the cell 
proliferation, different combinations of transfection reagents and RNAi constructs were 
compared. The expression level between targeted and housekeeping genes is compared 
showing that the transfection of siRNA conducted by lipofectamine® 2000 has a stronger 
effect than esiRNA transfected by silenceMagTM (Figure 3.8). However, it is interesting that 
in the transfection reaction using silenceMagTM, the knock down efficiency of gene silencing 
induced by siRNA is statistically similar to esiRNA.  
Genes with significant sequence conservation to target genes may result in an off-target 
effect of RNAi induced gene silencing, which may lead to a misinterpretation to the 
importance of the target gene [140]. In addition, it has been suggested that near-perfect 
matches between targeted mRNA sequences and the antisense strands of the siRNA can 
influence RNAi induced gene silencing.  
If off-targeting is not mediated due to a perfect match between the antisense strand of siRNA 
and the mRNA, then overall identity makes little or no contribution to determining whether 
the expression of a particular gene will be affected by given siRNA [143]. In this case off-
targeting is mediated by perfect matches between the 2-7 or 2-8 bps (the seed region) and the 
3’ UTR (untranslated region) of the mRNA [143]. Reducing the concentration of siRNA or 
timing of the transfection dose not completely minimise the off-target effects [140].  
esiRNA induced gene knockdown shown in Figure 3.12,  demonstrates a robust knock down 





affected the cell proliferation. The esiRNA that can knock down targeted genes with a 
minimal off-targeting effect and was therefore used in RNAi screening [121].   
Since the effect of RNAi on cell proliferation is determined by the trace of CI over time, it is 
important to minimize any potential side effects, such as cytotoxicity that will arrest dividing 
cells synchronising the cell cycle. In addition, cell viability assessment using flow cytometry 
demonstrated a high cell viability of cells transfected via silenceMagTM (Figure 3.9). Cell 
viability analysis shows that the knocking down known cell cycle regulation CCNB1, 
FOXM1, and the non-essential gene COL1A2 does not induce the cell death, when 
transfected using silenceMagTM (Figure 3.9). The magnetofection was therefore selected to 
transfect cells in RNAi screening. 
Ratio transformation of CI over time stabilizes the standard deviation between 
wells and plates to improve the comparison of RNAi across the RTCA profile  
Given the optimized conditions for RNAi screening, CI profiles that changed over time were 
extracted from the RTCA system and normalized according to the manufacturers’ 
instruction. Periodical maximum effect of RNAi on CI over times was used to determine the 
effect of knockdown genes on cell proliferation. The CI between plates cannot be compared 
directly as the variance of cell seeding, transfection, minor oscillation of CO2 concentration, 
and temperature can all influence the trace of CI [115]. In order to compare the effect of 
RNAi across the RTCA dataset, normalization was required to minimize the diversity 
between wells and plates.   
Following the manufactures’ instructions, the trace of CI at the fixed time point of 
normalization was readjusted from the recorded value to 1. It was found that standard 
deviation increased between technical and biological triplicates as time progressed from the 
fixed time point. To overcome this, Zhang et al., 2011 suggests using the cell index growth 
rate (CIGR) instead of the CI to determine the effect of RNAi [115]. The CIGR represents 
the rate of change of CI over time, indirectly reflecting the dynamic of cell proliferation 
affected by RNAi (Figure 3.11). In addition, the standard deviation of the CIGR did not 
accumulate following a fixed time point selected for normalization but rather stayed constant 







The trace of CIGR in comparison with a negative control determines the time 
window of RNAi effect on cell proliferation 
Using CIGR over time to determine the effect of RNAi on cell proliferation, stabilized the 
diversity between wells and plates, allowing categorization of the RTCA profile based on the 
time window of maximum effect of RNAi. However, owing to the complexity of 
determining the difference between traces of CIGR that oscillate over time against controls, 
it is still difficult to accurately define the time window of maximum RNAi effect. Therefore, 
the profile of CIGR affected by RNAi is demonstrated with the respect to negative control.  
It is interesting that in Figure 3.11, the trace of CIGR plotted with respect to the control 
showed two major populations of samples with a maximum effect of RNAi at 48 and 72 h 
after transfection.  For example, the knock down of gene RPL39L, KIAA0586, ANKRD32, 
and ANP32E affected the value of CIGR over time at 48 h. On the other hand, the knock 
down of gene ATL2, C17orf53, AHGAP11A, FIGNL1, FAM111A, ZNF367, CCDC77, 
GSTCD, FAM72B, REEP4, and TMEM194A affected the CIGR over time at 72 h after 
transfection (Figure 3.11). 
Half-life of protein influences the effect of RNAi 
Knocking down of some known cell cycle associated genes that do not or only weakly affect 
cell proliferation. It is believed that this is due to the longer half-life of encoded proteins, 
which minimize the effect of gene silencing. In addition, by examining the high-throughput 
half-life data demonstrated by Yen et al., 2008 [292], supportive evidence suggests that these 
are mostly identified as long life proteins, such as gene E2F8, MCM10, PCNA, and CDC20.  
In contrast to the list of genes that were verified by RNAi using RTCA system, it is 
interesting that the knock down of some of the known cell cycle-associated genes didn’t 
have an effect on cell proliferation e.g. CCNE2, the regulatory cyclin for CDK2, a known 
regulator that progresses the S-phase. However, it has been suggested that cell cycle can be 
progressed in mammalian cells without cyclin E activity by targeting both genes encoding 
cyclins E1 and E2 [293,294]. This potentially explains why the knocking down of gene 








Limitation of RNAi and scoring cut-off 
In order to determine the effect of gene silencing on cell proliferation, Z-score cut-off, an 
end-point score cut-off is widely used in typical high-throughput RNAi screening. This 
method was used to determine the hits of targeted genes based on their CIGR, providing a 
global scale of hits that determined the effect of RNAi between wells and plates [130-
132,147,287]. To level the effect of RNAi on cell proliferation, which was indirectly 
monitored by highly sensitive RTCA system, normalization was required to minimize the 
diversity between wells and plates. For scoring the effect of the RNAi screen, the R package 
‘cellHTS2’ which is developed for end-point high-throughput RNAi screen, was used to 
normalize average CIGR over time between wells and plates (Figure 3.11 and Table 3.3) 
[287].  
Due to the limitation that a Z-score can only determine which genes in the RNAi screening 
are hit at a fixed time point, Zhang, et al., 2011 suggested calculating the average of CIGR 
over time as a single value. Therefore averaged CIGR can be used to analyse the effect of 
gene silencing on cell proliferation [115]. However, adopting this scoring system instead of a 
typical end-point analysis might also lead to misinterpretation of the results of the RNAi 
screen. 
In addition, RNAi is purely a loss-of-function technique aimed to target the gene of interest. 
The quality of this technique is affected by a number of conditions i.e. transfection 
efficiency, poor chemical stability allowing for degradation by RNases leading to low half-
life, difficult to silence the targeted genes with high transcriptional activity in cells, and poor 
understanding of the true endogenous function of dsRNA molecules in vivo [295].  
In summary, a real time esiRNA screening was carried out using silenceMagTM, a 
cytotoxicity free transfection reagent to knock down unknown cell cycle-associated genes 
without off-target effects. RTCA was used to profile the effect of RNAi on cell proliferation 
based on electrical impedance as the output. The optimized culture system for NHDF cells 
provides a robust environment for a gene silencing experiment, which consists of optimised 
seeding densities, and an optimised length of time for cell proliferation tracking. 
Transformation of CI over time as CIGR stabilizes the standard deviation, which can be used 
to compare the effects of RNAi between wells and plates, demonstrated with respect to 
negative control; the Z-score cut-off method that may potentially miss the unknown weak 





In addition, conditions that include the statistical analyses and various influences may 
determine the accuracy of results and could possibly miss weak effects, only highlighting the 
RNAi with strong effects on cell proliferation can be identified. Therefore, the design and 
analysis determine the genes that play important role in the cell proliferation. 
Manual curation of genes to determine their role and location 
Knowing the location of unknown proteins is the first step to predicting their role and 
function. The functional activities of proteins are associated with their subcellular 
localisation and protein-protein interactions. To predict putative role of target gene in cell 
proliferation, public resources including ‘The Human Protein Atlas’ and other published 
literatures were utilised in this analysis (Table 3.4) [288].  
It was reported that C17orf53 and REEP4 appeared to be localised to the cytoplasm. REEP4 
was found to be involved in the regulation of endoplasmic reticulum (ER) clearance during 
[296]. Little is known, however, about the putative role of C17orf53 in the cell proliferation. 
GSTCD and UBR7 were both reported to be localised to the nucleus. GSTCD was found to 
be highly expressed in the human lung tissues [297]. UBR7 was reported to be involved in 
the spermiogenesis [298]. However, there is little information available for these genes that 
is relevant to cell proliferation. Protein ZNF367 and TMEM194A were both reported to be 
localised to the nucleus but not the nucleoli. The expression of ZNF367 was reported to 
regulate the development of cancer progression [299]. In contrast, little information is 
available for the role of TMEM194A and additional experimental are required to identify the 
role of these genes in cell division (Table 3.4). Proteins THAP10 and KIAA1549L are also 
reported to be localised to the cytoplasm and vesicles respectively. The expression of 
THAP10 has been reported to be regulated by promoter hypermethylation in breast cancer 
[300]. However, little is known about the role of KIAA1549L (Table 3.4). 
Other proteins localised to the nucleus including, FAM111A and ARHGAP11A which were 
both reported to be localised to the nucleus and nucleoli. In addition, GPN3 and 
ARHGAP11A were both reported to be localised to the nucleus and cytoplasm. GPN3 was 
known to be involved in the regulation of RNA polymerase II during the transcription [301]. 
A functional mutation of FAM111A was found to be associated with a skeletal disorder 
[302]. Interestingly, it has been suggested that ARHGAP11A influences cell proliferation by 
involving the p53 pathway (Table 3.4) [303].  
Five of the proteins have no further information suggesting their position in cells i.e. RIBC2, 





Golgi apparatus pathway and ER morphogenesis [304]. RPL39L has been reported to be 
highly expressed in embryonic stem cells and also suggested to be strongly associated with 
the hepatocellular carcinoma tumours (HCC) [305]. ARHGAP11B was reported to be 
involved in the development of human neocortex [306]. In contrast, little information is 
available for protein RIBC2 and FAM72B. CCDC77 appears to be localised to nuclear 
membrane according ‘The Human Protein Atlas’, however, further experimental approaches 
are required to identify its role in cell proliferation (Table 3.4).   
In contrast to the proteins with poor information relevant to their involvement in cell 
proliferation, DEPEC1B was reported to be localised to the Golgi apparatus involved in the 
regulation of de-adhesion of mitotic HeLa cells. The expression activity of DEPDC1B was 
found to be up-regulated during the G2-phase and degraded during mitosis which is 
consistent with the expression periodicity observed in our array dataset [307]. Protein 
FIGNL1 was suggested to be localised to the nucleus and cytoplasm in association with the 
DNA repair proteins [308].  
In summary, the knockdown of 19 of 42 unknown genes appears to have an effect on cell 
proliferation. Protein DEPDC1B, FIGNL1, and ARHGAP11A appear to be involved in cell 
cycle-associated events and online resources suggested their position in the cell. However, 5 
of the 19 unknown genes have no information of their subcellular location. Therefore, to 
further identify their position in the cells and study their activities in cell proliferation, in 
Chapter 4, a subcellular protein localisation was performed. In addition, evidence of 
















































Chapter 4.  
Subcellular localisation of putative cell cycle proteins 
 
Introduction 
In Chapter 3, evidence was presented that 19 genes of unknown function may have a role in 
cell proliferation. Since the start of this project, evidence has been published by other 
research groups that confirms the role of 3 of these genes in cell cycle regulation. To further 
investigate the association of these genes with the cell cycle, the subcellular localisation of 
the proteins they encode was studied. 
The subcellular localisation of a protein can be highly informative as to its biological 
function. To further our understanding of the uncharacterised genes and their putative roles 
in cell proliferation, the expression of GFP tagged full length clones (i.e. ORFs) in Gateway 
vectors was used to identify their subcellular localisation.  
The studies used full length protein-coding cDNA clones from the human ORFeome project 
version 8.1, a public resource containing 12,230 clonal isolates (i.e. clonally-derived and 
sequence-verified ORFs cloned as a set of Gateway Entry clones) representing at least 
11,149 human genes [170]. Gateway cloning is a universal cloning method dependent on 
site-specific recombination properties of the bacteriophage lambda [172]. This vector system 
provides a rapid and efficient way to deliver DNA sequences into multiple vector systems 
for protein expression [173].  
Using a mammalian host for protein expression ensues the recombinant proteins undergo 
normal modifications at the post-transcriptional stage e.g. NHDF or HEK293T [309]. Of the 
cell lines used to express mammalian proteins, HEK293T are by far the most widely used 
cells [309]. This is because they stably synthesise SV40 T-antigen for effective plasmid 
expression. In comparison with NHDF, HEK293T has exhibited a transfection efficiency of 
between 95 and 100% [310]. Considering the time required to optimise the protein 
localisation experiment using NHDF, HEK293T were therefore chosen as an alternative 
platform for optimisation for protein subcellular localisation.  
Protein localisation studies on 12 of the ‘hits’ i.e. genes of unknown function shown to cause 
a decrease in proliferation when knocked down by RNAi screening) from Chapter 3 (clones 





analysis were also included. Transfection of HEK293T cells was performed with expression 







































Figure 4.1: Flow chart of experimental steps in the protein localisation analyses. 
Table 4.1 includes a list of genes of unknown function shown to reduce proliferation when 
knocked down by RNAi, as discussed in Chapter 3 and other genes of interest. Known cell 
cycle genes of interest were expressed to demonstrate their subcellular localisation for 
















































 ATL2 Atlastin GTPase 2 
C17orf53 Chromosome 17 open reading frame 53 
ARHGAP11A Rho GTPase activating protein 11A 
FIGNL1 Fidgetin-like 1 
FAM111A Family with sequence similarity 111, member A 
RIBC2 RIB43A domain with coiled-coils 2 
KIAA1549L KIAA1549 like 
RPL39L Ribosomal protein L39-like 
REEP4 Receptor accessory protein 4 
GSTCD Glutathione S-transferase, C-terminal domain containing 
UBR7 Ubiquitin protein ligase E3 component n-recognin 7 (putative) 
























 ANLN Anillin, actin binding protein 
DEPDC1 DEP domain containing 1 
FAM111B Family with sequence similarity 111, member B 
KIAA0101 Proliferating cell nuclear antigen-associated factor 
KNSTRN Kinetochore-Localised Astrin/SPAG5 Binding Protein 
KPNA2 Karyopherin alpha 2 (RAG cohort 1, importin alpha 1) 
RACGAP1P Rac GTPase activating protein 1 pseudogene 















CEP55 Centrosomal Protein 55kDa 
CEP57 Centrosomal Protein 57kDa 
CEP72 Centrosomal Protein 72kDa 
CEP85 Centrosomal Protein 85kDa 
PCM1 Pericentriolar Material 1 
Table 4.1: List of genes used for protein localisation by expressing GFP-fusion protein in 
HEK293T cells.  This table includes genes of unknown function identified by RNAi screening, genes 
identified by network structure analysis only (i.e. genes on the cell cycle list), and 5 centrosome-
associated genes. Transforming Acidic Coiled-Coil Containing Protein 3 (TACC3) tagged with GFP 









Generation of entry clone by the Wiemann laboratory 
 
 
Figure 4.2: Fully-sequenced cloned human ORFs were flanked by combinational sites B1 and 
B2 and cloned into the P sites of pDONR223 using the BP reaction. This was performed by the 
Wiemann laboratory to produce the ORFeome version 8.1 library. 
 
ORFs cloned in the pDONR223 plasmid were received as a gift from Prof. Stefan Wiemann, 
German Cancer Research Centre, Heidelberg  (Figure 4.2) [170]. E. coli containing the 
plasmids were stored in 96-well plates. Inoculation from the 96 well plates were grown up in 
15 ml tubes with 5 ml Luria Broth (LB) medium and incubated at 37oC shaker overnight 
with aeration.  Plasmids were harvested using the PureLink® Quick Plasmid Miniprep Kit 
(Life technologies, Paisley, UK) according to manufacturer’s instructions and quantified on 
the ND-1000 Spectrohotometer (Nano-Drop Technologies, Wilmington, North Carolina, 
USA).  
To prepare an expression clone, 150 ng of entry clone and 150 ng of destination vector 
(Gateway® pcDNA™-DEST53 or -DEST47 Vector, Life technologies) were mixed with 1 
µl ddH2O, and LR clonase II enzyme (Life technologies) and incubated at 25oC for 1 h. 1 µl 
(2 µg/ µl) of proteinase K was then added to stop the activity of the enzyme (LR clonase II) 








Sub-cloning the gene of interest from the entry clone (pDONR223) 




Figure 4.3: ORFs flanked by L1 and L2 sites were transferred from entry clones into 
R1::ccdB::R2 destination vectors by using the LR reaction.  
Transformation 
For transformation, competent DH5α cells stored at –80oC were thawed on ice. 1 µl of 
recombined plasmids were mixed with 50 µl competent cells. The DNA mixture was then 
kept on ice for 30 min. Each tube was given a heat shock by placing the tube in a 42oC water 
bath for 45 seconds and then transferred to ice for 2 min. 950 µl LB media (without 
antibiotics) was added to each tube and incubated in a shaker for 1 h at 37oC.  Cells were 
then spun down at 3,000 rpm for 1 min, and the pellets re-suspended in 100 µl LB media. 
Re-suspended cells were then plated on to a 10 cm diameter LB agar plate with ampicillin 
(100µg/ml). Plates were incubated at 37oC overnight. Single colonies were selected and 
grown up in a 15 ml tube with 5 ml LB containing ampicillin (100 µg/ml) for 17 h in a 
shacking incubator at 37oC in preparation for the harvesting of expression clones. 
Transfection of cells for protein localisation 
For the transfection of HEK293T cells plated on coated microscope coverslips, the medium 
in the 24 well plates was replaced with the same volume (i.e. 500 µl) of antibiotic free 
medium. The transfection reagent K2® Transfection System (Biontex Laboratories, Munich, 
Germany) was used to deliver the expression clone. The transfection efficiency was 
calculated from repeats (n = 3) according to the number of HEK293T cells expressing 







Poly-L-Lysine coating and cell plating on cover slips 
Poly-L-Lysine is commonly used to coat microscope slips to improve cell adherence [311]. 
Ultraclean 13 mm round glass coverslips were placed in 24-well plates, allowed to dry for 10 
min, coated with 300 µl poly-L-Lysine at 100 µg/ml and incubated for 2 h at room 
temperature (Sigma-Aldrich, UK). HEK293T cells were then added to the 24 well plates 
with 500 µl DMEM (Dulbecco’s Modified Eagles Medium, Sigma-Aldrich), including 10% 
(v/v) Fetal Bovine Serum (FBS) (GE Healthcare, Little Chalfont, UK), antibiotics (25 U/ml 
penicillin and 25 µg/ml streptomycin, Life technologies, UK), Non-Essential Amino Acids 
(NEAA) (1X) (Life technologies, UK), glutmax (1x) (Life technologies, UK), and fungizone 
antimycotic (1.25 µg/ml) (Life technologies, UK). The coated cover slips were growth with 
HEK293T cells were incubated in a 37oC incubator overnight. The standard culturing 
conditions of HEK293T cells, are detailed in Chapter 2 materials and methods.  
Labelling nuclei and cytoskeletal actin with DAPI and Phalloidin 
For staining of HEK293T cells, the culture medium was removed and the cells were fixed in 
4% paraformaldehyde (PFA) (Fisher Scientific, Leicestershire, UK) for 10 min. PFA was 
then replaced with PBS with 0.1% Triton X-100 (Sigma-Aldrich) and the sample stored at 
4°C overnight. 200 µl of phalloidin (i.e. 7.5 units) was then added to replace the PBS (0.1% 
Triton X-100) for 30 min. Coverslips stained by phalloidin were then washed 3 times in PBS 
before adding 200 µl DAPI (300 nM) for 10 min. To mount on slides, the coverslips were 
washed 3 times in PBS. 5 µl Vectorshield (containing DAPI, Vector laboratories, 
Peterborough, UK) was placed on the frost-free slides before the coverslips were gently 
lowered onto each slide. 4 spots of nail polish were placed around the coverslips and allowed 
to dry for 10 min. The edges of the coverslips were then completely sealed with nail polish.  
Microscopic inspection 
Slides were inspected using a Nikon e-C1 confocal scanning laser microscope (Nikon 
Instruments, Surrey, UK).  For each slide, 3 images were taken at 1000x magnification. 
Nikon EZ-C1 software (Nikon Instrument, Surry, UK) was used to control the 2-D optical 
sections to provide images from each channel with minimal spectral overlap. The stains and 
laser/filter combinations used were: phalloidin stain (excitation 543 nm, emission BandPass 
605/75 nm), DAPI stain (excitation 408 nm, emission BandPass 461/30nm), and GFP 


































In Chapter 3, evidence was presented that 19 genes with unknown function play a role in cell 
proliferation. In order to further investigate their role in cell division, the subcellular protein 
localisation of 12 of the 19 proteins has been analysed by expressing them as GFP-fusion 
proteins. Known cell cycle-associated proteins and other proteins of interest involved in 
interphase or mitosis were also expressed fused to GFP to demonstrate their subcellular 
localisation and expression compared to published literature (Table 4.2B and C). 
Table 4.2 summarises the subcellular localisation of proteins of interest expressed as fusions 
with GFP. Proteins were expressed with GFP located at their N- [using ORF cloned in 
pdDNA-DEST53 plasmid] or C-terminal [using ORF cloned in pcDNA-DEST47 plasmid]. 
Table 4.2A shows the 12 of 19 genes with unknown function expressed in HEK293T cells. 
ATL2 protein tagged with GFP at the N-terminal was expressed in HEK293T cells. In 
interphase, the expression of ATL2 shows three spots proximal to the nucleus with weaker 
granular expression throughout (Figure 4.5A). In prometaphase, the localisation of ATL2 
expression shows these discrete spots in the cytoplasm. These cells were representative of 
other cells expressing GFP in the samples (Figure 4.5B).  
C17orf53 tagged with GFP was expressed in HEK293T cells. In interphase, the expression 
of C17orf53 with both N- or C-terminal GFP tagged protein shows a single spot proximal to 
the nucleus in the cytoplasm or throughout the cell (Figures 4.6A, B, C, and D). During 
prophase, the expression of C17orf53 tagged with the N-terminal shows three spots proximal 
to the nucleus (figure 4.6E). In prometaphase, the expression of C17orf53 tagged with GFP 
at the C-terminal shows a number of spots grouped in several clusters in the cytoplasm 
(Figure 4.6F). In telophase, the expression of C17orf53 tagged with GFP at the C terminal 
shows spots proximal to the chromosomes and weaker granular expression throughout the 
cell except in the condensed chromosomes (Figure 4.6G)  
ARHGAP11A tagged with GFP at the N-terminal was expressed in HEK293T cells. In 
interphase, the expression of ARHGAP11A shows a granular expression throughout the 
nucleus but not the nucleoli (Figure 4.7A). During metaphase and cytokinesis, the granular 
expression of ARHGAP11A appears to be co-localised to the metaphase chromosomes with 
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Figure 4.5: Subcellular localisation of ATL2 in HEK293T cells. The left column shows 
DAPI staining of the nucleus. The middle column shows HEK293T cells expressing ATL2 
with N-terminal GFP tag. The right column shows the merged images of GFP expression, 
labelling with DAPI, and Phalloidin staining. A) Expression of ATL2 tagged with GFP at 
the N-terminal during interphase. B) Expression of ATL2 tagged with GFP at the N-
terminal during prophase. Cell images were captured by confocal microscopy (Nikon EC-
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Figure 4.6: Subcellular localisation of C17orf53 in HEK293T cells. Expression of 
C17orf53 tagged with GFP at the C-terminal during interphase (A and B), prometaphase 
(F), and telophase (G), respectively. Expression of C17orf53 tagged with GFP at the N-
terminal during interphase (C and D) and prophase (E). Cell images were captured by 
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Figure 4.7: Subcellular localisation of ARHGAP11A in HEK293T cells.  The 
localisation of ARHGAP11A tagged with GFP at the N-terminal expression during A) 
interphase, B) metaphase, and C) cytokinesis. Cell images were captured by confocal 









FIGNL1 tagged with GFP at the N-terminal was expressed in HEK293T cells. In interphase, 
there is a single spot of expression proximal to the nucleus in the cytoplasm (Figure 4.8A). 
During prophase, there are two bright spots of GFP expression proximal to the nucleus with 
weaker granular expression throughout the cytoplasm (Figure 4.8B). In prometaphase, the 
majority of GFP expression appears to be proximal to the mitotic chromosomes (Figure 
4.8C). 
FAM111A tagged with GFP was expressed in HEK293T cells. In interphase and prophase, 
FAM111A with N-terminal GFP tagged protein is expressed with one or two spots proximal 
to the nucleus and weaker granular expression throughout the cytoplasm (Figures 4.9A and 
B). FAM111A tagged with GFP at the C-terminal is expressed as a cluster of spots in the 
nucleus and the cytoplasm during interphase (Figure 4.9C). 
RIBC2 was expressed in HEK293T cells to show its localisation. In interphase, RIBC2 
tagged with GFP at the N-terminal is expressed in two spots proximal to the nucleus in the 
cytoplasm (Figures 4.10A and B). These spots appear to move to opposite poles of the cell 
(Figure 4.10B). In prophase, RIBC2 is expressed as a number of spots proximal to the 
condensed chromosome (Figure 4.10C). During prometaphase, the majority of spots appear 
to be localised to opposite poles proximal to mitotic chromosomes with weaker granular 
expression throughout the cytoplasm (Figure 4.10D). During metaphase, the expression of 
RIBC2 appears to be a clump of spots associated with metaphase chromosomes (Figure 
4.10E). In anaphase, the majority of RIBC2 expression appears to be localised to opposite 
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Figure 4.8: Subcellular localisation of FIGNL1 in HEK293T cells. The localisation of 
FIGNL1 expression during A) interphase, B) prophase, and C) metaphase. Cell images 
were captured by confocal microscopy (Nikon EC-1) 1000X and are 1.6 μm optical 
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Figure 4.9: Subcellular localisation of FAM111A in HEK293T cells during 
interphase. A) and B) show the localisation of FAM111A expression tagged with GFP at 
the N-terminal during interphase. C) The localisation of FAM111A expression tagged with 
GFP at the C-terminal during interphase. Cell images were captured by confocal 









              Genes of unknown function identified by RNAi screening 
 
          RIBC2 




























   



























   


























   





































             Genes of unknown function identified by RNAi screening 
 
           RIBC2 





























   




























   
 
Figure 4.10: Subcellular localisation of RIBC2 tagged with GFP at the N-terminal in 
HEK293T cells. RIBC2 expression in the cytoplasm during A) interphase, B) prophase, 
C) prophase D) prometaphase, E) metaphase, and F) anaphase. Cell images were captured 














During interphase, KIAA1549L tagged with GFP at the N-terminal is expressed as two spots 
proximal to the nucleus with weaker granular expression in the cytoplasm (Figure 4.11A). In 
contrast, expression of KIAA1549L tagged with GFP at the C-terminal shows weaker 
granular expression throughout the nucleus but not the nucleoli (Figure 4.11B). 
The protein expression of RPL39L tagged with GFP at the N-terminal appears to be 
localised to the nucleus in interphase (Figure 4.12). A number of green spots are randomly 
positioned in the nucleus with weaker granular expression (Figure 4.12A, B, and C). To 
determine whether this is due to the overexpression of clones, the expression of RPL39L 
fused with GFP at the C-terminal is required.   
REEP4 tagged with GFP was expressed in HEK293T cells. During interphase, the protein 
expression of REEP4 tagged with GFP at the N-terminal is localised throughout the 
cytoplasm (Figure 4.13A). In prophase, the spots of REEP4 expression tagged with GFP at 
the N-terminal are proximal to the chromosome with weaker granular expression in the 
cytoplasm (Figure 4.13B). For expression of REEP4 with GFP tagged at the C-terminal, two 
spots are proximal to the nucleus during interphase (Figure 4.13C). During prophase, the 
majority of spots are associated with the condensed chromosome with weaker granular 
expression in the cytoplasm (Figure 4.13D) 
GSTCD was tagged with GFP at the N-terminal and expressed in HEK293T cells (Figure 
4.14). Granular expression of GSTCD was found to be unevenly distributed throughout the 
cytoplasm during interphase (Figures 4.14A, B, and C). Additional localisation of GSTCD 
tagged with GFP at the C-terminal is required to determine whether or not the expression of 
GSTD is an artefact.   
UBR7 tagged with GFP at the N-terminal was expressed in HEK293T cells (Figure 4.15). 
The granular expression of UBR7 appears to be ubiquitously localised to the nucleus but not 
nucleoli in interphase. To determine whether the pattern of UBR7 expression is an artefact, 
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Figure 4.11: Subcellular localisation of KIAA1549L in HEK293T cells. A) Expression 
KIAA1549L tagged with GFP at the N-terminal during interphase in the cytoplasm. B) 
Expression of KIAA1549L tagged with GFP at the C-terminal in the nucleus and 
cytoplasm during interphase. Cell images were captured by confocal microscopy (Nikon 
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Figure 4.12: Subcellular localisation of RPL39L in HEK293T cells. A) B) and C) 
Expression of RPL39L expression tagged with GFP at the N-terminal is localised to the 
nucleus during interphase. Cell images were captured by confocal microscopy (Nikon EC-
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Figure 4.13: Subcellular localisation of REEP4 in HEK293T cells. The localisation of 
REEP4 expression during A and B) interphase and C and D) prophase, respectively. Cell 
images were captured by confocal microscopy (Nikon EC-1) 1000X and are 1.6 μm optical 
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Figure 4.14: Subcellular localisation of GSTCD in HEK293T cells. A), B) and C) 
Expression of GSTCD expression tagged with GFP at the N-terminal is localised to the 
cytoplasm. Cell images were captured by confocal microscopy (Nikon EC-1) 1000X are 
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Figure 4.15: Subcellular localisation of UBR7 in HEK293T cells. A), B), and C) 
Expression of UBR7 tagged with GFP at the N-terminal is localised to the nucleus but not 
the nucleolus. Cell images were captured by confocal microscopy (Nikon EC-1) 1000X are 










DEPDC1B tagged with GFP was expressed in HEK293T cells. The expression of DEPDC1B 
with GFP at the N-terminal shows a number of clusters of spots with weaker granular 
expression throughout the nucleus (Figure 4.16A). The expression of DEPDC1B tagged with 
GFP at the C-terminal shows granular expression throughout the cytoplasm and nucleus 
(Figures 4.16B and C). 
ANLN tagged with GFP at the N-terminal was expressed in HEK293T cells. Expression of 
ANLN during interphase was found throughout the cytoplasm but appeared uneven in 
distribution (Figures 4.17A, B, and C). 
DEPDC1 tagged with GFP at the N-terminal was expressed in HEK293T cells. DEPDC1 
was expressed as a clump of spots in the nucleoli and cytoplasm during interphase (Figures 
4.18A and C). Spots as can be seen proximal to the cell membrane associated with weaker 
granular expression in interphase (Figure 4.18B).  
FAM111B tagged with GFP was expressed in HEK293T cells. FAM111B tagged with GFP 
at the N-terminal was expressed as one spot proximal to the nucleus during interphase 
(Figure 4.19A). FAM111B tagged with GFP at the C-terminal was expressed as two spots 
proximal to the nucleus during interphase (Figure 4.19B). It is interesting that the expression 
of FAM111B tagged with GFP at the C-terminal shows two spots proximal to the nucleus 
but at opposite poles (Figure 4.19C). 
KIAA0101 tagged with GFP was expressed in HEK293T cells. The localisation pattern of 
KIAA0101 tagged with GFP at the N-terminal exhibited a thick dashed line (worm like) 
throughout the nucleus. Expression of KIAA0101 tagged with GFP at the C-terminal 
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Figure 4.16: Subcellular localisation of DEPDC1B in HEK293T cells. A) Expression of 
DEPDC1B expression tagged with GFP at the N-terminal was localised to the cytoplasm 
and nucleus. B) and C) Expression DEPDC1B tagged with GFP at the C-terminal was 
localised to the nucleus and cytoplasm. Cell images were captured by confocal microscopy 
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Figure 4.17: Subcellular localisation of ANLN in HEK293T cells. A), B) and C) 
Expression of ANLN expression tagged with GFP at the N-terminal was localised to the 
cytoplasm during interphase. Cell images were captured by confocal microscopy (Nikon 
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Figure 4.18: Subcellular localisation of DEPDC1 in HEK293T cells. A) and B) 
Expression of DEPDC1 tagged with GFP at the N-terminal was localised to cytoplasm and 
the nucleolus. Cell images were captured by confocal microscopy (Nikon EC-1) 1000X are 
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Figure 4.19: Subcellular localisation of FAM111B in HEK293T cells. A) Expression of 
FAM111B tagged with GFP at the N-terminal was localised at the cytoplasm during 
interphase. B) and C) The expression of FAM111B tagged with GFP at the C-terminal was 
localised to the cytoplasm during interphase. Cell images were captured by confocal 









        Genes of unknown function identified by network structure analysis only 
 
           KIAA0101 


























   

























   

























   
Figure 4.20: Subcellular localisation of KIAA0101 in HEK293T cells. A) and B) 
Expression of KIAA0101 tagged with GFP at the N-terminal was localised to the nucleus. 
C) Expression of KIAA0101 tagged with GFP at the C-terminal was localised to the 
nucleus. Cell images were captured by confocal microscopy (Nikon EC-1) 1000X and are 









KNSTRN tagged with GFP at the N-terminal was expressed in HEK293T cells. KNSTRN 
was expression as a cluster of spots proximal to the nucleus in the cytoplasm (Figures 4.21A, 
B, and C). 
KPNA2 tagged with GFP at the N-terminal was expressed in HEK293T cells. Expression of 
KPNA2 exhibited a discrete single spot with weaker granular expression proximal to the 
nucleus during interphase (Figures 4.22A and B). 
RACGAP1P tagged with GFP at the N-terminal was expressed in HEK293T cells. During 
interphase, the expression of RACGAP1P exhibited a number of intense spots with weaker 
granular expression throughout the cytoplasm (Figure 4.23A). During prometaphase, the 
expression of RACGAP1P exhibited a number of clumps, spots with weaker granular 
expression in the cytoplasm (Figure 4.23B). 
TCF19 tagged with GFP at the N-terminal was expressed in HEK293T cells. Expression of 
TCF19 exhibited a number of discrete spots with weaker granular expression throughout the 
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Figure 4.21: Subcellular localisation of KNSTRN in HEK293T cells. A), B), and C) 
Expression of KNSTRN tagged with GFP at the N-terminal was localised to the cytoplasm 
during interphase. Cell images were captured by confocal microscopy (Nikon EC-1) 
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Figure 4.22: Subcellular localisation of KPNA2 in HEK293T cells. A) and B) 
Expression of KPNA2 tagged with GFP at the N-terminal was localised to the cytoplasm. 
Cell images were captured by confocal microscopy (Nikon EC-1) 1000X and are 1.6 μm 
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Figure 4.23: Subcellular localisation of RACGAP1P in HEK293T cells. A) and B) 
Expression of RACGAP1P tagged with GFP at the N-terminal was localised to the 
cytoplasm during interphase and prometaphase, respectively. Cell images were captured by 
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Figure 4.24: Subcellular localisation of TCF19 in HEK293T cells. A) and B) 
Expression of TCF19 tagged with GFP at the N-terminal was localised to the nucleus. Cell 
images were captured by confocal microscopy (Nikon EC-1) 1000X and are 1.6 μm optical 










To better understand expression of known cell cycle-regulated proteins within the 
centrosome, CEP55 expression tagged with GFP was used in this analysis. CEP55 tagged 
with GFP fusion at the N-terminal was expressed in HEK293T cells. During interphase, 
expression of CEP55 exhibited a cluster of spots proximal to the nucleus (Figure 4.25A). In 
prophase, the expression of CEP55 showed two clusters of spots proximal to the nucleus 
(Figure 4.25B). In prometaphase, the expression of CEP55 exhibited two or three spots with 
weaker granular expression throughout the cell with the exception of the mitotic 
chromosome (Figures 4.25C and D). In metaphase, CEP55 was expressed as two spots and 
another cluster of spots proximal to the mitotic chromosomes (Figure 4.25E). In anaphase, 
CEP55 was expressed as five spots and a large cluster of spots proximal to the sister 
chromatids (Figure 4.25F). The expression of CEP55 provides a good example to study the 
developing features of the centrosome in this analysis.  
CEP57 tagged with GFP fusion at the N-terminal was expressed in HEK293T cells. During 
interphase, CEP57 was expressed as shows a number of spots and dots proximal to the 
nucleus (Figures 4.26A and B). During prophase, CEP57 was expressed as a cluster of spots 
proximal to the condensed chromosome (Figure 4.26C). In prometaphase, CEP57 was 
expressed as shows a cluster of spots proximal to the mitotic chromosomes (Figure 4.26D). 
CEP72 tagged with GFP tagged at the N-terminal was expressed in HEK293T cells. During 
interphase, CEP72 was expressed as groups of spots throughout the cytoplasm (Figures 
4.27A and B).  
CEP85 expression tagged with GFP at the C-terminal was expressed in HEK293T cells. 
CEP85 was expressed as two spots proximal to the nucleus in interphase (Figure 4.28A). 
During prophase, CEP85 was expressed as two spots proximal to the mitotic chromosomes 
(Figure 4.28B). In prometaphase, CEP85 was expressed as two clumps localised to opposite 
poles of the cell proximal to the mitotic chromosomes (Figure 4.28C).  
PCM1 tagged with GFP at the N-terminal was expressed in HEK293T cells. During 
interphase, PCM1was expressed as one or two spots proximal to the nucleus (Figure 4.29A 
and B). In prophase, PCM1 was expressed as a spot proximal to the condensed chromosomes 
(Figure 4.29C). In prometaphase, PCM1 was expressed at a large spot proximal to the 
mitotic chromosome in the cytoplasm. PCM1 expression provides a good example of the life 
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Figure 4.25: Subcellular localisation of CEP55 in HEK293T cells. Expression of 
CEP55 was proximal to the nucleus and mitotic chromosomes during A) interphase, B) 
prophase, C), D) prometaphase, E) metaphase, and F) anaphase. Cell images were 
captured by confocal microscopy (Nikon EC-1) 1000X and are 1.6 μm optical sections. 














               Known cell cycle genes tested 
          CEP57 




























   



























   



























   





























   
Figure 4.26: Subcellular localisation of CEP57 in HEK293T cells. Expression of CEP57 tagged 
with GFP at the N-terminal during interphase (A and B), prophase (C), and prometaphase (D). Cell 
images were captured by confocal microscopy (Nikon EC-1) 1000X and are 1.6 μm optical sections. 
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Figure 4.27 Subcellular localisation of CEP72 in HEK293T cells. A), B) Expression of 
CEP72 tagged with GFP at the N-terminal was localised to the cytoplasm. Cell images 
were captured by confocal microscopy (Nikon EC-1) 1000X and are 1.6 μm optical 
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Figure 4.28 Subcellular localisation of CEP85 in HEK293T cells. A) Expression of 
CEP85 tagged with GFP at the C-terminal during interphase, B), and C) show the 
localisation of CEP85 expression during prophase and prometaphase, respectively. Cell 
images were captured by confocal microscopy (Nikon EC-1) 1000X and are 1.6 μm optical 
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Figure 4.29 Subcellular localisation of PCM1. Expression of PCM1 tagged with GFP at the N-
terminal in HEK293T cells during A), B) interphase C) prophase, and D) prometaphase. Cell images 
were captured by confocal microscopy (Nikon EC-1) 1000X and are 1.6 μm optical sections. Scale 
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Figure 4.30 Subcellular localisation of TACC3 tagged with GFP at the N-terminal in HEK293T 
cells was used to determine the transfection efficiency. Cell images were captured by confocal 
microscopy (Nikon EC-1) 1000X and are 1.6 μm optical sections. Scale bar 20 μm. 
The transfection efficiency was calculated using TACC3 tagged with GFP at the N-terminal. 
The number of cells expressing GFP in a field of view was composed of the total number of 
















Subcellular protein localisation using GFP-fusion proteins in HEK293T cells was performed 
to provide evidence that the proteins of interest are involved in specific biological events 
during the cell cycle e.g. chromosome segregation conducted by the centrosomes during M-
phase. Out of a total of 706 clustered genes that appear to be associated with transcriptomic 
activities in S-, G2-, and M-phase, 69 genes were of unknown function (see Chapter 2). Of 
these genes of unknown function, 42 genes were selected according to the quantitation of 
their expression profile (see Chapter 2 methods). Screening by RNAi (see Chapter 3) 
resulted in identification of 19 of these genes with evidence for a role in proliferation 
(Chapter 3). Of these 19 genes, we were unable to obtain 7 clones (ARHGAP11B, CCDC77, 
FAM72B, GPN3, THAP10, TMEM194A, and ZNF367), whilst the other 12  clones were 
obtained and subcloned into expression vectors to study the localisation of the proteins in the 
cells using GFP (ATL2, C17orf53, ARHGAP11A, FIGNL1, FAM111A, RIBC2, 
KIAA1549L, RPL39L, REEP4, GSTCD, UBR7, and DEPDC1B).  
In addition, I tested another 8 genes from the S, G2/M-phase cell cycle list (Chapter 2). Of 
these genes, 3 are known cell cycle genes (i.e. ANLN, KIAA0101, and KNSTRN) and 5 are 
genes of unknown function (i.e. DEPDC1, FAM111B, KPNA2, RACGAP1P and TCF19). 
KIAA0101 and FAM111B had been previously screened in the RTCA experiment (Chapter 
3) but their knockdown had not affected cell proliferation. 
During the course of this project, reports were published that 10 of these proteins are 
associated with the cell cycle. It has been shown that ARHGAP11A/p53 complexes arrest 
the cell cycle and induce apoptosis [303], FIGNL1 is involved in DNA homologous 
recombination repair [308], REEP4 has a role in ER clearance and nuclear envelope 
reassembly [296], ANLN is involved in abscission (the final part of cytokinesis) [312], 
DEPDC1 regulates mitotic progression [313], KIAA0101 is involved in DNA repair [314], 
KNSTRN conducts the metaphase to anaphase transition [315], KPNA2 promotes cell 
proliferation [315] and TCF19 is necessary for cell proliferation [316]. The fact that ten 
proteins from the list of proteins of unknown function have been characterised as cell cycle 
proteins during this period represents very good evidence for the validity of the cell cycle list 
(Chapter 2). 
In order to localise the expression of proteins within cells, the use of GFP-tagged proteins is 





proteins with GFP may alter the localisation of the protein [317]. To minimise the potential 
for localisation artefacts, each protein can be tagged with GFP at the N- or C- terminal [317]. 
In the current study, the localisation of the GFP tag affected the protein localisation of 
FAM111A, KIAA1549L, and DEPDC1. In order to confirm the localisation of these 
proteins, immunofluorescence could be used to provide additional evidence [317].  
It is interesting to note that for the proteins where localisation was not seen in M-phase cells 
(ARHGAP11A, KIAA1549L, RPL39L, GSTCD, UBR7, DEPDC1B, ANLN, DEPDC1, 
KIAA0101, KNSTRN, RACGAP1P, and TCF19), it is possible that the expression of these 
proteins may arrest the cells at interphase or result in apoptosis. This would account for the 
failure to observe cells expressing GFP-fusion proteins in mitosis. Further analysis e.g. flow 
cytometry and SYTOX® Blue staining (see Chapter 3) could be used to determine the cell 
cycle population and viability. 
In general, M-phase duration is 3-5% of the total time of the cell cycle [318]. As the 
doubling time of HEK293T is between 16 to 24 h, the M-phase duration would be on 
average less than 1 hour. It might be that localisation in M-phase was not detected due to 
there being too few cells expressing GFP during this phase, the result of a lower transfection 
rate. Therefore, using cell cycle synchronisation techniques to generate a synchronous major 
population of cells might be useful to identify localisation of these proteins in M-phase cells.  
As a member of the dynamin-superfamily, it has been reported that ATL2 is localised to the 
ER and involved in protein trafficking between the ER and Golgi apparatus [304]. In 
addition, it was reported that the knock down of ATL2 resulted in morphological changes of 
the Golgi apparatus and ER [304]. This suggests that ATL2 may be heavily involved in 
dynamin regulation that delivers the proteins from the ER to the Golgi. The localisation of 
ATL2 in Rismanchi et al., 2008, showed numerous green spots (protein localisation fused 
with GFP at the N- or C-terminal) throughout the cytoplasm in HeLa cells which is different 
to the localisation pattern identified in this thesis where only several small patches of 
expression were observed in the cytoplasm. The C-terminal GFP fusion was not expressed in 
my study. Further experiments would use GFP fusion at the C-terminal in localisation 
experiments to test whether this agrees with the N-terminal protein localisation or the data of 
Rismanchi et al., 2008. It is possible that the protein trafficking mechanism varies in 





To further determine protein localisation, further analysis is required using co-localisation 
with known centrosomal proteins (e.g. γ-tubulin) or immune staining of specific antigens to 
identify particular cellular organelles.    
C17orf53 appears to be localised throughout the cells in interphase, mitosis, and cytokinesis. 
This result was achieved by tagging with GFP tagged at the N- or C-terminal (Figure 4.6). It 
is interesting that C17orf53 is either localised to the cytoplasm as one or two spots proximal 
to the nucleus or as numerous spots throughout the cells. To further validate the localisation 
of C17orf53, co-localisation with known centrosomal proteins (e.g. γ-tubulin to determine if 
the spots of expression proximal to nucleus co-localises with centrosome) could be 
performed. The two distinct localisation patterns observed during interphase with both fusion 
proteins might be due to a difference in localisation at different time points during the cell 
cycle, this could be investigated by tracking cells expressing fusion proteins over a 24 h 
cycle. 
It was reported that the function of FIGNL1 has been characterised during the course of this 
thesis, it has been shown to be involved in homologous recombination repair during S phase 
[308]. In addition, previous studies demonstrated that FIGNL1 is localised to both the 
nucleus and cytoplasm, and potentially plays a role in cell proliferation and differentiation 
[319]. However, FIGNL1 in this experiment appears to be localised to the cytoplasm as one 
or two spots proximal to the nucleus in interphase and mitosis (Figure 4.8). The C-terminal 
GFP fusion was not expressed in this study. To further study the localisation of FIGNL1, 
additional localisation of proteins fused with GFP at the C-terminal is required.  
FAM111A fused with GFP at the C-terminal was localised to discrete patches of expression 
proximal to and within the nucleus (Figure 4.9C). However, when FAM111A was fused with 
GFP at the N-terminal, it was expressed in discrete patches proximal to the nucleus and at 
lower levels throughout the cytoplasm (Figures 4.9A and B). It is most likely that this 
difference in expression is due to the N-terminal fusion protein being expressed at a higher 
level. Tagging of GFP at different position of proteins might also influence the protein 
trafficking system in HEK293T cells e.g. the discrete nuclear patches of expression observed 
only with the C-terminal fusion protein. Further experiments might use immunofluorescence 
if suitable antibodies were available. There is little data published for FAM111A but a 
previous study suggested that FAM111A plays an important role in viral host range 
restriction i.e. depletion of FAM111A may increase SV40 viral gene expression [320]. It 





response to viral infection. However, this is not what we observed in the knockdown 
experiments in Chapter 3 where a decrease in FAM111A expression resulted in a decrease in 
cell proliferation. Further experiments might investigate the role of FAM111A on the cell 
cycle whilst infected with a virus. 
FAM111B appears to be localised to the position of the centrosome in the current study (i.e. 
consistent pattern of FAM111B localisation as a discrete patch proximal to the nucleus when 
fused with GFP at the N- or C-terminal) (Figure 4.19). Little is known of the biological role 
of FAM111B in the cell cycle or other mechanisms. To confirm the centrosomal localisation 
of FAM111B, additional analysis is required e.g. co-localisation with a known centrosomal 
protein such as γ-tubulin.  
KIAA1549L fused with GFP at the N-terminal appears to be localised to the position of the 
centrosome during interphase (Figure 4.11A). However KIAA1549L fused with GFP at the 
C-terminal appears to be localised throughout the nucleus and cytoplasm (Figure 4.11B). To 
determine whether the localisation with the N-terminal GFP fusion protein is co-localised 
with the centrosome, it is necessary to perform co-localisations with a known centrosomal 
protein e.g. γ-tubulin. To determine which of the conflicting patterns of localisation is 
correct, analysis using immunofluorescence could be performed if a suitable antibody was 
available.  
Recent studies suggest that REEP4 is involved in the regulation of microtubule binding with 
chromosomes during mitosis [296]. It was reported that REEP4 also conducts the NEBD by 
removing the mitotic ER from metaphase chromosomes and therefore playing an important 
role in the cell cycle [296]. REEP4 was characterised during the current study, and has been 
reported to be localised to the ER [296]. REEP4 appears to be localised to the cytoplasm in 
this thesis and therefore shares a similar location with the published evidence i.e. localised to 
the cytoplasm.  
As a member of the karyopherin family, it has been reported that KPNA2 functions as a 
nucleocytoplasmic transporter to deliver p65 (transcriptional activator) to the nucleus [321]. 
In addition, KPNA2 is reported to be overexpressed in epithelial ovarian carcinoma (ECO) 
promoting the G1/S cell cycle transition [322]. The knockdown of KPNA2 effectively 
suppressed the proliferation of ECO [322].  In this thesis, KPNA2 appears to be localised to 
the cytoplasm proximal to the nucleus as one or two bright spots when tagged with GFP at 





terminal GFP fusion was not expressed in this study. To further determine its localisation in 
the cells, expression of c-terminal GFP fusion proteins should be performed. Co-localisation 
with known cell cycle-associated proteins e.g. CEP55, and immunofluorescence studies 
could also be performed. 
KIAA0101 appears to be localised to the chromosomes appearing as dashed line patterns 
throughout the nucleus. It has been reported that KIAA0101 is a proliferating cell nuclear 
antigen (PCNA) binding protein [314]. PCNA plays a role in DNA replication and damage 
repair during S-phase. Since DNA repair is conducted by a protein complex composed of 
PCNA and KIAA0101, the overexpression of KIAA0101 fused with GFP at the N-terminal 
could result in a thick bright green dashed line in the nucleus (Figure 4.20A). Both 
KIAA0101 fused with GFP at the N- and C-terminal are localised to the nucleus. However, 
the localisation pattern of KIAA0101 fused with GFP at the C-terminal is different compared 
to the expression of KIAA0101 tagged with GFP at the N-terminal. The expression of 
KIAA0101 fused with GFP at the C-terminal appears to be localised as numerous dots 
throughout the nucleus (Figure 4.20B).  
ARHGAP11A appeared to be localised to the nucleus during interphase and to the 
chromosomes during metaphase and cytokinesis. The C-terminal GFP fusion was not 
expressed in this study and further experiments would examine this localisation. 
ARHGAP11A is reported to be involved in cell cycle arrest by binding with p53 [303]. 
Combination with ARHGAP11A stabilises the tetrameric conformation of p53, enhancing 
the binding with DNA and eventually resulting in cell cycle arrest [303].  
As a member of the APC/C, ANLN plays an important role in cell cycle progression [312]. 
During cytokinesis, ANLN has been reported to conduct the separation of daughter cells by 
assembling an actin and myosin contractile ring [312]. In addition, ANLN has been found to 
be primarily localised to the nucleus in interphase and appears to be localised to the cell 
cortex upon nuclear envelope breakdown [312]. The cell cortex is a specialised layer of 
cytoplasmic protein assemblies on the inner face of the plasma membrane at the cell 
periphery. ANLN has also been found to be localised to the cleavage furrow during 
cytokinesis [312]. This is not what was observed by expressing the N-terminal GFP fusion in 
HEK293T cells where expression was observed as a large mass in the cytoplasm (Figure 
4.17). The C-terminal GFP fusion was not expressed in these studies and further experiments 





DEPDC1B is localised to the nucleus and cytoplasm (Figure 4.16). In contrast to the 
localisation pattern of DEPDC1B, DEPDC1 appears to be localised to the cytoplasm and the 
nucleoli but not the nucleus, which is consistent with the published literature [313]. 
DEPDC1B is involved in the de-adhesion events of cells in mitosis [307]. The knockdown of 
DEPDC1 resulted in mitotic arrest suggesting it is heavily involved in cell cycle regulation 
[313]. It appears to that DEPDC1 and DEPDC1B are both heavily involved in M-phase 
activities. 
KNSTRN appears to be localised to the cytoplasm as grouped spots in interphase (Figure 
4.21). KNSTRN is reported to be an essential component of the mitotic spindle which is 
heavily involved in chromosome segregation [315]. It is also involved in the transition 
between metaphase and anaphase, which is important in the preparation for chromosome 
segregation [315]. However, the localisation of KNSTRN was not identified in mitotic cells 
in this experiment. It is possible that in rapid dividing cells e.g. HEK293T the time window 
of M-phase shifts rapidly. To identify the localisation pattern in mitotic cells, it would be 
useful to localise KNSTRN in cells after a synchronisation treatment. 
TCF19 appears to be localised to the nucleus as a number of green spots (Figure 4.24). 
Recent experimental approaches suggest that the knockdown of TCF19 may decrease cell 
proliferation and induce apoptosis in an insulinoma cell line [316]. In addition, it has been 
reported that the knocking down of TCF19 results in the down regulation of cyclin A, B, and 
E suggesting it is heavily involved in cell cycle regulation [316].  
RPL39L appears to be localised to the nucleus when it is tagged with GFP at the N-terminal 
(Figure 4.12). However, it has been reported that the sequence of RPL39L is known to be 
highly homologous to RPL39 (ribosomal protein L39) suggesting that RPL39L may also be 
localised to the ribosome in the cytoplasm [323]. It is possible that GFP tagging at the N-
terminal affects the protein trafficking proteins in HEK293T cells. To confirm the protein 
localisation with the N-terminal fused GFP, further studies would perform localisation of 
protein with GFP tagged at the C-terminal. 
In summary, main conclusion for this chapter is that FAM111B and KIAA1549L were found 
to be localised to the position of the centrosome. To provide additional evidence, further 
studies would test co-localisation with γ-tubulin to confirm this. However, the role of these 
genes in centrosome regulation remains unknown. In order to begin to understand the role of 





pathway diagram of protein-protein interaction in the centrosome regulatory network would 





















































Chapter 5.  
 
Construction of a large-scale molecular model of 
centrosome and its duplication during cell division 
 
Introduction 
Protein localisation (Chapter 4) analyses produced a list of proteins, which may be 
associated with the centrosome e.g. FAM111B. In order to depict the putative position of 
these poorly characterised proteins in the centrosome, a large-scale pathway map was 
constructed. 
Centrosomes are known to play an important role in cell division. During prophase, the 
centrosomes migrate to the opposite poles of the cell. The nuclear membrane then breaks 
down in preparation for mitotic spindle assembly, which connect the centrosome and 
chromosome. Upon microtubule contraction condensed sister chromatids segregate into two 
daughter cells [324].  
Under the regulation of CDK2, centrosomes only duplicate once per cell cycle during S-
phase giving each daughter cell one centrosome [325]. Each centrosome normally consists of 
two centrioles, which are surrounded by PCM. Centrioles are composed of triplet 
microtubules arranged as barrel-shaped structures. Paired parental centrioles that carry distal 
appendages can be distinguished by staining the marker proteins, such as centrosomal 
protein 164kDa (CEP164) [326,327]. The centrosome regulation is the primary microtubule-
organizing centre and governs protein-protein interactions that occur in interphase and 
mitosis [328].  
A biological process can be described by text and sentences in papers e.g. the cyclic 
adenosine monophosphate (cAMP) signalling pathway [329]. However, it is difficult to 
describe a large-scale regulatory system e.g. the cell cycle control system [175], and immune 
response [174] that includes many protein acting as a complex network.  
In the past 30 years, huge amounts of data have been generated in the field of molecular 
biology, including information on individual proteins, and their interactions within a cell. 





centrally, such as KEGG [330] and REACTOME [188] or by the community, including 
WikiPathways [331].  
A pathway map could simply be considered as a network composed of many workflows of 
protein-protein interactions, linking upstream and downstream interactions [177]. In a 
pathway map, the proteins are considered as components and the protein interactions are 
depicted as arrows between components. For further information of pathway map please see 
pathway modelling at page 37 in Chapter 1. 
Over the last decade, several approaches for representing pathway maps have been proposed. 
The SBGN is a graphical representation language for visualising the biological processes as 
a pathway map [179].  The mEPN is an alternative graphical language based on a pathway 
notation system first proposed by Moodie et al., [176] in 2006 and first published in its 
current form by Raza et al., 2008 [174].  
The SBGN and mEPN schemes are similar in concepts; components, processes, and cellular 
compartments used to construct pathway nodes in both schemes. SBGN based pathway 
mapping is developed by various members of the community, such as the REACTOME, and 
the mEPN is developed by a team of scientists at the Division of Pathway Medicine and the 
Roslin Institute in the University of Edinburgh.  
The aim of this chapter is to construct a detailed centrosome-associated protein network by 
studying existing models and published literatures. In this study, I have constructed a large-
scale regulatory of the centrosome life cycle, which is used to improve current understanding 












Materials and methods 
Data mining, information curation, and organisation 
 
Figure 5.1: Flow chart of pathway mapping. The flow chart summarizing the assembly of 
information across three main stages from concept to diagrams. The tools and methods used at each 
stage are listed in the grey boxes. 
A scaffold pathway map was composed of well-characterised centrosome-associated 
proteins. PubMed (http://www.ncbi.nlm.nih.gov/pubmed) and Google scholar 
(http://scholar.google.co.uk/) were used to perform searches for literature on centrosome 
proteins involved in interphase and during mitosis (Figure 5.1). Data mining on known 
protein-protein interactions between centrosome proteins was carried out using online 
databases, including String (http://string-db.org/) [332]. In addition, online pathway map 
databases, such as KEGG and REACTOME were used to provide the pathway maps in 
which proteins with additional unknown functions may be involved.  
All components have been depicted based on standard human gene nomenclature (HGNC) 
[333]. For each relevant interaction, the following details were recorded: the PubMed IDs of 
the publication the reported the protein-protein interaction, the Enterz IDs of the proteins, 







The entire protein-protein interaction network in this pathway was built as directional 
networks and finished in 6 months. The rules and details are provided in 































Figure 5.2: List of the glyphs used by the modified Edinburgh Pathway Notation (mEPN). 
Different shapes and identifiers are adopted to distinguish between each element of the notation 
scheme. The notation scheme consists of the following categories of A) nodes representing ‘place’ for 
subcellular location, B) the state of components, C) ‘Transitions’ for protein-protein interactions, and 
‘Boolean logic operators’ for the relationship between multiple inputs into a biological process, D) 
‘Edges’ for the biological regulation in the cells. E) ‘Compartments’ for the cell and locations. For 
full scale images please see attached PDF file in CD. 
The entire pathway of centrosome-regulated proteins can be considered as a network of 
interactions between components. To visualise knowledge from literature systematically, the 
mEPN scheme is explained here. Graphs can be classified into four categories. First, entity 
nodes are used to represent any physical entity that is involved in the biological interactions, 
such as a protein, protein complex, nucleic acid, and other molecules (Figure 5.2A). To 
further display the state of proteins, the abbreviation of descriptions within the brackets can 
be used e.g. [A] means activate, [P] means phosphorylated (Figure 5.2B).  
Transition nodes, such as ‘B’ means the binding between proteins, ‘P’ means the 





5.2C). Direction of biological interactions are depicted with arrows of various colours and 
shapes (Figure 5.2D). To define the position where these biological processes happens, 
compartments are used to define the location in cells, such as cytoplasm and nucleus (Figure 
5.2E). 
Pathway maps were constructed and optimised using graph editor program yEd (yFiles 
software, Tubingen, Germany). Information of components and their associated evidence of 
interactions between proteins, PubMed IDs are stored on appropriate edges and nodes. 
Pathways saved as ‘.graphml’ files. The optimisation of the pathway map also involved 
redirecting the edges that connect proteins interactions such as, catalysis, and inhibition.  
Design of the centrosome regulation pathway in longitudinal and cross sectional 
displays 
The aim of pathway mapping is to systematically incorporate and visualise information from 
literature curation. However, the number of components in a pathway determines the 
information accessibility i.e. understanding the regulatory logic of a single interaction is 
easier than the entire regulatory network of the centrosome life cycle which is composed of 
more than 100 proteins. To help users effectively access the pathway map, a flow chart that 
represents the centrosome regulation at each stage by longitudinal and cross sectional images 
is used here. 
Pathway overlay of the transcriptional analysis of fibroblast before and after 
cell cycle synchronisation 
To understand the regulatory logic of centrosome-associated genes, overlapping genes 
between the map and array dataset (Chapter 2) in this thesis are labelled with different 














































Construction of a framework diagram of centrosome regulation 
pathways 
 
Of those proteins associated with centrosomes, 117 were selected as having the most 
significant involvement in centrosome regulation based on literature mining. Other 
associated proteins, which are not necessarily involved in the regulation of centriole 
duplication were not included in this pathway map.  
The pathway map of centrosome regulation includes 667 nodes of which 270 represent 
proteins, 203 complexes, and 192 make up other components.  A total of 93 interactions are 
described in the pathway map, of these interactions 37 are various activation state 
modulations (20 phosphorylations, 3 dephosphorylations, 6 cleavages, 2 translocations and 6 
activations by processes not defined).  
There are 6 inhibition reactions, 5 of these are inhibition of cleavage while the other inhibits 
microtubule nucleation. A total of 2 translocation events occur during disjunction of paired 
parental centrosomes. In many circumstances the same paper may describe multiple 
interactions, for example the recruitment of CEP55 to the midbody during cytokinesis was 
inhibited by PLK1 [43].   
To describe centrosome duplication at different stages in the cell cycle, different terms are 
used (see below). The developing of procentrioles happened on both of mother and daughter 
centriole during interphase (Figure 5.6 and Appendix III). It is important to note that during 
M-phase, both mother and matured daughter centriole are separated at opposite positions 
with its own procentrioles wrapping with PCM (Figure 5.6 and Appendix III). To 
specifically point out which stage where there are, ‘parental centrosome’ is used to define the 
M-phase centrosomes. 
• G1-early Mother centrosome: A completely developed centriole with appendages 
wrapped with PCM. 
• G1-late & S Procentriole: A daughter centriole undergoing the duplication during 
S-phase. 
• S Interphase centrosome: A matured mother centriole wrapped with PCM and a 
procentriole. 
• S & G2 Daughter centriole: A completely developed centriole by the end of S-
phase. 
• G2 Daughter centrosome: A daughter centriole just dissociated from its mother 
centrosome ‘wrapping with PCM’. 
• M Parental centrosome: Once the cell enters M-phase, two matured centrosomes 
are ready to function as mother (parental) centrosomes 





For important elements of the centriole structure, there are 2 proteins located in 
procentrioles, 3 in proximal end of the centriole, 8 in distal end, 10 in 9 symmetrical 
microtubules, and 9 in appendages (Table 5.1). The PCM is consisted of various areas 
including inner layers (4 proteins), outer layers (6 proteins), basement of daughter centriole 
(4 proteins), basement of mitotic spindle assembly (11 proteins), and centriolar satellite (12 
proteins) (Table 5.1).  The linker fibre includes 5 proteins (Table 5.1). The cohesion complex 
includes 9 proteins (Table 5.1). The other centrosomal proteins are located in the cytoplasm 
(26 proteins) and midbody (9 proteins) (Table 5.1). 
To understand the life cycle of centrosome during cell proliferation, figures that explain the 
structure of centrosome from the literature are shown (Figure 5.3). The following figures 
were the base for building the pathway map. For the longitudinal section of the diagrams, 
figure 5.3A shows the structure of the mother and the daughter centrioles according to the 





Figure 5.3: Examples of centrosome structure in 2D and 3D. A) The electro micrograph 
demonstrates an interphase centrosome including a mother and daughter centriole at longitudinal 
section. This figure is courtesy of Gonczy et al., 2012 [324]. B) The development of a mother 
centrosome is shown in a cartoon flowchart that includes the electron micrograph of centriole at 
proximal and distal end. This figure is courtesy of Bornens et al., 2002 [334]. C) The microtubule 
assembly shown in 3D. This figure is courtesy of Oakley et al., 2000 [335].  D) A mother and 






Figure 5.3B demonstrates the development of a centriole from the assembly of the cartwheel 
structure to the recruitment of appendages [334]. This figure also includes the electron 
micrograph demonstrating the centriole structure at different levels of cross section, which 
was used to depict cartoon style diagrams. Figure 5.3C explains the development of 
microtubule assembly including α, β, and γ-tubulin as the basic elements in a 3D 
environment [335]. Figure 5.3D shows the entire structure of mother and daughter centrioles 
wrapping with PCM in a 3D environment to provide more detail of centrosome at structure 
level [336]. 
Contemporary view on centrosomes structure and function  
The centrosome is known to be composed of multiple functional complexes consisting of 
hundreds of proteins [337,338]. Of those proteins, 44 important proteins are believed to be 
essential in the structured core of a post-mitotic centrosome and are demonstrated in cross 
and longitudinal sections (Table 5.1 and Figure 5.4).  
Centrosome structure 
A fully developed centrosome consists of two centrioles surrounded by the PCM (Table 5.1, 
Figure 5.4A and D) [52]. More specifically, a mother centrosome is composed of a cartwheel 
structure [339], a 9-fold symmetrical structure of microtubule triplets (A, B, and C-tube) 
[340], a PCM from the centre to surrounding materials (Table 5.1). 
  Centriole    
 Procentrioles                           NPM1, ROCK2 
 Proximal end  (Cartwheel structure)  CENPJ, CEP135, SASS6 
 Distal end CETN1, ODF1, USP33, POC1B, CCNF, CCP110, POC1A, 
POC5 
 9 symmetrical microtubules  TUBGCP2, TUBGCP6, TUBE1, TUBA1B, TUBB3, 
TUBD1, TUBG1, TUBGCP3, TUBGCP4, TUBGCP5 
 Appendages                                 MAPRE2, MAPRE3, CEP170, ODF2, CEP164, CNTRL, 
MAPRE1, NIN, KIF24 
  PCM   
 Inner layers  AKAP9, CDK5RAP2, CEP120, PCNT 
 Outer layers CEP63, ASPM, CEP152, CEP57, CNN, NEDD1 
 Basement of daughter centriole  PLK2, CEP192, PLK4, STIL  
 Basement of mitotic spindle assembly  PAFAH1B1, NUMA1, HAUS5, HAUS1, HAUS2, HAUS3, 
HAUS4, HAUS6, HAUS7, HAUS8, KIF11 
 Centriolar satellite  DCTN1, DISC1, BBS4, HOOK3, OFD1, KIZ, CEP90, 
PARD6A, CEP290, CEP72, FOPNL, PCM1 
  Linker fibre  CROCC, CEP250, CEP68, LRRC45, CTNNB1 
  Cohesin complex  STAG3, PP2A, CC2D1A, RAD21, SGOL1, SMC1, SMC3, 
SPAG5, STAG2 
  Cytoplasm CASS4, CDH1, PPP1CA, PPP1R2, DNAH2, TEKT1, NEK6, 
NEK9, NDEL1, SAV1, MAPK1, CCNE1, ANAPC, CDK1, 
FZR1, KATNB1, KPNB1, PLK1, TPX2, FBXW5, AURKA, 
NEK2, NEK7, PPP1CC, STK3, CDK2 
  Midbody STAG3, PP2A, CC2D1A, RAD21, SGOL1, SMC1, SMC3, 
SPAG5, STAG2 





Between the mother and daughter centrioles, the linker fibres provide dynamic connections 
by binding with their proximal ends (Table 5.1 and Figure 5.5) [341]. Compared to the 
daughter centriole, the mother centriole has additional distal and subdistal appendages (Table 
5.1, Figure 5.4A and D) [52]. 
 
Figure 5.4: Centrosome structure. Cross and longitudinal sections of the interphase centrosome 
depicted according to the electron micrograph of centrosome. The structure includes matured mother, 
daughter centrioles, and a highly structured PCM. A) The longitudinal section of a daughter 
centrosome. B) Electron micrograph of the interphase centrosome. The top and bottom inset 
demonstrates the cross-section of subdistal appendages and proximal part of the centrosome. Image 
was generated by Paintrand, et al., 1992 [342]. C) The cross section of a mother centrosome at 
proximal end. D) The longitudinal section of a mother centrosome.  E) The cross section of a mother 












Cartwheel structure and the proximal end of the centriole 
The cartwheel structure at proximal end of a centriole is composed of protein spindle 
assembly 6 (SASS6), CEP135, and centromere protein J (CENPJ) (Figures 5.5A3 and B2). 
Composed of nine spokes radiating from the centre hub, the cartwheel assembly at the 
proximal end of the centriole structure is entirely composed of protein SASS6 [340]. SASS6 
is the central scaffolding component of the centrioles building a 9-fold symmetrical structure 
of microtubule triplets (A, B, and C-tube) [340]. In connection between SASS6 and 
microtubule triplet, CEP135 plays a role as the scaffolding structure during early stage of 
centriole cartwheel structure biogenesis [258].  CENPJ plays a structure role in maintaining 
the integrity of the cartwheel scaffold and the spindle morphology in connection with C-tube 
and CEP135 in cell proliferation [343].  
Proteins located at the distal end of the centriole 
At the distal end of the centriole structure, the protein complex includes centriolar coiled-coil 
protein of 110 kDa (CCP110), ubiquitin specific peptidase 33 (USP33), proteome of centriolar 
protein A (POC1A), proteome of centriolar protein B (POC1B), proteome of centriolar protein 
5 (POC5), outer dense fibre of sperm tails 1 (ODF1), outer dense fibre of sperm tails 2 
(ODF2), centrin-1 (CETN1) (Figures 5.5A5 and B3). CCP110 is a cell cycle-dependent CDK 
substrate regulating centrosome duplication [344]. Protein USP33 inhibits the ubiquitination 
of CCP110 progressing the centrosome duplication [345]. POC1A and POC1B were both 
involved in the early stages of centriole duplication stabilising the structure integrity of 
centriole and proper mitotic spindle formation after daughter centrosome fully developed 
[346]. POC5 is known to have an essential role in the centriole elongation at the distal half of 
centrioles [347]. 
Other distal end centriole proteins include ODF1 which regulates the length and distal 
structures of centrioles [348], and ODF2 is required for the formation of the distal and 
subdistal appendages on the mother centriole (Figures 5.4B, 5.5A5, and 5.5B3) [349]. 
Protein CETN1 is involved in the regulation of microtubule assembly, the coordination with 
the MTOC, and the duplication of centriole in mammalian cells (Figures 5.4B, 5.5A5, and 
5.5B3) [350,351]. The phosphorylation of CETN during mitosis determines centriole 















Figure 5.5: Longitudinal and cross section of a mother centrosome. A completely developed 
interphase centrosome includes A1) Linker fibres, A2 and B4) Centriolar satellites, A3 and B2) 
proximal end scaffolds, A4 and B5) PCM, A5 and B3) distal end scaffolds, A6 and B1) 9 fold of 
symmetrical microtubule triplicate, A7 and B6) distal/subdistal appendages. A matured mother 
centriole is paired with a daughter centriole via the connection of A1) linker fibre-associated proteins. 
The dashed black line separates the sections between the cartwheel structure A3 and B2) and the 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Both the mother and daughter centrioles possess a 9-fold symmetry structure of microtubule 
triplet (Figures 5.5A6 and B1). The long axes of the microtubule determine the length of the 
cylinder. Each of the microtubule triplets consists of an A-, B-, and C-tubule at the internal, 
middle, and external positions respectively. In contrast, the length of C-tubule is only two-
thirds of the centriole without its distal portion.  
The protein A-C linker, which provides the structural connection between A- and C-tubule 
also maintains the integrity of cartwheel scaffold structure [341]. In addition, the A-C linker 
connecting the A- and C-tubule belongs to one triple and previous one respectively in the 
proximal centriole.  
PCM 
Owing to the essential role of parental centrioles in the progression of the microtubule 
nucleation, it is important to have PCM, a cloud of proteins, responsible for microtubule 
nucleation and anchoring activity (Figures 5.5A4 and B5) [52]. During interphase, most of 
the PCM surrounds the mother centriole, but it is equally distributed around mother and 
daughter centrioles by the end of G2-phase after the daughter centriole is completely matured 
[52].  This ensures that the developing daughter centriole is inactivated during S-phase [52] .  
The inner layer functions as a main organiser of the PCM complex (Figures 5.5A4 and B5) 
[353]. In contrast, the outer layer provides most of the microtubule nucleation functionality 
by acting as a platform for the docking of γ-TuRC [353].  
In order to initiate the assembly of microtubules for segregating the duplicated chromosomes 
in mitosis, the γ-TuRC functions as the MTOC acting with other centrosome-associated 
proteins in PCM (Figures 5.6E, F, and G). Only fully developed γ-TuRCs are capable to 
conduct the disjunction of mitotic chromosomes.  
For the microtubule nucleation in M-phase organised by PCM, it is γ-tubulin that plays a 
pivotal role providing a platform for the initiation of the polymerisation of α- and β-tubulin 
heterodimers into developing microtubules (Figures 5.6E, F, and G). Collectively, the 
tubulin gamma 1 (TUBG1) and tubulin gamma 2 (TUBG2) and other associated proteins are 
known as γ-tubulin complex proteins (TUBGCP2~6) [354-356]. Two copies of TUBG1 
together with one copy of tubulin gamma complex associated protein 2 (TUBGCP2) and one 
copy of tubulin gamma complex associated protein 3 (TUBGCP3) form a tetramer complex 





complex associated protein 4, 5, and 6 (TUGCPs 4, 5, and 6) are able to be assembled into a 
high-order complex known as γ-TuRC [356].    
Other core elements of the γ-TuRC in association with PCM, such as neural precursor cell 
expressed, developmentally down-regulated 1 (NEDD1) and mitotic spindle organizing 
protein 2 (MZT2) are thought to not to have essential role in the γ-TuRC assembly [357-
360]. As a PCM-associated protein located at inner and outer layer of the PCM, NEDD1 is 
known to be independently recruited by γ-TuRC conducting the attachment between γ-TuRC 
and PCM [358,359,361-363]. Mitotic spindle organizing protein 1 (MZT1) is co-localised 
with NEDD1 at the inner layer of PCM and is required for the recruitment of γ-TuRC to 
centrosomes during the M-phase [153,364].   
The PCM are a layered structure composed of various proteins from inside to the surface of 
its structure (Figures 5.5A4 and B5). Of the outer layer proteins in PCM complex, protein 
pericentriolar material 1 (PCM1) is known to locate at the centriolar satellites that conduct 
the assembly of centrosomal proteins and microtubule [365]. For the proteins that are equally 
distributed across inner and outer layers of PCM including a kinase anchor protein 9 
(AKAP9) [366] and pericentrin (PCNT) [367], PCNT is known to be the integral component 
of PCM in the initial establishment of microtubule arrays organisation in both mitosis and 
meiosis [368]. AKAP9 provides sites for microtubule nucleation in the mammalian 
centrosome by anchoring γ-TuRC by binding with TUBGCP2 and/or TUBGCP3 at their 
amino-terminal regions [369].  
For the protein complex positioned in inner layer of PCM, CDK5 regulatory subunit 
associated protein 2 (CDK5RAP2) is important for the binding of γ-TuRC and functions as 
negative regulator of centriole disengagement maintaining mother and daughter centriole 
engagement and cohesion (Figures 5.5A4 and B5) [370,371]. Other PCM-associated proteins 
located in the inner layer, including centrosomal protein 63kDa (CEP63), centrosomal 
protein 120kDa (CEP120), and centrosomal protein 152kDa (CEP152), are also necessary 
components in the regulation of γ-TuRC conducting microtubule assembly in M-phase. 
CEP63 is required for normal spindle assembly and plays a key role in mother-centriole-
dependent centriole duplication, through centrosomal recruitment of CEP152 [372]. CEP152 
acts as a molecular scaffold facilitating the interaction of polo-like kinase 4 (PLK4) and 
CENPJ, both of which are involved in centriole formation [373]. Both CEP63 and CEP152 
are dependent on one another for the localisation of mitotic centrosome [372]. CEP120 





Distal and subdistal appendages of the mother centriole 
Distal appendages promote the membrane anchoring [50]. A complete structure composed of 
distal and subdistal appendages is an extension network that equally radiates from the distal 
end of the mother centriole (Figures 5.5A7 and B6) [375]. In distal appendages, protein 
CEP164 and outer dense fibre of sperm tails 2 (ODF2) are thought to be the conservative 
elements involved in primary cilia formation (Figures 5.4B and 5.5) [376]. CEP164 is 
required in the distal appendages of mature centrioles [327]. ODF2 functions as a general 
scaffold protein in both distal and subdistal appendages [349]. 
Subdistal appendages conduct the nucleating of microtubule network (Figures 5.5A7 and 
B6) [51,334]. The subdistal appendage contains protein ninein (NIN), centriolin (CNTRL), 
tubulin, epsilon 1 (TUBE1), kinesin family member 24 (KIF24), microtubule-associated 
protein, RP/EB family member 1 (MAPRE1), MAPRE2, MAPRE3, ODF2 and centrosomal 
protein 170kDa (CEP170) (Figures 5.4B, 5.5A7, and 5.5B6) [376]. NIN is known to be a 
centrosomal protein required for the position and anchorage of microtubules [377,378]. 
CNTRL is involved in the centrosome maturation [379]. TUBE1 is involved in the 
microtubule assembly during centriole duplication [380]. KIF24 is a microtubule-dependent 
motor protein responsible for mediating recruitment of CCP110 to the mother centriole in 
cycling cells [381]. MAPRE1, 2, and 3 are known to play important roles in microtubule 
dynamic regulation, cytokinesis, and mitotic spindle positioning [382]. CEP170 is known to 
function as the major microtubule-organizing centre [383,384]. 
The centrosome life cycle 
Owing to its complexity and role in the regulation of cell cycle, particularly during S- and 
M- phase, a categorisation of proteins and their regulation network is formed in this analysis. 
The following section describes the processes of centriole duplication and maturation during 
S-, G2-, and M-phase of the cell cycle by using cartoon-style flow chart and regulatory 














Figure 5.8: Licence activation of NPM1 that initiates the cartwheel structure development. 
Proteins that located in A) the longitudinal section of centrosome structure and B) network motif in 
pathway map are labelled by numbers. A1 and B3) Structure of parental centrosome showed at 
longitudinal section (red square with dash line) and pathway. A2 and B5) Linker fibres. A3 and B6) 
Daughter centrioles. A4 and B4) CEP152 located in parental PCM is phosphorylated resulting in the 
recruitment of PLK4 and SCL/TAL1 interrupting locus (STIL). A5 and B2) Cartwheel structure 
development is located at proximal end of the parental centrosome. B1) Recruitment of 















Centrosome duplication initiated in G1-phase 
Starting on G1-phase, the polo-like kinase 2 (PLK2) catalyses the phosphorylation of protein 
NPM1 shuttling it into the unduplicated centrioles and licenses the development of the 
cartwheel structure (Figure 5.8B1) [25,385,386]. Phosphorylated NPM1 when initiates 
centrosome duplication during G1/S-phase at the mother centriole [387,388], when a number 
of key proteins are recruited. This includes PLK4 [389], CEP152 [389], CENPJ [371,390-
392], and SASS6 [393] initiating the processes of procentriole development (Figure 5.8B). 
Prior to the development of procentrioles, CEP152 is phosphorylated. This is mediated by 
PLK4 (Figures 5.8A4 and B4). PLK4 and STIL then localise to the proximal end of the 
mother centriole attaching on phosphorylated CEP152 where the SASS6 will be recruited. 
This initiates the cartwheel structure development (Figures 5.8A5 and B2) [394-397]. 
Additionally, centrosomal protein 192kDa (CEP192) and CEP152 are both involved in the 
PLK4 recruitment and centriole duplication [398]. For other locations (labelled by numbers), 
position figure 5.8A1 and B3 represent a longitudinal section and notations represent mother 
centrosomes in the pathway. Figure 5.8A2 and B5 represent the linker fibres. Figure 5.8A3 
and B6 represent the daughter centrioles. 
 
Duplication of the daughter centriole in S-phase 
To avoid the over reproduction of procentrioles, cadherin 1 (CDH1) and f-box and WD 
repeat domain containing 5 (FBXW5) are involved in the ubiquitination of over expressed 
SASS6 during the development of cartwheel structure (Figure 5.9B2) [340,399]. This 
double-safety mechanism prevents the re-initiation of procentriole development. STIL then 
interacts with SASS6 binding to procentrioles stabilising the cartwheel structure (Figure 
5.9B1) [400-403].  CEP135 is then recruited to localise nearby the SASS6 at the proximal 
end (Figure 5.9B3) [404-406]. CENPJ is then recruited to localise beside the CEP135 
preparing to nucleate the microtubule (Figure 5.9B4) [371,390-392]. 
Once the cartwheel assembly is positioned on the proximal end of a mother centrosome, 
CENPJ and other proteins are then involved in the nucleation and extension of microtubules 
(Figure 5.10). Following in an orderly fashion, the A-tube of a microtubule is first added to 
the tail of the radiation spokes of SASS structures binding on γ-TuRC complexes and then 
continues microtubule assembly of the B- and C-tubes until whole structure is completed for 
cross and longitudinal section of a cartwheel structure and microtubules of A-, B-, and C-











Figure 5.9: Initiation of procentriole development and the emerging of cartwheel structure. A) 
Longitudinal section of cartwheel structure development. B) Pathway of the cartwheel-structured 
protein assembly. A1 and B5) Location of fully developed cartwheel structure at longitudinal section 
of procentrioles structure and pathway. B1) Expression and stabilisation of SASS6. B2) 
Ubiquitination of over expressed SASS6 regulated by FBXW5 and CDH1. B3) Recruitment of 

















Figure 5.10: Assembling and extension of the microtubule in procentriole development. A) 
Longitudinal section of microtubule assembly. B) Pathway of the microtubule assembly. A1 and B4) 
Location of fully developed 9-fold symmetrical microtubule triplicate structure at longitudinal section 
of procentrioles structure and pathway. B1) Protein complex, which mediates the recruitment of 












Progression of A-, B-, and C-tube recruitment constructs a microtubule-based cylindrical 
structure, Centrosomal Protein 350kDa (CEP350) is thought to be involved in the developing 
of procentrioles by stabilising the microtubule structure (Figure 5.10B1) [408]. Protein 
Centrosomal Protein 57kDa (CEP57), MZT2A, and MZT2B are thought to be involved in 
the recruiting of γ-TuRC complexes during the interphase (Figure 5.10B1). CEP57 localises 
around the proximal end of the centriole during the interphase and then conducts microtubule 
anchoring in M-phase (Figure 5.10B1) [270]. MZT2A and MZT2B are involved in the 
recruitment of γ-TuRC complexes for PCM of centrioles undergoing maturation (Figure 
5.10B1) [360,364].  
Microtubule assembly that starts from a template is provided by γ-TuRC complexes (Figure 
5.10B) [354,356]. For the development of γ-TuRC complexes, two copies of TUBG1 
together with TUBGCP2 and TUBGCP3 are clustered together forming a tetramer called γ-
TuSC [409,410]. Other family members of γ-tubulin including TUBGCP4, 5, and 6 are also 
recruited to bind with γ-TuSC resulting in a higher order of γ-TuRC complexes [356,410-
413]. In comparison with the A-tube that is composed of TUBA1B, TUBB3, and γ-TuRC 
complex, B- and C-tube of microtubules are assembled with the recruitment of additional 
TUBD1 and TUBE1 (Figures 5.10A1 and B4) [414,415].  
The centrin-binding protein POC5 is involved in the regulation of distal procentriole 
development (Figure 5.11B3) [347]. Other proteins, including CCP110 [381], PCOC1A  
[346], and POC1B [346], are also recruited to the procentriole structure at distal end (Figures 
5.11A1 and B4). Protein USP33 interacted with CCP110 binding to procentriole in late S-
phase and finishes the capping of procentriole at distal end (Figure 5.11B2) [416]. In 
addition, it is interesting that protein Cyclin F (CCNF) is involved in both of the inhibition of 
over reproduction of DNA and the centrosome by catalysing the ubiquitination of protein 
CCP110 (Figure 5.11B1) [416]. CETN1 located at the distal end of procentriole during the 
interphase, plays a role in positioning and segregation of the centrosome in mitosis (Figures 














Figure 5.11: Recruitment of the protein complexes at distal end of procentriole. A) Longitudinal 
section of a procentriole. B) Pathway of the recruitment of linker fibres and the proteins at distal end 
of the procentriole. A1 and B4) Protein complex at distal end of procentriole structure. B1) DNA and 
centrosome reproduction are regulated by CCNF. B2) USP33 mediates the recruitment of CCP110 to 
procentrioles terminating the centriole duplication. B3) POC5 regulates the distal procentriole 

















Figure 5.12: Recruitment of PCM and the maturation of daughter centrioles. A) Redistribution 
of PCM between a parental centrosome and a procentriole. B) Pathway of the recruitment of PCM 
distributed from parental centrosomes. A1, B1, B2) PCNT and AKAP9 conducts the recruitment of 
PCM from mother centrosome from inner to outer layer. A2, B5, B6, B7) PCM-associated proteins 
located at inner and outer layer. B3) Located at the inner layer, CEP192 not only recruits CEP120 and 
CDK5RAP2 to PCM but also catalyses the recruitment, maturation of it. B4) PLK1 catalyses the 

















The layered structure of PCM includes inner and outer sphere orbited by centriolar satellites. 
The recruitment of PCM for procentriole initiates from the nucleating of PCNT and AKAP9 
localised at inner layers, which forms the PCM structure (Figures 5.12A1, B1, and B2). In 
addition, PLK1 induces the centrosome maturation which is essential for procentriole in the 
next cell cycle (Figure 5.12B4) [417-419]. CEP192 not only is involved in the catalysis of 
PCM recruitment and maturation but also localises with CEP120 and CDK5RAP2 at the 
inner layers of the PCM structure (Figure 5.12B3) [416,420]. Clusters of functional protein 
complexes including NEDD1 [358,359,361], centrosomin (CNN) [52], CEP63 [52], 
abnormal spindle homolog, microcephaly (ASPM) [52], CEP152 [52], and TUBG1 [52] are 
located at outer layer of the PCM structure (Figures 5.12A2, B5, B6, and B7).   
The disjunction between mother and developing procentriole is known to be a prerequisite to 
licence the centrosome reproduction and is tightly regulated by PLK1 (Figure 5.13B8) [417]. 
In order to prevent the premature centrosome splitting during the interphase, cohesion is 
recruited to stabilise the connection between mother and procentriole (Figures 5.13A1, B3, 
and B4) [421,422]. In order to against the attacking of separase that induces the 
disengagement between the mother and developing procentrioles, protein coiled-coil and C2 
domain containing 1A (CC2D1A) and sperm associated antigen 5 (SPAG5) catalyse the 
recruiting of double-strand-break repair protein rad21 homolog (RAD21) to the centrosome 
inactivating separase (Figures 5.13B1 and B6) [421,423,424].  
In addition, in combination with protein phosphatase 2 α (PP2A), cohesin-associated protein 
shugoshin-like 1 (SGOL1) is recruited to the cohesin complexes being conducted by PP2A 
(Figures 5.13B2 and B7). The SGOL1 and PP2A complex inhibit the phosphorylation 


















Figure 5.13: Cohesin that engages mother and pre-matured centrosomes is stabilised by SGOL1 
and PP2A complexes. A) Cohesin protein complex that tethers paired parental centrosomes at the 
proximal end (see red line). B) Assembly and the recruitment of cohesin-associated protein complex 
that engages parental and developing centriole. A1, B3, B4) Cohesin complex. B1 and B6) 
Recruitment of RAD21 inhibits the dissociation of cohesin complex. B2 and B7) Recruitment of 
SGOL1 inhibits the dissociation of cohesin complex. B5) A protein complex composed of SGOL1 
and PP2A inhibits the phosphorylation of SGOL1 catalysed by PLK1. B8) PLK1 mediates the 





















Figure 5.14: Recruitment of centriolar satellites that initiates the nucleating of microtubules. A) 
Recruitment of centriolar satellites. B) Pathway of assembly and recruitment of the cohesin complex-
associated proteins. The dissociation of licence proteins that terminates the centrosome duplication by 
the end of S-phase. B1) Recruitment of the primary component of centriolar satellites. B2 and B3) 
Recruitment of centriolar satellites. B4) A protein complex composed of NPM1 and ROCK2 
antagonists the binding of CDK2 and CCNE1.B5) Dissociation of NPM1 catalysed by the complex 










The complexes of centriolar satellite-associated proteins are recruited to surround the PCM 
during the G2/M border (Figure 5.14B2). The assembly of the centriolar satellite-associated 
proteins starts from the clustering of primary components, including protein centrosomal 
protein 290kDa (CEP290), PCM1, bardet-biedl syndrome 4 (BBS4), and oral-facial-digital 
syndrome 1 (OFD1) (Figure 5.14B1) [428].  CEP290 and BBS4 both cooperate with the 
PCM1 to be recruited to centriolar satellite [429,430]. OFD1 is involved in the assembly of 
microtubules for a centriolar satellite [428]. PCM1 is recruited to the centriolar satellite via 
the cooperation with BBS4 (Figure 5.14B1) [431].  
The primary component of centriolar satellite provides a foundation to continue the assembly 
of other associated proteins including protein dynactin 1 (DCTN1), disrupted in 
schizophrenia 1 (DISC1), FGFR1OP N-terminal like (FOPNL), hook microtubule-tethering 
protein 3 (HOOK3), kizuna centrosomal protein (KIZ), OFD1, and partitioning defective 6 α 
(PARD6A) (Figures 5.14B1 and B2). DCTN1 plays an important role to recruit the 
centrosome-associated proteins [432] and is also involved in cell division and intracellular 
transport [433].  In addition, DCTN1 also coordinates with PARD6A and PCM1 to regulate 
the centrosomal protein recruitment [432]. DISC1 is known to coordinate with BBS4 
recruiting PCM1 to the centriolar satellite [431].  HOOK3 coordinates with PCM1 to 
regulate PCM [434]. FOPNL is localised in the centriolar satellite but there is little 
information on its biological function [435].  
In order to terminate the duplication of centrosome, phosphorylation of licence protein 
NPM1 is mediated by CDK2 and CCNE1 (Figure 5.14B5) [436,437]. Phosphorylated NPM1 
is then combined with ROCK2 and dissociates from the procentriole. The protein complex 
composed of ROCK2 and phosphorylated NPM1 engages with the combination of CDK2 
and CCNE1 that mediates the phosphorylation of NPM1 (Figure 5.14B4) [436,437]. 
Duplication of centrosome is then terminated after licence protein NPM1 is disengaged from 















Figure 5.15: Disjunction of mother and daughter centrioles at the G2/M-phase border. A) 
Dissolution of linker fibres between paired parental centrosomes (see red dashed line). B) Regulation 
of activated kinase that initiates the dissolution of two key linker fibre proteins including centrosomal 
protein 250kDa (CEP250) and ciliary rootlet coiled-coil rootletin (CROCC) leading to the disjunction 
between paired parental centrosomes. B1, B3, B17) Transition of PLK1 to be phosphorylated by 
phosphorylated AURKA is catalysed by PCM1. B2) AURKA phosphorylation catalysed by TPX2. 
B4) Phosphorylation of STK3 is catalysed by phosphorylated PLK1 and then combined with B5) 
PPP1CC as a protein complex that catalyses the B7 and B13) dephosphorylation of activated CEP250. 
B6) A protein complex composed of PPP1R2 and PPP1CA inhibits the phosphorylation of NEK2 
dimers. B8) PCNT inhibits the phosphorylation of NEK2 dimers. B9) Dimerization of NIMA-related 
kinase 2 (NEK2). B10) Salvador family WW domain containing protein 1 (SAV1) catalyses the 
phosphorylation of NEK2 dimers. B15 and B16) PCM1 conducts the transferring of phosphorylated 
NEK2 dimers. B11) PPP1CA indirectly conducted the activation and deactivation of NEK2 dimers. 
B12) CASS4 inhibits the transition of activated NEK2 dimers. B14) NEK2 dimers catalyse the 





















In order to conduct the segregation of paired parental chromosomes bonded with their 
mature daughter centrosomes in M-phase, paired parental centrosomes disengage moving to 
opposite positions in a cell [438]. NEK2 accumulates during the S- and G2-phase and its 
activity determines the dissolution of the linker fibres (Figure 5.15B9). NEK2 dimers can be 
phosphorylated by triggering a down-stream chain reaction to dissolve the linker fibre 
proteins (Figure 5.15B14) [439,440]. SAV1 is also involved in the catalysis of NEK2 dimer 
phosphorylation (Figure 5.15B10) [441]. Two key components of the linker fibres, CEP250 
and CROCC, are phosphorylated mediated by NEK2 and results in a disjunction of paired 
parental centrosomes (Figure 5.15B14) [442,443]. The recruitment of NEK2 is conducted by 
PCM1 from the cytoplasm to localise at linker fibres (Figures 5.15B15 and B16) [444].  
As NEK2 plays a deterministic role in linker fibres dissolution, it needs tight regulation in 
order to prevent a premature centrosome segregation and over reproduction of centrosomes 
during interphase. An important on-off bi-stable switch at up-stream regulation is the 
phosphorylation and dephosphorylation of protein phosphatase 1 catalytic subunit α 
(PPP1CA) that conducts the activation and deactivation of NEK2 dimers (Figure 5.15B11) 
[445]. Dephosphorylated PPP1CA can also inhibit the phosphorylation of NEK2 dimers by 
binding with protein PPP1R2 (Figure 5.15B6) [445]. Another inhibitor of NEK2 dimer 
induced phosphorylation is PCNT (Figure 5.15B8) [446]. CASS4 inhibits the dissolving of 
linker fibre protein CROCC by preventing the transferring of NEK2 dimers (Figure 
5.15B12) [446].  
Another branch of the regulation the phosphorylation of aurora kinase A (AURKA) 
catalysed by TPX2, microtubule-associated (TPX2) (Figure 5.15B2). This is induced by 
phosphorylated PLK1 trafficking by PCM1 in centriolar satellite (Figures 5.15B1, B3, and 
B17), which is then combined with phosphorylated serine/threonine kinase 3 (STK3) (Figure 
5.15B4), protein phosphatase 1 catalytic subunit (PPP1CC) (Figure 5.15B5), and 
phosphorylated NEK2 dimer (Figure 5.15B7) [447,448]. This complex antagonises the 
activation of NEK2 not by directly dephosphorylating but by mediating the 
dephosphorylation of activated CEP250 to stop the linker fibres dissolution (Figures 5.15B7 














Figure 5.16: Nuclear envelope break-down and recruitment of spindle assembly-regulated 
proteins. A) Nuclear envelop break down and the separation of disengaged parental centrosomes 
heading to opposite positions. B) Cell cycle-regulated kinases that initiate the dissociation of 
centrosome protein CEP55 and the regulation of key microtubule assembly-regulated protein KIF11.  
B1) A MAPK1/CDK1 complex initiates the cascade of phosphorylation of CEP55 that dissociates it 
from the mother centrosome. B2 and B3) Recruitment of protein complex involves in the regulation of 
microtubule assembly. B4) CDK1 and a phosphorylated protein complex composed of NEK6 and 
NEK7 antagonises the inhibition of a NEK6/NEK7 complex that activates or inactivates KIF11. For 












In addition, AURKA is involved in the phosphorylation of CETN1 in the centrosomes 
[352,449]. Following the separation of paired parental centrosomes at G2-phase, the NEBD 
resulting in two separate centrosomes moving to opposite poles of a cell. 
Maturation of the daughter centriole at S/G2 border 
After the disjunction of linker fibres that connect paired parental centrosomes, motor 
proteins involved in the assembly of microtubules are recruited. To prepare the regulation of 
microtubule assembly after centrosome separation in M-phase, protein nuclear mitotic 
apparatus protein 1 (NUMA1) [450], NIN [377,378,451], CETN1 [352], MZT1 [364] and 
KIF11 are recruited (Figures 5.16B2 and B3). Of these proteins involved in the mitotic 
microtubule assembly, the kinesin KIF11 plays a major role in centrosome separation and 
accumulates at spindle poles between G2- and prometaphase (Figure 5.16B2) [452-454].  
Kinase CDK1 and PLK1 determine the activation of KIF11 by directly phosphorylating 
KIF11 and trigging a cascade of phosphorylation stream composed of NEK9, NEK7, and 
NEK6, respectively  (Figure 5.16B4). To prevent the over-accumulation of activated KIF11 
that induce the over extension of microtubules, the complex composed of NEK6 and NEK7 
antagonises the activation of the phosphorylated complex (Figure 5.16B5) [46]. The NEBD 
is finished at the end of prometaphase while disjunctive parental centrosomes complete the 
recruitment of the regulatory proteins involved in the microtubule assembly. 
In combination with MAPK1, CDK1 is then able to catalyse the phosphorylation of CEP55 
located in the mother centrosome, which then activates PLK1 catalysing further 
phosphorylation of CEP55. The phosphorylated CEP55 is then dissociated from the mother 
centrosome, shifting to midbody conducting the physical dividing of cells during the 

















Figure 5.17: Nucleating, anchoring, extension of mitotic microtubule assembly. A) Assembly and 
extending of microtubule to attach sister chromatids. B) Pathway of the recruitment of microtubule-
associated protein complexes leading to the elongation of microtubules. A1 and B2) Proteins ODF2 
and NIN located at PCM and regulate its recruitment A2 and B3) HAUS family for microtubule 
capping and anchoring. B1) Proteins DNAH2 and KATNB1 catalyse the recruitment of a PCNT 
complex for microtubule nucleation. B4) KPNB1 and CEP57/TEK1 complex catalyse the microtubule 
elongation heading to the kinetochore of duplicated sister chromatids. For full scale images please see 












The recruitment of PCNT complex is conducted by dynein axonemal heavy chain 2 
(DNAH2) and katanin p80 subunit B1 (KATNB1) initiating the microtubule nucleating 
(Figure 5.17B1). At the stage of microtubule capping and anchoring, interpolar, astral, and 
polar microtubules are recruited and anchored to the PCM. Protein ODF2 and NIN are 
recruited to mitotic spindle which is anchored to the PCM of the centrosomes (Figures 
5.17A1 and 5.17B2). ODF2 may be involved in the maturation event of daughter centrioles 
and is required for the development of appendages that render a platform anchoring the 
microtubules [349,455-457]. NIN is responsible for the anchorage of microtubules to 
centrosomes [368,377,378]. The family of proteins HAUS1 to 8 are preferentially associated 
with the γ-TuRC complexes in mitosis and localise γ-TuRC complexes to mitotic spindles 
(Figures 5.17A2 and B3) [153,358,359]. Protein CEP57 directly recruits and cooperates 
together with tektin 1 (TEKT1) to trigger the initiation of microtubule elongation localising 
at central spindle as a spindle organiser in cytokinesis [458]. Karyopherin β1 (KPNB1) is 
involved in the microtubule assembly in mitosis (Figure 5.17B4) [459,460].   
Before attaching of extended microtubules to the aligned chromosomes in the metaphase, a 
number of proteins involved in the nuclear distribution pathway are recruited to centrosome 
including protein DCTN1 [334,433,461], NDEL1 [462,463], DNAH2 [464], and platelet-
activating factor acetylhydrolase 1B regulatory subunit 1 (PAFAH1B1) (Figure 5.18B1) 
[464]. These cytoplasmic dynein-regulated proteins are involved in the organization of the 
cellular microtubule array and microtubule, anchoring at the centrosomes [409].  
At metaphase, aligned chromosomes attached by microtubules are transferred to two 
daughter cells. The binding between the kinetochore of chromosomes and the microtubules 
are conducted by cascade of the activated NUMA1 and TPX2 triggering by activated 
KPNB1. TPX2 (i.e microtubule-associated protein) is involved in the regulation of spindle 
assembly [422,465,466]. KPNB1 plays a role in the microtubule assembly [459,460]. Little 
is known of the mechanism that actives the KPNB1. NUMA1 is involved in the regulation of 
microtubules during the mitosis (Figures 5.18A1 and B2) [450]. 
At telophase, sister chromatids attached by microtubules are disengaged after the dissolution 
of cohesion being induced by separase. The cohesin that tethers mother and matured sister 
centrosomes are also dissociated by separase and the phosphorylation of RAD21, which is 











Figure 5.18: Segregation of sister chromatids conducted by mitotic centrosomes. A) Attachment 
of aligned sister chromatids during the metaphase. B) Pathway of nuclear distribution, kinetochore 
attachment, and the dissociation of cohesin complex between paired parental centrosomes. A1 and 
B2) Activation of KPNB1 triggers the activation of TPX2 and NUMA1 that drives the kinetochore 
binding. B1) Recruitment of DCTN1, NDEL1, DNAH2, and PAFH1B1 conducts the microtubule 
elongation toward the attachment of sister chromatids. B3) Separase conducts the dissociation of 
cohensin complex after the phosphorylation of RAD21 catalysed by PLK1. For full scale images 

















Figure 5.19: Cytokinesis and segregated sister chromatids that are equally transferred into two 
daughter cells. A) Segregated sister chromatids are equally shifted to two daughter cells being 
conducted by microtubule retraction at the anaphase. B) Reconstructing on the nuclear envelops in 
two daughter cells at the end of cytokinesis after abscission in midbody. A1 and B1) Linker fibres. For 
the cytokinesis at system level, please see next page. For full scale images please see attached PDF 
file in CD. 
In Figure 5.19, the linker fibre-associated proteins are then recruited with cohesin to replace 
the mother and daughter centrosomes in preparation for further centrosome duplication in 
divided cells (Figures 5.19A1, B1, and C1). Protein fizzy/cell division cycle 20 related 1 
(FZR1) is known to function as a key regulator of anaphase promoting complex (ANAPC) 
[467]. To enter the late stage of M-phase, phosphorylated NEK9 activates the FZR1, leading 
to the activation of ANAPC that conducts the microtubule retraction (Figure 5.19C2). 








microtubule retraction entering the cytokinesis where it physically divides a parental cell into 
two daughter cells. 
C 
 
ANAPHASE TELOPHASE CYTOKINESIS 
Figure 5.19: Cytokinesis and segregated sister chromatids that are equally transferred into two 
daughter cells. C) Pathway of the recruitment of linker fibres and the regulation of abscission in 
midbody at the end of cytokinesis (see next page). C1) Recruitment of linker fibres after the 
dissociation of the cohesion complex. C2) Cascade of activation includes FZR1 and ANAPC that 
triggers the microtubule retraction bring attached chromosomes to the opposite pole. C3) BRCA2 
catalyses the binding of CEP55, programmed cell death 6 interacting protein (PDCD6IP), and TSG1 
conducting the abscission to physically separate cells by the end of the cytokinesis. 
To finish the last stage of cytokinesis, abscission conducts the separating of midbody that 
connect two dividing daughter cells [416]. The midbody provides a platform to regulate the 
cytoskeleton rearrangement, cell membrane remodelling, and other functional protein 
complexes recruited for abscission [416]. Protein BRCA2 mediates the recruitment of 
CEP55, PDCD6IP, and tumour susceptibility 101 (TSG101) to localise at midbody serving 












Expression periodicity of centrosome-associated genes in the pathway map 
To further investigate the regulatory mechanism that conducts the centrosome duplication 
and other associated events at transcriptional level, genes which are overlapped between 
array dataset and centrosome pathway map were highlighted by colours showing their 
expression periodicities at different stages of the cell cycle i.e. genes which are consistently 
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Figure 5.20: Expression periodicity of genes in association with centrosome biology at system 
level. A) Expression profile of genes that are periodically up-regulated or consistently expressed were 
labelled by different colours according to the array dataset in this thesis. B) Expression level of genes 
that consistently expressed throughout the cell cycle. C) Expression level of genes up-regulated during 
G0-phase. D) Expression level of genes up-regulated during G0-phase (red box). E) Expression level 
of genes up-regulated during S-, G2-, and M -phase. Black dashed line represents variation in gene 
expression signal. Details of centrosome regulation at transcriptional and proteomic level were 
summarized in appendix 5.1. Full-scale PDF files are saved in the CD attached. Genes in association 






     Centriole    
 Procentrioles                           G1 : ROCK2 
 S/ G2 /M : NPM1 
 Proximal end  (Cartwheel structure)         
 S/ G2 /M : CENPJ, CEP135, SASS6  
 Distal end  
 Consistent expression : CETN1, ODF1, USP33 
 G1 : POC1B 
 S/ G2 /M : CCNF, CCP110, POC1A, POC5 
 9 symmetrical microtubules   
 Consistent expression : TUBGCP2, TUBGCP6 
 G0 : TUBE1 
 S/ G2 /M : TUBA1B, TUBB3, TUBD1, TUBG1, TUBGCP3, TUBGCP4, TUBGCP5 
 Appendages                                G0 : MAPRE2     
 G1 : MAPRE3, CEP170 
 S/ G2 /M : ODF2, CEP164, CNTRL, MAPRE1, NIN, KIF24 
     PCM   
 Inner layers                         
 G1 : AKAP9 
 S/ G2 /M : CDK5RAP2, CEP120, PCNT 
 Outer layers  
 Consistent expression : CEP63 
 S/ G2 /M : ASPM, CEP152, CEP57, CNN, NEDD1 
 Basement of daughter centriole                                                   
 G1 : PLK2 
 S/ G2 /M : CEP192, PLK4, STIL 
     Basement of mitotic spindle assembly                                               
 Consistent expression : PAFAH1B1 
 G1 : NUMA1 
 
S/ G2 /M : 
HAUS5, HAUS1, HAUS2, HAUS3, HAUS4, HAUS6, HAUS7, HAUS8, 
KIF11 
 Centriolar satellite                                                                              
 Consistent expression : DCTN1 
 G1 : DISC1, BBS4, HOOK3, OFD1, KIZ, CEP90 
 S/ G2 /M : PARD6A, CEP290, CEP72, FOPNL, PCM1 
     Linker fibre                                                                               
 Consistent expression : CROCC, CEP250, CEP68, LRRC45 
 G1 : CTNNB1 
     Cohesin complex                                                                                         
 Consistent expression : STAG3 
 G0 : PP2A, CC2D1A 
 S/ G2 /M : RAD21, SGOL1, SMC1, SMC3, SPAG5, STAG2 
     Cytoplasm 
 Consistent expression : CASS4, CDH1, PPP1CA, PPP1R2, DNAH2, TEKT1 
 G1 : NEK6, NEK9, NDEL1, SAV1, MAPK1, CCNE1 
 
S/ G2 /M : 
ANAPC, CDK1, FZR1, KATNB1, KPNB1, PLK1, TPX2, FBXW5, 
AURKA, NEK2, NEK7, PPP1CC, STK3, CDK2 
     Midbody 
 Consistent expression : TSG101 
 G1 : PDCD6IP 
 S/ G2 /M : BRCA2 
Table 5.2: Expression periodicities of proteins in the pathway map. The expression periodicities of genes 
relevant to the centrosome pathway map are categorised according to the centrosome structure. Genes 
highlighted in red (gene that inhibits the centrosome reduplication), blue, orange, green, and black (consistent 
expression but has not yet been proved to be involved in the inhibition of centrosome reduplication) show their 
position and expression periodicities in centrosome biology. Genes in association with the appendages are only 







Centrosome regulatory network translated in 3D environment 
BioLayout Express3D is a software using network based analysis utilising 3D graphic 
application programming interface (API) OpenGL [112]. BioLayout Express3D provides a 
powerful tool to visualise various type of ‘omic’ data as networks [112]. mEPN diagram 
drawn in yEd can now be integrated into many tools. 
Using BioLayout Express3D, a 2D pathway, which is composed of nodes and edges can be 
viewed in 3D environment. In 3D environment, node walks indicate the parents or children 
nodes allowing the discovery of network connectivity between components.  
The centrosome pathway map in structure and system level was visualised in BioLayout 
Express3D. At system level, a snapshot of centrosome pathway map in 3D shows the nodes, 
edges, and components representing different functional protein complexes (Figure 5.21) and 
the centrosome during interphase and M-phase are also visualised in 3D environment at the 
structural level (Figure 5.22).  The centrosome pathway maps at structure and system level 



















































































































































































































































































































































































































































































































































































































































































































































































































































































Analysis of the localisation of unknown protein in Chapter 4 implicated that a number of 
them (e.g. FAM111B) may have a putative role in the centrosome life cycle. To examine 
their putative positions in the regulatory network of the centrosome-associated proteins, a 
large-scale pathway was developed including 117 important proteins. 
The complex regulatory network of the protein-protein interactions involved in the 
centrosome life cycle is difficult to demonstrate accurately. The entire pathway map includes 
117 proteins i.e. the development of procentrioles, recruitment of microtubule, and the 
redistribution of PCM between mother and matured daughter centrosomes.   
This map gives a clear guide to the structure of centrosome and regulatory system that 
conduct the biological activities following the progression of cell cycle. For example, the 
disjunction of paired parental centrosomes is conducted by a complicated regulatory protein-
protein interaction network (Figure 5.15B). However, the biological event of paired parental 
centrosome disjunction can be simply demonstrated by the red dash line in connection with 
parental centrosomes showing an ongoing process of disjunction. Therefore, demonstrating 
the centrosome-associated biological events as a pathway can enhance the information 
accessibility.    
Construction of a large-scale regulatory network of centrosome-associated 
proteins in the cell cycle 
The aim of constructing a large-scale biological process network is to create a pathway 
resource providing consensus view from literature curation. In order to continuously update 
the role of proteins in the centrosome life cycle, the pathway scheme needs to be designed in 
a way that optimisation and expansion of network structure can be made with updates by 
new publications and research observations. To support the work, the pathway software has 
to be user friendly, easy to access i.e. yEd.  
To find the pathway model using approach that could work the needs of this thesis, a number 
of modelling schemes were evaluated e.g. SBGN and mEPN. The mEPN and SBGN 
schemes both provide similar network structure but different ways to visualise a biological 
processes. Similar concepts are used in the two systems to depict biological process, 





In comparison with SBGN scheme, a number of features in mEPN scheme make it suitable 
for this task. Firstly, for the interactions that are widely distributed in biological processes, 
each unique notation is only depicted once enabling efficient use of space in the pathway 
map. For example, PLK1 is involved in multiple reactions in this pathway map, including 
maturation of daughter centrioles (Figure 5.12), regulation of cohesin between parental 
centrosomes (Figure 5.13), disjunction of paired parental centrosomes (Figure 5.15), etc. 
Secondly, the use of colour and one or two letters to represent biological reactions in the 
pathway map provide enhanced visual accessibility. It is very useful to identify particular 
biological processes within the pathway, such as process nodes ‘B’ for binding with yellow 
colour and ‘Ub’ for ubiquitisation with light blue colour (Figure 5.2C). Thirdly, the 
compatibility of computational simulation in 3D aids in further analysis. Since there is a 
growing market of the computational graphic industries, such as gaming or animation, lots of 
technologies were developed to support the visualisations of data analysis in virtual 3D 
environments. A good case is that BioLayout Express3D is that employs a 3D API 
(Application programming interface) OpenGL, providing powerful platform to analyse 
different types of ‘omics’ data visualised as a network structure [112,113].  
Therefore, BioLayout Express3D can import the pathway map saved as ‘.graphml’ format and 
visualise the file in 2D and 3D. The translation of a pathway map from 2D into 3D 
environment allows the map to be rotated and zoomed in from multiple angles for particular 
biological events of interest (Figures 5.20, 5.21, 5.22, and 5.23). In addition the parent and 
children nodes connected to a node of interest can also be explored in a large-scale pathway 
network in 3D environment as well. This enhances the information accessibility in studying 
the regulatory logic of a protein or gene on interest (Figures 5.21 and 5.23).  
In addition, the power of mEPN scheme is that it can be used to demonstrate not only the 
regulatory network but also the structure of centrosome at different stages in 2D and 3D, 
something not possible with SBGN diagrams (Figure 5.23). Owing to a number of 
advantages discussed above, the mEPN scheme was considered to satisfy the need of 
building a large-scale regulatory network of centrosome with the yEd software [177].  
The genes associated with daughter centriole development are up-regulated; the 
regulatory genes that control the number of centrosomes are consistently 
expressed 
In order to investigate the mechanisms that regulate centrosome biogenesis and duplication 





centrosome pathway map were summarised into a number of groups, according to expression 
pattern and the location of the protein in the centrosome highlighted on the pathway (Table 
5.2 and Figure 5.20).  
There are a total of 33 centrosomal genes, which are up-regulated during the S/G2/M-phase 
duplication (Table 5.2). This includes the centrosome-associated genes involved in the early 
stage of centrosome development, such as SASS6, CCP110, RAD21, and TUBG1. SASS6 is 
involved in the cartwheel structure development, CCP110 is localised at the distal end of 
procentriole that inhibits the over extending centriole structure (Table 5.2) [344,345,381]. In 
addition, RAD21 is localised at the cohesin complex and not only maintains the pairing of 
parental centrioles but also avoids the re-duplication of centrosome [270,414,415], and the 
protein TUBG1 that belongs to γ-TuRC complexes [468].  
For the proteins positioned in the inner and outer layer of PCM, many of their genes are also 
up-regulated in preparation to surround the procentriole such as CEP120 (inner layer of 
PCM) [374,420] and NEDD1 (outer layer of PCM) [358,361-363,469,470] involved in the 
organisation of PCM structure and recruitment of microtubule, respectively.  
Of those genes, which have a cell cycle associated expression pattern as mentioned above, it 
suggests that the proteins are essential for the development of daughter centriole structure 
present only in S-phase. In contrast, consistent expression of these genes may potentially 
increase the possibility of centrosome re-duplication, therefore the nature of their expression 
behaviour only appear to be up-regulated across the G1/S-border (Table 5.2). 
For genes, which are constantly expressed according to the array dataset in this thesis (Table 
5.2). It is interesting that 11 of 18 gens are involved in the regulation of centrosome 
duplication guaranteeing that the centrosomes only duplicate once per cell cycle (Table 5.2).  
It appears that the genes, which are essential for the structural development in centrosome 
duplication, are up-regulated during the G1/S- and S-phase.  
A new module for centrosome duplication and biogenesis that improves the 
current understanding of centrosome biology  
To see whether that this has been proposed previously, further literature review was 
undertaken to provide the current understanding of centrosome biogenesis and duplication. 
The majority of experimental approaches in the last 20 years are mostly aimed to identify the 





structural level of the centrosome biogenesis, duplication, and the regulation of chromosome 
segregation in M-phase [52,337,471-474]. However, they are mainly focused on the 
proteomic level ignoring the mechanism that conducts the regulation between transcriptomic 
and proteomic level [52,337,471-474]. Therefore, little is known about the regulatory logic 
that governs the ‘global scale networks of centrosome biology’ covering the gene expression 
and protein-protein interactions networks.  
To develop a model that can be used to explain centrosome biology, a methodology that 
combines the pathway mapping (i.e. a large-scale centrosome pathway map) and 
transcriptomic analysis (i.e. array experiments that provides time series transcriptomic 
profile) was first introduced in this thesis (Table 5.2 and Figure 5.20). It is interesting that 
the new model suggests a multiple level regulation between transcriptomic and proteomic 














Chapter 6.  
Conclusions 
Overview of major approaches 
The work described in this thesis explores the use of systems-level analyses to identify and 
study a number of novel cell cycle-associated genes. Specifically, the work outlined in 
Chapter 2 described the identification of genes that may function in the cell cycle regulation. 
Identification of cell cycle-associated genes at a transcriptional level has been performed in 
human cells since 1999, where serum deprivation was used to generate synchronised human 
fibroblasts for array analysis. We were able to discover cell cycle-associated genes using 
microarray technology capable of investigating the expression profiles of all human genes in 
parallel. In order to provide samples for two microarray analyses, fibroblasts were selected. 
These cells were selected because they responded to serum-deprivation and arrested at a 
quiescent stage and then re-entered the cell cycle after serum refeeding with at least one 
synchronised cell cycle within 24 hours. In contrast, a transformed cell line THP-1 was 
found to be difficult to get to synchronise by serum stimulation. Furthermore, the cell cycle 
of THP-1 was longer than 24 hours, and it had been suggested that a prolonged period of one 
complete cell cycle was difficult to maintain. For HEK293T, the transfection with the SV40 
virus forces cells to skip G0-phase to enter the cell cycle even after serum deprivation 
suggesting that HEK293T was not an ideal cell type for this experiment either. 
Known cell cycle-regulated genes were initially tested by RT-qPCR. Subsequently two 
repeatable array experiments were performed and analysed by network structure analysis in 
BioLayout Express3D after quality assessment in the R environment. RMA normalisation 
minimised the technical variation between array samples. Animation of the network was 
used to demonstrate that the up-regulation of genes follows the order of a sequence of time 
points from G0- (0 h) to M- phase (24 h). Using GO term enrichment analysis to profile the 
feature of clustered genes in four major groups, a higher proportion of genes placed in the 
S/G2/M-phase cluster were associated with the ‘cell cycle’ term reflecting the re-entry of the 
cell cycle. Results of the network structure analysis identified four major clusters of genes 
including the G0-, the early and late stage of G1-, and S/G2/M-phase. Our group worked on 
categorising a parts list of S/G2/M-phase associated genes suggesting that 78, 69, 75, and 484 






Chapter 3 describes the utilisation of the RTCA system in real time RNAi screening to 
determine the role of targeted genes in dividing cells. The RTCA system is a highly sensitive 
real time cell proliferation monitoring system. Electron sensors arrayed on the plates 
evaluate the number of cell population by detecting the electronic resistance from the lipid 
bilayer cell membrane. This allows the recording of the change in the cell population as CI 
declining was used to determine the effect of gene silencing on cell proliferation.  
In order to find the best conditions for gene silencing with minimal cytotoxicity, that might 
potentially decreased the accuracy of RNAi screening, silenceMagTM, a positively charged 
practice transfection reagent, was used to deliver dsRNA molecules into NHDF cells 
targeting the genes which were thought to be important in cell proliferation in Chapter 2. In 
contrast, liposome conducted transfection was found to arrest cell proliferation according to 
the profile of cell proliferation arrest monitored using the RTCA system. In addition, to 
avoid the off-target effects induced by siRNA mediated gene silencing, esiRNA was used to 
target the genes of interest. SYTOX® blue staining of cells that showed a higher cell 
viability was determined by flow cytometry.   
A total of 42 unknown genes of interest were knocked down by RNAi, and verified by 
qPCR. 16 and 3 of them were classified as activators or regulators after knocking down, 
respectively. The hits on target genes in the RNAi screening were determined by Z-scoring 
cut-off. In addition, a time series of transformed CI over time series as CIGR and CIGR with 
respect to the negative control were used to demonstrate the time point at which there was a 
maximum effect on cell proliferation after transfection.  
Protein localisation described in Chapter 4 was performed using HEK293T cells to 
determine their role in the cell proliferation. To provide an effective expression system, 
selected genes in chapter 3 were expressed in HEK293T cells using Gateway cloning 
technology. To demonstrate the control of proteins localisation, centrosome-regulated 
proteins e.g. CEP55, CEP57, CEP85, and CPM1 were expressed. The comparison between 
proteins of interest and control demonstrated similar localisation pattern implying their 
potential involvement in centrosome regulation e.g. FAM111B. 
In order to conclude the discovery of the genes that may potentially have a putative role in 
centrosome regulation, a large-scale pathway network was constructed. A total of 117 
proteins known to be important to the centrosome were included in the pathway. The 





proteins for procentriole development, redistribution of PCM during the procentrioles 
maturation, and disjunction of paired parental centrosomes serving for duplicated sister 
chromatids segregation across the entire cell cycle.  
Chapter 5 also summarises the regulation network of the centrosome pathway map at a 
transcriptional level as determined by the microarray dataset. It is known that to avoid the re-
duplication of daughter centrioles, which may lead to unequal segregation of duplicated 
centrosomes, it is important to maintain the pairing of parental centrosomes by regulation at 
the transcriptional level. To avoid the over development of procentrioles, the genes encoding 
proteins, which are involved in the development of daughter centriole structure, are 
periodically expressed. In contrast, for proteins which are involved in the inhibition of 
daughter centriole re-duplication, the majority of their genes are consistently expressed. This 
concept of a regulatory mechanism has not been suggested before. 
To further testify the originality of this hypothesis, literature review was performed. 
However, the majority of experimental approaches are mainly focused on the structure level 
of centrosome biology. In contrast, the strategy that uses the pathway map to investigate the 
regulation mechanism at transcriptional level here is first used in this thesis. 
In summary, two genes of interest (i.e. FAM111B and KIAA1549L) have been identified that 
they may have putative roles in the centrosome biology using array analysis, RNAi 
screening, and a large-scale pathway map. In addition, a new module that improves the 
understanding of centrosome biology was first discovered showing that the mechanism 
which controls the centrosome duplication may be involved in multiple levels of gene 
expression behaviour. Literature review suggests that this a new methodology first used here. 
Challenges 
The challenge in this project has been to use different methodologies including cell cycle 
synchronisation follower by array analysis, RNAi screening, and pathway mapping to 
investigate the cell cycle associated transcription. 
In order to provide the samples for transcriptomic analysis, in which the cellular regulation at 
transcriptional level reflects the nature of cell physiology, the first challenge was to choose 
non-chemical dependent techniques as it has been suggested that the off-target effects of 
chemical components may induce non-specific biological events. Of those non-chemical 





use of primary cells line can profile the gene expression periodicities as it has been suggested 
that the cell cycle-associated genes in transformed cell lines are mostly over expressed.  
There are two array experiments in this work, where the time series datasets are at different 
intervals. It is difficult to adopt conventional statistical analysis identifying the gene 
expression without enough number of repeats. In doing so, we introduce the network based 
analysis using BioLayout Express3D. This allows us to cluster the gene of interest.  
However, the complexity of various annotations highlighted the difficulty in integrating the 
information, e.g. UniPort and ENSEMBL ID.  Therefore, one of the biggest challenges is to 
systematically categorise the gene clusters. To provide a solution, Freeman’s group equally 
share the work of manual curation and annotation of a large number of clustered genes 
finalizing into a list of 706 genes in association with the cell biology during S/G2/M-phase. 
Of these 706 genes, 42 of the most interesting were selected for further analysis as literature 
mining suggest that were not previously associated with in the cell cycle. To test whether 
they are important in the cell proliferation, the RNAi screening was used to see the loss of 
function effect on cell division using RTCA system. However, a number of elements may 
affect the results of RNAi screening e.g. the liposome dependent transfection that arrests the 
cell proliferation and the off-target effects induced by siRNA components. To minimize the 
artifacts, the solution is to use magnet-assisted transfection delivering esiRNA components 
avoiding cytotoxicity of liposome-based reagents and to dilute the off-target effects of 
siRNA components. The result of RNAi screening identified 19 genes which appear to play 
important role in cell proliferation. 
To further investigate the genes identified by RNAi, their protein products were localized 
using GFP tags in the cells. In this thesis, fibroblast cells were used for the array analysis and 
RNAi screening. However, transfection efficiencies in fibroblast cells were poor. In contrast, 
the subcellular protein localisation in HEK293T cells shows robust transfection efficiency. 
Therefore, the HEK293T were chosen for the experiments. The result of subcellular protein 
localisation studies suggests that the protein products of FAM111B and KIAA1549L are 
localised to the centrosome. 
Encouraged by this approach, literature mining of centrosome-associated proteins was 
carried out predicting their putative roles in the centrosome biology. However, the majority 





relevant to centrosome biology. To provide integrated information of centrosome biology 
from global aspects, a large-scale pathway model was developed including the protein-
protein networks that comprise of centrosome biogenesis, duplication, and the mitotic 
activities.  
As the pathway is highly complicated, it was a challenge to illustrate the biological events at 
system level where the network composed of components (i.e. proteins) and edges (i.e. 
direction of biological events). Therefore, the best solution was to draw a flowchart at a 
structure level, where the change in centrosome structure at different stages. It is interesting 
that the centrosome biology at transcriptional level can be summarised into different patterns 
according to their localisation in the centrosome structure. The majority of regulators that 
control centrosome numbers are consistently expressed. In contrast, the genes that 
periodically expressed mostly play essential roles in daughter centriole duplication e.g. gene 
of the cartwheel structure-associated proteins are up-regulated in S/G2/M-phase. 
Future work 
In future plan, we would like to screen the rest of cell cycle clustered genes identified in our 
array dataset, identifying more putative genes that may be involved in cell division. Genes 
that appears to be involved in cell division will be co-localised with the known cell cycle-
associated protein in the cell cycle, e.g. gamma-tubulin.  
Encouraged by the success of using a pathway map we are able to better understand the 
regulatory mechanisms governing the centrosome-associated protein at transcriptional level, 
a full scale protein-protein interaction pathway that covers the cell cycle will be developed in 
combination with our array dataset to investigate the mechanisms that drive the cascade of 
cell cycle events. The computational simulation will be carried out to predict the regulation 
behaviour of protein of interest according to the result of RNAi screening and subcellular 
protein localisation. 
Overall, each of the chapters was organised following a logical flow in providing evidence to 
further investigate the putative function of novel genes associated with cell proliferation. The 
centrosome regulatory network analysis provided a global scale for interpreting centrosome 
regulation at a transcriptional level. Further evidence and pathway modelling of putative 
novel cell cycle-associated genes is needed to fill in the last pieces of information to 





such models will be able to provide predictive power to identify protein function based on 
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Appendix II. R source code used for between Array normalisation and annotation. 
    
 R command lines 
 After: 
Appendix 
Source code for R x64 3.0.1 with oligo version 1.24.2 
 








# Annotation of transcripts using 
packages from Affymetrix 







# Reorganise terms for transcripts 
annotation using R function 


































cels <- list.celfiles() 
celfiles <- read.celfiles(cels) 
celfiles.norm <- rma(celfiles) 
eset <- as.data.frame(exprs(celfiles.norm)) 
eset[,c(1:40)] <- 2 ** eset[,c(1:40)] 




symbols <- mget(probe, hugene11sttranscriptclusterSYMBOL, 
ifnotfound=NA) 
entrezids <- mget(probe, 
hugene11sttranscriptclusterENTREZID, ifnotfound=NA) 
descriptions <- mget(probe, 
hugene11sttranscriptclusterGENENAME, ifnotfound=NA) 
eset$Symbol <- unlist(symbols) 
eset$EntrezID <- unlist(entrezids) 
















GO <-sapply(contents(hugene11sttranscriptclusterGO), paste, 
collapse=", ") 








sapply(data.frame(GO2ALLPROBES_2), paste, collapse=", ") 
GO2ALLPROBES <-
sapply(contents(hugene11sttranscriptclusterGO2ALLPROBES), 














# Annotate transcripts using R 















# Save files as ‘.csv’ format for 
further analyses. 
 


















paste, collapse=", ") 
PFAM <-sapply(contents(hugene11sttranscriptclusterPFAM), 











































































Appendix III Centrosome duplication cycle. This figure is courtesy of Atlas of Genetics and 
Cytogenetics in Oncology and Haematology [475]. 
 
